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Abstract 
Characterization of changes in glia-related protein expression following a history of 
excessive cocaine taking. 
by 
Sierra M. Webb 
 
 The majority of addiction research examining the brain has centered on neuronal 
adaptations both resulting from cocaine use and contributing to the development of addiction. 
However, neurons constitute a small minority of the total cells within the central nervous 
system (CNS) and the role of glial cell types, which make up the vast majority of CNS cells, 
in cocaine addiction is largely unexplored. Imaging studies have revealed white matter 
deficits within the corpus callosum and post-mortem tissue analysis has revealed decreased 
oligodendrocyte-specific protein expression within the brains of chronic cocaine users. The 
extended access (6h/day) cocaine self-administration paradigm conducted in rodents is used 
to model the escalation of cocaine intake seen within human cocaine users and is critical for 
gaining insight to the molecular adaptations that result from excessive cocaine use. The series 
of experiments detailed in this dissertation utilize this model to address three specific aims: 
(1) characterize changes in glial-specific proteins and mRNA expression in cortical and 
limbic brain regions of rats with a history of extended access cocaine self-administration, (2) 
characterize the behavioral consequences of decreased myelin basic protein on a variety of 
prefrontal cortex-dependent tasks that are impaired following a history of cocaine use, and 
(3) to determine the functional significance of decreased myelin basic protein expression on 
behavioral measures in an animal model of cocaine addiction, including the acquisition and 
maintenance of intravenous cocaine, dose sensitivity, as well as the extinction and 
	  viii	  
reinstatement of drug-seeking. Taken together, the experiments detailed herein provide 
further support for an enduring effect of cocaine on the expression of glial-specific proteins 
within the forebrain and highlight a role for myelin basic protein within the ventromedial 
prefrontal cortex in regulating impulsive choice, but not other cocaine addiction- related 
behaviors. 
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“…the user is gripped by a visceral emotional state, experiences a highly focused incentive to 
act, and is remarkably unencumbered by the memory of the negative consequences of drug 
taking.” 
(Childress et al., 1999) 
 
1.1 Human Cocaine Addiction 
1.1.1 Prevalence of Cocaine Addiction 
 Cocaine addiction is a chronic disorder characterized by drug craving, compulsive 
drug-seeking and persistant drug-taking behavior despite serious negative consequences 
(Camí & Farré, 2003). In 2013, the National Survey on Drug Abuse and Health for 2010-
2012, was published revealing 1.1 million Americans are either dependent upon or abuse 
cocaine and 16.5% of adults aged 26 and older have used cocaine in their lifetime (Substance 
Abuse and Mental Health Services Administration, 2013a). Of the 656,025 estimated 
emergency room visits for illicit drug use in 2011, over 40% were for cocaine-related adverse 
reactions including convulsions, hyperthermia, and sudden cardiac death (Dietrich, 2009; 
O’Leary & Hancox, 2010; Substance Abuse and Mental Health Services Administration, 
2013b). Highlighting the importance of the substance use/abuse problem within the United 
States, of those 23.1 million Americans who needed treatment in 2012, only approximately 
2.5 million (~1%) received treatment in a specialized facility (Substance Abuse and Mental 
Health Services Administration, 2013a). High rates of relapse, even after extended 
abstinence, and the lack of effective treatment for cocaine addiction remain significant 
obstacles to recovery. While much knowledge has been gained through human 
neuropsychological testing, imaging and animal models of addiction, there are currently no 
approved pharmacotherapies for cocaine addiction. 
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1.1.2 Cocaine Associated Cognitive Deficits in Humans 
 Higher organisms are driven by internal motivational states that are kept under 
control by the inhibitory mechanisms of the frontostriatal regions, which augment behavior 
to allow for the attainment of far-removed goals (Jentsch & Taylor, 1999; Miller, 2000). 
Dysfunction of this frontostriatal system is thought to reduce inhibition on underlying reward 
circuitry, allowing habitual or compulsive drug-seeking and taking to continue despite the 
increase in personal and social costs (Everitt & Robbins, 2005; Jentsch & Taylor, 1999). 
Chronic cocaine intake results in impaired prefrontal cortex (PFC) function, resulting in 
deficits in executive processes such as behavioral inhibition and/or impulsivity, working 
memory, and decision-making (Antoine Bechara & Damasio, 2002; Jentsch & Taylor, 1999). 
However, some of these deficits are apparent in individuals prior to beginning their drug 
intake and predict, to some extent, future substance abuse. Block, Erwin, & Ghoneim (2002) 
have shown that performance on the fourth grade Iowa Test of Basic Skills is poorer for 
individuals who later develop major substance abuse problems. Additionally, individuals 
who later develop stimulant use perform poorer than alcohol or polydrug users. When these 
same individuals were tested in early abstinence, stimulant users performed more poorly than 
controls and other substance users on tests of verbal and mathematical skills and abilities, 
abstraction ability, verbal memory and imagery, even after controlling for premorbid 
cognition, and these deficits failed to improve even after 3 months of abstinence.  
Chronic cocaine users show behavioral inhibition deficits as measured by a go/no-go 
task, whereby they have a decreased probability of inhibiting a response on a stop-signal and 
a slower reaction time to the stop signal than controls, even when showing similar reaction 
times to go-signals and an equivalent number of choice errors (Fillmore & Rush, 2002). 
Additionally, current and abstinent cocaine users discount monetary rewards at a steeper rate 
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than control participants and alcohol abusers, suggesting a higher propensity to make 
impulsive choices of smaller immediate rewards while forgoing larger delayed rewards (Heil, 
Johnson, Higgins, & Bickel, 2006; Kirby & Petry, 2004). 
 Imaging studies utilizing fMRI and PET technologies corroborate executive 
functioning deficits with alterations in neural activity in cocaine users. Castelluccio, Meda, 
Muska, Stevens, & Pearlson (2014) used BOLD fMRI to reveal hyperactivity in Brodman’s 
areas (BA) 25 (cingulate gyrus, pregenual) and 40 (lateral agranular/supramarginal gyri) in 
response to no-go signals on the go/no-go task in current cocaine users, compared to drug-
free participants. Interestingly, hyperactivity negatively correlated with self-reported 
measures of impulsivity, indicating that cocaine users with higher behavioral impulsivity 
have lower neural activity associated with omitting a go response when a no-go signal is 
present. In another go/no-go task by Kaufman, Ross, Stein, & Garavan (2003) cocaine users 
made significantly more errors of omission and commission than healthy controls, and 
exhibited significantly less activation of the anterior cingulate cortex (ACC; BA 32) for 
successful and failed inhibitions for stop signals. However, they did not differentiate between 
left and right ACC activation, and previous authors have found discrepant activation based 
on laterality (Kaufman et al., 2003). The right ACC (BA 32) has also been shown to have 
increased activity, while the left ACC and lateral PFC have decreased activity in response to 
word-color conflicts in a modified Stroop task conducted in 23-day abstinent cocaine users 
compared to controls (Bolla et al., 2004). Moreover, decreased activity in the dorsal ACC for 
error signals in both male and female cocaine users predicted relapse (Luo et al., 2013). 
Although, these studies do not necessarily replicate each other, a consistent trend is altered 
function of the PFC of cocaine users and recovering addicts compared to healthy controls. 
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 The neuropsychological tests of delayed non-matching to sample (DNMS) and 
various gambling tasks are sensitive to damage to the the dorsolateral and ventromedial PFC 
(dlPFC and vmPFC, respectively) (GT), respectively. These tests are not only useful in 
distinguishing the area of prefrontal damage, but also in detecting decreased function in 
relation to substance use. Bechara & Martin (2004) studied working memory and decision-
making in individuals with substance dependence using a DNMS and GT. Compared to 
healthy controls, individuals abusing alcohol and stimulants (methamphetamine and/or 
cocaine) made a lower percentage of correct responses across all delay time points on the 
DNMS and chose more cards from the disadvantageous decks in the GT. Consistently, 
individuals abusing alcohol and stimulants perform more poorly on decision-making tasks 
(e.g. the GT) than controls, but not as poorly as individuals with lesions in the vmPFC, 
indicating a dysfunction of the vmPFC without complete loss of function (Bechara et al., 
2001; Bechara & Damasio, 2002). Moreover, lesions of the dorsomedial PFC or dlPFC do 
not show this same deficit, revealing this process is dependent on a functional vmPFC 
(Rogers et al., 1999). One study did find similar impairments in decision-making for 
individuals with vm- or dl-frontal lobe damage on the Iowa Gambling task when the large 
reward cards were placed first, followed by large losses later in the deck (Fellows & Farah, 
2005). When the cards were shuffled so that large losses were experienced before large wins, 
eliminating the need for reversal learning, only those patients with dm-frontal lobe damage 
continued to show impairments in decision-making, suggesting vm-frontal lobe patients may 
have a deficit in reversal learning and not overall problems with decision-making per se. 
Lastly, Ernst et al. (2002) has shown activation of the “anterior cingulate cortex” (BA 32 and 
	  6	  
24) during the GT of normal healthy subjects, which is interesting given the vmPFC, and not 
more dorsomedial PFC, lesions lead to deficits in this task. 
 Consistent with the cognitive deficits seen in substance abusers, imaging studies 
reveal altered metabolic rates of brain areas controlling executive function and implicated in 
addiction processes in a variety of cued studies to elicit craving (Grant et al., 1996; Volkow 
et al., 1999). In drug-free states, glucose utilization measured in positron emission 
tomography (PET) studies reveal an increase in the orbitofrontal cortex (OFC; both whole 
OFC and medial component of the OFC) in a control condition where non-drug stimuli are 
presented to cocaine users compared to the activity of control participants, and under baseline 
scanning conditions (Grant et al., 1996; London, Ernst, & Grant, 2000; Stapleton et al., 
1995). Additionally, in studies using drug-associated stimuli or acute administration of the 
stimulant methylphenidate, enhanced glucose utilization is seen in the OFC and is correlated 
with self-reported craving (Grant et al., 1996; Volkow & Fowler, 2000; Volkow et al., 1999; 
Wang et al., 1999). Acute administration of cocaine in cocaine-dependent individuals leads 
to enhanced blood-oxygen level dependent (BOLD) functional magnetic resonance imaging 
(fMRI) signal activity in the lateral frontal cortices and medial frontal cortex (BA 32) 
(Breiter et al., 1997). The activity increases in the PFC were also correlated with subjective 
ratings of “rush”. 
 Several regions of the human PFC have an integral role in cocaine addiction, 
however, inconsistent findings could partly result from differences in how the brain was 
“sectioned” to compare for differences in function. The following sections will discuss the 
correspondence between different PFC regions in the human and rodent brains, and highlight 
the importance of clear definitions and consistency of naming conventions when making 
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connections between animal models of addiction-related behaviors and relating those 
findings to the human condition. Regardless, given the overwhelming evidence from clinical 
studies implicating the importance of the PFC in executive function and addiction, and 
consistent alterations in activity following cocaine abuse, the focus of this dissertation will be 
on the role of the corresponding rat PFC in cocaine-taking, -seeking, and cognitive deficits 
resulting from cocaine-induced changes in physiology. 
1.2 Ventromedial Prefrontal Cortex Circuitry 
1.2.1 Defining the vmPFC by reciprocal connectivity with the mediodorsal nucleus of 
the thalamus 
 The vmPFC is defined by the reciprocal connections with the mediodorsal (MD) 
nucleus of the thalamus and contains the prelimbic (PL) and infralimbic (IL) subregions 
(Conde, Maire-lepoivre, Audinat, & Crepel, 1995; Hoover & Vertes, 2007; Rose & Woolsey, 
1948; Takagishi & Chiba, 1991; Uylings & van Eden, 1990). A common feature of many 
neural networks is a topographical organization of inputs and outputs, as seen in sensory 
input from the retina through the thalamus and into the primary visual cortex (Bear, Connors, 
& Paradiso, 2007) Likewise, the MD thalamic projections to the PFC are organized in a 
lateral to medial projection onto the dorsal to ventral medial PFC, though there is overlap 
concerning the input to the medial agranular frontal cortex (AGm) (Hoover & Vertes, 2007; 
Uylings & van Eden, 1990). Retrograde tracing studies in rat using fluorogold show almost 
exclusive input of the ventromedial MD of the thalamus to the IL; central MD of the 
thalamus input to the PL, lateral MD of the thalamus input to the ACC; while the AGm 
receives input from the extent of the MD of the thalamus (Hoover & Vertes, 2007).  
 Similar findings have been observed using non-human primates where reciprocal 
connections are found with the medial magnocellular portion of the MD of the thalamus 
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(MDmc) and Brodman’s areas 11-14 (OFC), area 25 (approximately the IL in rat), area 32 
(approximately the PL in rat), and ventral portions of area 24 (approximately the ventral PL 
in rat) (Giguere & Goldman-Rakic, 1988; Uylings & van Eden, 1990; Wise, 2008). 
Interestingly, this shift of medial MD thalamic projections to ventral portions of the OFC in 
primates is also reflected in a shift in the medial PFC efferents to the ventral striatum, in 
comparison to the pattern seen in rodent connectivity (Wise, 2008).   
 The vmPFC of rats has reciprocal projections to the MD of the thalamus; anterograde 
tracers into the IL of the rat almost exclusively labeled the medial portion of the MD of the 
thalamus with a shift to the central division of this nucleus for injections encompassing the 
dorsal IL and ventral PL (Takagishi & Chiba, 1991). Likewise, a further shift in injection site 
dorsally (dorsal PL and ACC), reveals terminals in the central to lateral divisions of the MD 
of the thalamus (Uylings & van Eden, 1990). In both non-human primates and rodents, the 
PFC is reciprocally connected with many other thalamic nuclei, though to a lesser degree 
than the MD, including the anteromedial, central lateral, central medial, interanteromedial, 
paracentral, paratenial, paraventricular, nucleus reuniens, rhomboid, and ventromedial 
(Heidbreder & Groenewegen, 2003; Hoover & Vertes, 2007). 
1.2.2 vmPFC Connectivity with Other Brain Reward Centers 
 The vmPFC is intimately connected with many brain areas known to be involved in 
various aspects of goal-directed and addiction related-behaviors, including the ventral 
striatum (VS), basolateral amygdala (BLA), ventral tegmental area (VTA), ventral pallidum 
(VP), and interconnections with prefrontal cortical areas (Kalivas & Volkow, 2005; 
Tzschentke, 2000).  Cortico-cortical efferent projections of the IL innervate the medial 
orbital cortex, PL, IL, ventral agranular insular area, piriform, entorhinal, perirhinal, and to a 
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lesser extent, the ACC; the PL innervates the same targets, often in more dorsal aspects 
(Barbas & Pandya, 1989; Heidbreder & Groenewegen, 2003; Hoover & Vertes, 2007; 
Takagishi & Chiba, 1991). The vmPFC is reciprocally connected with the BLA, a region 
known to be involved in reinforcer valuation and the ability of conditioned stimuli to guide 
behavior (Hoover & Vertes, 2007; Jentsch & Taylor, 1999; Takagishi & Chiba, 1991). 
Additionally, the vmPFC has reciprocal connections with VTA dopamine (DA) neurons, a 
cell group that also sends projections to the nucleus accumbens (NAc) (Carr & Sesack, 
2000). This mesoaccumbens DA projection from the VTA to the NAc is a key element in the 
generation of reward and goal-directed behavior (Tzschentke, 2000).  
 A distinct difference becomes apparent when examining the vmPFC efferents to the 
ventral striatum in the rat, compared to tracing studies of the Macaque monkey. Tracing 
studies in rat reveal a dorso-ventral gradient of outputs to the lateral to medial subregions of 
the NAc, respectively (Gorelova & Yang, 1997; Sesack, Deutch, Roth, & Bunney, 1989; 
Takagishi & Chiba, 1991).  Rostral-caudal and dorsal portions of the PL send a majority of 
their projections to the core of the NAc, while ventral PL and IL send the majority of their 
efferents to the shell of the NAc. However, there is not a distinct division, and all regions 
send some efferents throughout the extent of the NAc. In line with this dorsal-ventral, lateral 
to medial trend, the IL also sends a dense projection to the medial olfactory tubercle, the 
most ventral region of the ventral striatum and also a region involved in reward (Ikemoto & 
Donahue, 2005; Sesack et al., 1989; Takagishi & Chiba, 1991). Anterograde tracer injections 
into various subregions of the orbital cortex only reveal sparse labeling in the NAc core 
(from the ventral orbital area) and the most lateral part of the NAc shell (from ventral lateral 
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and lateral orbital injections), while the densest projections are throughout the caudate-
putamen (CP) (Schilman, Uylings, Galis-de Graaf, Joel, & Groenewegen, 2008). 
 In the non-human primate, the division of afferents to the ventral striatum occurs 
more ventrally and laterally in portions of the OFC. Retrograde tracer injections into the NAc 
shell reveal dense labeling in areas 32 and 25 (approximately the PL and IL in rat); into the 
NAc core labeling occurred in orbital areas 11-14 and areas 32 and 25 (Haber, Kunishio, & 
Mizobuchi, 1995). Similarly, Ferry, Ongür, An, & Price (2000) found areas 32 and 14r to 
project to the CP and NAc core, while area 25 was the only region to project to the NAc 
shell, along with similar projections to the CP and NAc core. These authors suggested a 
“medial” and “orbital” network of prefrontal-striatal projections, rather than a strict division 
based upon BAs; this is consistent with the medial MD thalamic projection fields in the 
mPFC expanding ventrally in the primate to encompass portions of the orbital cortex, and 
points to a similarity of connections between the rodent and primate mPFC.  
1.2.3 Homology Considerations From Primate to Rodent PFC 
Conclusions drawn based on research across species, without a consideration of 
homology of brain regions of interest, has the potential to lead to misconceptions about the 
function of those areas. Campbell & Hodos (1970) proposed a list of principles for inferring 
homology among brain regions across species, including afferent and efferent connections, 
topography, topology, cytoarchitectonic characteristics, electrophysiological properties, 
immunocytochemical properties, and embryologic development.  While the primate and 
rodent fiber connections between the MD of the thalamus and the medial PFC are quite 
similar, differences do arise in the OFC of the primate and rat in regards to efferent 
projections to the NAc. Additionally, the cytoarchitectonic features of these two species 
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differ across medial and orbitofrontal areas. The rodent PFC only includes allocortex and 
agranular cortex, the later encompassing the PL and IL found on the medial surface (Wise, 
2008). This is in contrast to the macaque and human PFC, which includes various types of 
granular cortex (Wise, 2008). Taking these architectonic features into consideration, IL, PL, 
agranular insular, agranular orbital, and ACC cortices in rats have presumed homologous 
regions in primates (Wise, 2008). The areas of the primate OFC (BA 14) that similarly 
projected to the NAc core, could have some functional similarities with the ventral orbital 
cortex in rat; an area with minor input to the NAc core. Other areas of the primate OFC, 
including 11-13, are defined as dysgranular cortex and most likely evolved later in primate 
evolution (Wise, 2008). Therefore, outside the presumed homologous areas discussed, 
conclusions drawn across species for other brain areas must be done with care.  
Caution must also be taken when drawing inferences from human imaging data using 
generalized terminology for large areas of the brain. Examples of such inconsistent 
terminology include naming of parts of BA 10 as medial PFC, which only include granular 
tissue, compared to other references of mPFC that include ACC, PL and IL cortices (Hare, 
O’Doherty, Camerer, Schultz, & Rangel, 2008; Sanfey, 2007). Many imaging studies will 
refer to OFC activity without distinguishing medial from lateral activation, an important 
distinction considering the differences in connectivity with other limbic structures. Bechara, 
Damasio, Tranel, & Anderson (1998) use the “ventromedial prefrontal cortex” in reference to 
ventral and low mesial areas of the frontal lobe of humans with major input to the limbic 
system and those structures processing reward and punishment; areas including ventral BA 
32 & 24 (ACC), BA 25 (IL), BA 11, 13 and 14 (medial OFC) (BA references, Wise, 2008). 
This definition coincides well with the tracing studies, as well as with areas that are 
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presumably homologous to rodents, and therefore accessible for study in this species. Taking 
into consideration the similarities between the human, non-human primate, and rodent 
vmPFC, and the human evidence of dysfunction within this brain area following prolonged 
cocaine use, the target of study for this dissertation is the vmPFC of the rodent as defined at 
the beginning of this section.  
1.3 The vmPFC in Pre-clinical Studies of Reward 
 A variety of experimental methods and animal models have been employed to 
elucidate the functions of the PFC in reward and addiction, with the understanding that the 
human PFC has evolved to a greater extent than that of non-human primates and rodents.  
Three paradigms are commonly used to assess the importance of brain areas in reward and 
whether drugs or treatments have rewarding properties: self-stimulation, conditioned place-
preference, and self-administration (Tzschentke, 2000) and the current status of our 
knowledge regarding the role for the PFC in reward processing are summarized below.  
1.3.1 Self-stimulation studies of the PFC 
 The classic demonstration of Olds & Milner (1954) that rats will learn to self-
stimulate discrete regions of the brain provided the basis for using this approach to delineate 
the neurocircuitry of reward behavior. Some of the first studies to reveal a role of the PFC in 
goal-directed or reward behavior came from self-stimulation studies conducted in rodents. 
Sites that sustain self-stimulation include the PFC (especially the PL-IL interface), MD of the 
thalamus, medial forebrain bundle-lateral hypothalamus, VTA, locus coeruleus (LC), and 
periaqueductal grey (PAG); all of which have connections with the PFC and most 
connections being reciprocal (Mora & Cobo, 1990; Mora & Ferrer, 1986; Vives, Morales, & 
Mora, 1986). Additionally, lesions to the VTA, MD of the thalamus, CP, and BLA all 
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decrease self-stimulation of the PFC in rats (Ferrer, Cobo, & Mora, 1987; Phillips & Fibiger, 
1978; Vives et al., 1986), indicating an important role for these efferents in regulating 
reward-related processing within PFC.  
 The VTA is known to supply DA to both the PFC and other reward-related structures 
(e.g. NAc) and lesions within the VTA or depletion of DA terminals within the mPFC result 
in a significant decrease in self-stimulation behavior (Phillips & Fibiger, 1978; Vives et al., 
1986). Self-stimulation of the medial PFC also enhances the activity of VTA DA neurons 
and causes an elevation of extracellular levels of DA in the NAc (You, Tzschentke, Brodin, 
& Wise, 1998). Dopamine release into the NAc from VTA afferents initially results from the 
experience with a rewarding drug, and subsequently transfers to cues that predict the delivery 
of reward (Jacobs, Smit, de Vries, & Schoffelmeer, 2003; Kalivas et al., 2005). Additionally, 
drugs that are thought to produce their rewarding effects through the mesolimbic DA system 
also enhance the rewarding effects of mPFC self-stimulation (Tzschentke, 2000). McGregor, 
Atrens, & Jackson (1992) found that a single systemic injection of cocaine enhanced mPFC 
self-stimulation rates under a FI-5 schedule of reinforcement by an average of 269%; 
enhanced responding continued for 48hrs after the single cocaine administration, and medial 
PFC self-stimulation was dependent on DA D1 receptors as shown by attenuated self-
stimulation after the administration of a D1 receptor antagonist.  
 Rats withdrawn from extended non-contingent and contingent administration of 
cocaine show an increased resting membrane potential and lack of the characteristic bistable 
neuronal membrane property within the mPFC (Trantham, Szumlinski, McFarland, Kalivas, 
& Lavin, 2002). However, the PL neuronal response to intravenous (IV) cocaine self-
administration is heterogeneous. PL neurons respond by excitatory or inhibitory anticipatory 
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responses to lever-presses for cocaine infusion, exhibit either excitation or inhibition 
following cocaine infusion, or exhibit no change in the firing rate related to anticipatory 
behavior or cocaine being on-board (Chang, Janak, & Woodward, 1998; Chang, Sawyer, 
Paris, & Kirillov, 1997).  Thus, cocaine not only enhances self-stimulation in the mPFC, but 
over time, it alters the excitability of these neurons and affects the PL in a heterogeneous 
manner. 
1.3.2 Conditioned Place Preference Studies of the PFC 
 The majority of studies examining mPFC and reward have used self-stimulation and 
self-administration methods, but a handful of conditioned place-preference (CPP) studies 
have supported the role of this region in reward. In the CPP paradigm, the motivational 
properties of a drug or some other reinforcing treatment are paired with a neutral set of 
environmental stimuli, while a control treatment is paired with a distinct set of neutral 
environmental stimuli (Tzschentke, 2007). Over the course of repeated pairings of 
reinforcing treatments with their respective environments, these environmental stimuli can 
acquire secondary motivational properties such that they can elicit approach or withdrawal 
when then animal is subsequently exposed to them in a “treatment-free” state (Tzschentke, 
2007). An example of such conditioning is demonstrated by electrical stimulation of the PL 
in rats, which results in preference for the side of the testing chamber paired with the 
rewarding stimulation; this effect is dependent on DA as the drug haloperidol dose-
dependently blocked preference for the stimulation-paired side (Duvauchelle & Ettenberg, 
1991).   
 In regards to conditioning with cocaine, one must be cognizant of methodological 
differences as the dose administered, number of pairings, length of time for each pairing, the 
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time between administration of drug and placement into the conditioning chamber, and the 
time of day testing occurred, can result in either CPP or conditioned place-aversion (CPA) 
(Tzschentke, 2007). Brabant, Quertemont, & Tirelli (2005) administered either 4, 8, or 12 
mg/kg intraperitoneal (IP) injections of cocaine to mice and immediately placed them in the 
conditioning chamber for 20 minutes with 1, 2, or 4 total pairings. While all doses elicited a 
CPP for the drug-paired side of the chamber, a minimum of 2 pairings was necessary to show 
a preference, with 4 pairings showing the strongest effect. However, a delay of 15, but not 5, 
minutes between a 0.75 mg/kg IV cocaine injection and placement in the conditioning 
chamber for a 5-minute session results in a significant CPA (Ettenberg, Raven, Danluck, & 
Necessary, 1999). Mice administered 10 mg/kg (IP) of cocaine and immediately placed in the 
conditioning chamber for 30 minutes showed a clear CPP when testing was conducted during 
the day, but the conditioned reward was significantly diminished when testing was conducted 
at night (Kurtuncu, Arslan, Akhisaroglu, Manev, & Uz, 2004). 
 Taking the above methodological differences into consideration in addition to 
differences in the size, location and technique used to lesion the mPFC, the majority of CPP 
studies have shown inconsistent results with respect to its role in regulating drug reward. 
Isaac, Nonneman, Neisewander, Landers, & Bardo (1989) lesioned large portions of the ACC 
and PL by aspirating tissue and found that this manipulation promoted the development of a 
CPA elicited by 6 pairings of 5 mg/kg subcutaneous cocaine with immediate placement into 
the apparatus for 20-minute sessions, while this conditioning procedure elicited a CPP in 
sham-lesioned controls. Thus, large lesions of the more dorsal aspects of the mPFC appear to 
promote the aversive properties of cocaine. In contrast, animals with lesions to the orbital or 
precentral frontal cortex exhibited neither CPP nor CPA in this study, indicating that these 
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regions are important for the manifestation of cocaine’s rewarding properties. Other studies 
found more specific lesions of the PL, using quinolinic acid to damage cell bodies but spare 
fibers of passage, to attenuate cocaine CPP, without eliciting CPA. Specifically, three 
cocaine (15 mg/kg, IP) injections immediately followed by 40 minute conditioning sessions 
resulted in an attenuation of CPP for PL impaired animals while a significant cocaine-
induced CPP was seen for sham-operated animals (Tzschentke & Schmidt, 1998). 
 Consistently, serotonin depletion of the mPFC, encompassing the PL subregion, 
prevents the acquisition of cocaine-induced CPP [10 mg/kg (IP) X 4, 30-min, pairings 
immediately upon injection; (Pum, Carey, Huston, & Müller, 2008). However, Zavala, 
Weber, Rice, Alleweireldt, & Neisewander, (2003) found that quinolinic acid lesions to the 
same PL region did not affect the acquisition of cocaine CPP (either one or three, 30 minute 
conditioning sessions following 15 mg/kg, IP cocaine injection), or the rate of extinction of 
the conditioned response, but did attenuate cocaine-primed reinstatement of CPP.  
The cocaine-induced CPA seen in the Isaac et al. (1989) study may be due to the 
majority of the extraction being much more posterior than the subsequent inactivation studies 
and also completely eliminated the ACC. While Zavala et al. (2003) did not find an effect on 
PL inactivation on CPP acquisition, a number of procedural differences exist between this 
and other studies, including the use of tactile, visual and olfactory stimuli. Additionally, 
Zavala et al. (2003) conducted the conditioning session during the dark phase of the rat’s 
circadian cycle, where the previous studies were conducted during the light phase of the 
cycle. As mentioned earlier, Kurtuncu et al. (2004) demonstrated that the time or phase of the 
light cycle affects the strength of cocaine-induced CPP and thus, timing of the conditioning 
may partially explain why Zavala and colleagues failed to find an inactivation effect on 
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acquisition. While methodological differences make defining a specific role of the mPFC in 
cocaine-conditioned reward difficult, there is some evidence to support a contribution of this 
region to this phenomenon. 
1.3.3 Cocaine Self-Administration Studies of the PFC 
1.3.3.1 Acquisition and Maintenance 
 The mPFC also supports various self-administration procedures, including the direct 
administration of drugs into this region and systemic administration of drugs. Rats will 
intracranially self-administer cocaine, phencyclidine, and some NMDA receptor antagonists 
into the mPFC (McBride, Murphy, & Ikemoto, 1999; Tzschentke, 2000). Goeders & Smith 
(1986) demonstrated that rats would self-administer cocaine intracranially into the PL 
subregion. This effect is DA-dependent as 6-OHDA lesions of the PL or co-infusion of the 
D2 receptor antagonist sulpiride attenuated intracranial cocaine self-administration. 
Moreover, rats will traverse a run-way to self-administer cocaine (12.5, 25, & 50 µg/0.5 µl 
per side) directly into the PL, a treatment that does not result in enhanced retreat behavior 
over time as seen for rats that are trained under run-way procedures for intravenous or 
intracerebroventricular injections of cocaine (Guzman, Moscarello, & Ettenberg, 2009). 
 In contrast to the equivocal results from cocaine CPP studies (see above), lesions of 
the PL with quinolinic acid or 6-OHDA result in enhanced acquisition and responding for IV 
cocaine (0.083 mg/inf or 0.25 mg/kg/inf), compared to sham-lesioned control rats (Schenk, 
Horger, Peltier, & Shelton, 1991; Weissenborn, Robbins, & Everitt, 1997). Moreover, 6-
OHDA lesions induced after the establishment of stable cocaine self-administration also 
facilitated responding for low cocaine doses versus sham-lesioned controls (Schenk et al., 
1991). Lesions of the mPFC (ACC, PL and IL) also produce elevated response rates for light 
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stimuli previously paired with cocaine under second-order schedules of reinforcement 
(Weissenborn et al., 1997). Additionally, Di Ciano, Benham-Hermetz, Fogg, & Osborne 
(2007) have assessed the role of discrete mPFC subregions on responding for drug-paired 
conditioned reinforcers, using reversible pharmacological inactivation approaches. 
Baclofen/muscimol microinjections into the PL attenuated lever-responding for the cocaine-
conditioned light cue (in the absence of cocaine delivery) on the first day of acquisition, but 
failed to have a lasting effect as animals quickly learned the behavior in subsequent sessions. 
In contrast, inactivation of the IL on the first day of lever-press acquisition, again in the 
absence of cocaine delivery, resulted in slightly lower response levels than vehicle controls 
but these IL-inactivated animals failed to increase responding and acquire behavior directed 
towards the cue-paired lever upon subsequent training. Extinction/reinstatement procedures 
were conducted in which the conditioned cues were no longer presented to reduce responding 
on the CS-paired lever and then, were subsequently reinstated by CS presentation; animals 
with PL inactivation failed to reinstate lever-pressing behavior, suggesting the PL may have a 
role in the ability of cocaine-paired cues to invigorate goal-directed behavior (Di Ciano et al., 
2007). 
1.3.3.2 Extinction and Reinstatement 
 Several inactivation studies have implicated the PL and IL subregions in extinction 
and reinstatement of drug-seeking behavior (Gass & Chandler, 2013). In animals with 
cocaine self-administration experience, GABA agonists microinjected into the IL 
immediately following short extinction sessions (30 minutes each and a total of 5 sessions) 
impaired extinction learning, while infusions of an AMPA receptor potentiator (administered 
in the same manner as GABA agonists) enhanced extinction training (LaLumiere, Niehoff, & 
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Kalivas, 2010). Thus, the IL appears to bidirectionally regulate animal’s ability to learn to 
suppress drug-seeking behavior in the absence of cocaine. Interestingly, when the PL or IL 
are inactivated by the microinfusion of baclofen/muscimol just prior to initiation of the first 
extinction session, inhibition of neither region impacts cocaine-seeking/extinction learning 
during a subsequent extinction session (Peters, LaLumiere, & Kalivas, 2008). Taken 
together, all of these data suggest that the PL and IL are not required for the ability to learn to 
suppress drug-seeking behavior per se, but are important for the consolidation of extinction 
memories that impact subsequent drug-seeking behavior.  
 Curiously, the results of the aforementioned studies contrast with effects of GABA 
agonist microinjection into the vmPFC observed in studies of drug-seeking following forced 
cocaine abstinence; microinjection just prior to the first extinction session conducted at 30 
days of forced abstinence decreased the high rate of responding on the active lever seen in 
vehicle-injected animals (Koya et al., 2009). Moreover, GABA antagonists microinjected 
into the vmPFC just prior to the first extinction session conducted at day 1 of forced 
abstinence elevated drug-seeking, compared to vehicle injected controls (Koya et al., 2009). 
Several differences in experimental conditions may account for this discrepancy in findings 
between the Koya et al. (2009) study and those described above. These include: the length of 
self-administration (2-hr vs 6-hr), the location of agonist/antagonist administration (IL vs PL 
and IL, timing of microinjection (following extinction training vs prior to onset of training), 
number of extinction sessions (5 sessions with microinjections vs 1 session with 
microinjection), and the presence of forced abstinence prior to the onset of extinction training 
(Koya et al., 2009; LaLumiere, Smith, & Kalivas, 2012).  
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 Examining extinction responding over one session may also account for the 
difference between these two studies as Peters, LaLumiere, and Kalivas (2008) failed to find 
a significant effect of GABA agonists in the vmPFC on drug-seeking during the first day of 
extinction training. Akin to the aforementioned negative findings for GABA agonists, 
mGluR5 antagonists microinjected into the IL subregion also do not affect extinction 
responding within the first training session, but animals failed to recall extinction learning 
from the previous day when tested subsequently (Fontanez-Nuin, Santini, Quirk, & Porter, 
2011). Consistent with this, acute microinjections of mGluR1/5 antagonists into the vmPFC 
(IL-PL interface) after 3 days of forced abstinence from cocaine self-administration did not 
affect within-session drug-seeking behavior during a 30-min extinction session; however, 
akin to the results of Fontanez-Nuin et al. (2011), there was no recall of that extinction 
learning the next day nor was there recall of the extinction learning the next day when the 
mGluR1/5 antagonists were infused immediately after the 30-min extinction sessions (Ben-
Shahar et al., 2013).  These findings indicate that inhibiting the vmPFC at the level of the IL-
PL interface does not prevent extinction learning but rather interferes with the consolidation 
of extinction memories. Conversely, acute stimulation of mGluR1/5 within the vmPFC after 
30 days forced abstinence from cocaine self-administration also failed to influence drug-
seeking behavior during a 30-min extinction session; however, this prior stimulation 
facilitated the development of extinction on a subsequent test, while that of vehicle-infused 
controls was normally impaired (Ben-Shahar et al., 2013). At least in the case of extinction, 
increased glutamate signaling and stimulation of mGluR1/5 receptors facilitates extinction 
learning when animals are tested in subsequent extinction sessions while decreased vmPFC 
activity either by increased GABA signaling or antagonizing mGluR1/5 receptors either prior 
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to or immediately following the first extinction session is sufficient to impair the 
manifestation of extinction learning the next day (Ben-Shahar et al., 2013; Fontanez-Nuin et 
al., 2011; Peters, LaLumiere, et al., 2008). Thus, the vmPFC appears to play a role in the 
consolidation of new contingencies between reward and behavior, and/or habitual responding 
– both of which can impact the ability of a cocaine-experienced individual to suppress drug 
craving/seeking behavior. 
 The recidivism rate for cocaine use is high, even after prolonged periods of 
abstinence and the extinction-reinstatement model has been developed to study this 
phenomenon in experimental animals (Knackstedt & Kalivas, 2009). In this model, animals 
are trained to self-administer a drug under operant procedures.  The operant response is then 
diminished or extinguished by allowing the animal to perform the response in the absence of 
the drug (extinction training).  The animal is subsequently presented with a stimulus 
predictive of drug delivery, a stressor (e.g., foot-shock) or an injection/infusion of the drug 
itself to instigate or “reinstate” the operant response (Knackstedt & Kalivas, 2009).  
 The PL and IL have also been shown to be involved in various forms of reinstatement 
of drug-seeking following extinction of self-administration. For example, inactivation of the 
PL with tetrodotoxin (TTX) or lidocaine reduces context-, conditioned stimulus-, foot-shock, 
and cocaine-induced reinstatement of drug-seeking (Capriles, Rodaros, Sorge, & Stewart, 
2003; Di Pietro, Black, & Kantak, 2006; Fuchs et al., 2005; Fuchs, Eaddy, Su, & Bell, 2007; 
McLaughlin & See, 2003). The Kalivas laboratory has consistently shown inhibition of the 
dmPFC with baclofen/muscimol microinjections or blockade of the intracellular effector, 
activator of G protein signaling 3 (AGS3), impedes reinstatement of drug-seeking following 
a cocaine priming injection (Bowers et al., 2004; McFarland & Kalivas, 2001; McFarland, 
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Lapish, & Kalivas, 2003; Peters, LaLumiere, et al., 2008; Peters, Vallone, Laurendi, & 
Kalivas, 2008; Shen, Gipson, Huits, & Kalivas, 2014). McFarland et al. (2001, 2003) trained 
rats to self-administer cocaine under short-access conditions (2 hr sessions), followed by 
extinction procedures. Then baclofen/muscimol was microinjected into the dmPFC prior to a 
10 mg/kg IP cocaine priming injection to reinstate drug-seeking. These GABA agonists 
inhibited cocaine-primed reinstatement of active lever-pressing when localized to the ACC 
and dorsal PL, but not when the vmPFC (PL and IL interface) was targeted. Additionally, a 
more specific neurochemical basis for dPFC-mediated blockade of reinstatement was shown 
by D1/D2 receptor antagonism hindering cocaine-primed reinstatement and a direct injection 
of DA into this same region was sufficient to reinstate drug-seeking in the absence of cocaine 
(McFarland & Kalivas, 2001).  
 The dmPFC projects to the NA core via glutamatergic efferents and causes a rise in 
extracellular glutamate following cocaine-primed reinstatement procedures (McFarland et al., 
2003). Baclofen/muscimol injections into the dPFC prevented this rise in extracellular 
glutamate following a 10 mg/kg IP cocaine-priming injection, providing further evidence for 
the role of the dPFC in the reinstatement of cocaine-seeking (McFarland et al., 2003). 
Consistent with this latter study, Shen et al. (2014), using similar cocaine self-administration, 
extinction and reinstatement procedures, found PL inactivation with baclofen/muscimol to 
block cocaine-primed reinstatement. Bowers et al. (2004) used a similar short-access (2 hr) 
cocaine self-administration-extinction-reinstatement model to show reduced AGS3 
expression via administration of oligonucleotides against AGS3 within the ventral PL and 
dorsal IL to attenuate cocaine-primed (10 mg/kg IP) reinstatement, an effect that was 
reversed upon cessation of oligonucleotide administration, additional extinction training and 
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identical reinstatement procedures. Together, these data support a necessary role for the 
ACC, both dorsal and ventral PL and the dorsal IL in the reinstatement of cocaine-seeking, a 
conventional model of drug relapse. 
 However, other reports in the literature provide discrepant results regarding the 
direction of effects of mPFC inactivation upon measures of relapse. For example, when rats 
were trained to self-administer cocaine under short (2 hr) access self-administration 
procedures, followed by extinction training, and roughly 28 days of forced abstinence in the 
home cage, injections of baclofen/muscimol into the IL, but not PL, enhanced the 
spontaneous recovery of cocaine-seeking when animals were run through an additional 
extinction session (Peters, Vallone, et al., 2008). This is consistent with additional studies by 
Peters and colleagues using similar self-administration and extinction procedures, where IL 
inactivation induced cocaine-seeking while activation of this region inhibited cocaine-primed 
reinstatement (Peters, LaLumiere, et al., 2008; Peters, Vallone, et al., 2008). Moreover, IL 
inactivation-induced cocaine-seeking relies on an activated PL, as baclofen/muscimol 
administered into both regions prior to reinstatement inhibits drug-seeking behavior (Peters, 
LaLumiere, et al., 2008). These results are consistent with the findings of LaLumiere et al. 
(2010) discussed above for extinction, in that inactivation of the IL inhibited extinction 
learning, as seen by enhanced cocaine-seeking, and activation of the IL via AMPA 
administration facilitated extinction learning (decreased cocaine-seeking). Despite some 
inconsistencies in results, the neuropharmacological evidence described above implicates 
both the PL and IL regions of the rat in drug reward and goal-directed behavior. Thus, these 
structures are the focus of the following series of studies described within this dissertation.  
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1.4 The Limited Study of Glial Cells in the Etiology of Addiction 
1.4.1 Astrocytes 
 The best characterized glial cell types that reside in the adult CNS tissue include 
astrocytes, microglia, and oligodendrocytes (OL) (Fields, 2008). Astrocytes are the most 
numerous cells in the human brain and each cell can support and modulate the function of up 
to an estimated 2 million synapses (Oberheim, Wang, Goldman, & Nedergaard, 
2006;Verkhratsky, 2009). They have essential roles in the regulation of ion and water 
homeostasis, blood-brain barrier maintenance, regulation of blood flow, proliferation of stem 
cells, neurotransmission, neurotransmitter metabolism, supply of energy metabolites, and the 
development and formation of synaptic connections (Miguel-Hidalgo, 2009; Oberheim et al., 
2006; Ullian, Sapperstein, Christopherson, & Barres, 2001). Astrocytes express receptors for 
most neurotransmitters and peptides, including but not limited to DA, glutamate, GABA, 
ATP, adenosine, glycine, acetylcholine, oxytocin and vasopressin, serotonin, and opioid 
making these cell types sensitive to neurochemical changes in the extracellular milieu 
(Verkhratsky, 2009; Volterra & Meldolesi, 2005). 
While astrocytes are not electrically excitable, they respond in a receptor-dependent 
manner to neural activity by the propagation of calcium waves that can result in the release of 
glutamate, serine, and ATP capable of affecting neighboring neuronal and glial physiology 
(Oberheim et al., 2006). Astrocytic calcium signaling is mediated predominantly through 
metabotropic receptors on the cell surface whose activation initiates phospholipase C-
mediated formation of inositol-triphosphate (IP3) triggering endoplasmic reticulum release of 
calcium stores (Deitmer, Singaravelu, & Lohr, 2009). Calcium waves can be initiated within 
microdomains surrounding synapses and propagate along the processes to other regions of 
the astrocyte, whereby both calcium and IP3 can permeate gap junctions connecting 
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neighboring astrocytes regenerating and furthering the signaling wave (Scemes & Spray, 
2009; Deitmer, Singaravelu, & Lohr, 2009). Therefore, astrocytes are not only capable of 
sensing neuronal signaling via receptor-dependent mechanisms, but are also capable of 
signaling through calcium waves to neighboring cells and releasing transmitters that form a 
feedback loop on a wide network of connected neurons. 
 While limited, evidence of astrocyte dysfunction in neuropsychiatric disease is 
beginning to accumulate even if primarily correlative in nature. The first instance of a disease 
with astroglial origin is Alexander disease distinguished by a mutation in the glial fibrillary 
acidic protein (GFAP) gene, which encodes the intermediate filament found exclusively in 
astrocytes (Brenner, Goldman, Quinlan & Messing, 2009). The most common symptoms 
include seizures, megaencephaly, failure to meet physical and intellectual milestones, 
spasticity, poor coordination, paralysis, vomiting, difficulty swallowing, and this disease 
ultimately results in premature death (Brenner et al., 2009).  A speculative role of astrocytes 
has also been proposed based on the finding of reactive gliosis in conjunction with neuronal 
loss within sclerotic hippocampi of deceased temporal lobe epilepsy patients (Binder & 
Steinhauser, 2009). Given the role of astrocytes in glutamate uptake from synapses, and their 
ability to directly excite neighboring neurons via calcium-dependent glutamate release, it is 
plausible an astrocytic abnormality could drive the excessive excitability underlying seizure 
disorders (Binder & Steinhauser, 2009). 
 Tissue collected from post-mortem patients with major depressive disorder (MDD) 
and examined via microarray and quantitative polymerase chain reaction (qPCR) 
technologies have revealed significant reductions in the astrocyte-specific transcripts GFAP, 
S100 calcium binding protein, gap junction protein α1 and β6, and aquaporin-4 in the LC, 
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but not in tissue collected from individuals diagnosed with bipolar disorder (Bernard et al., 
2011). Another study of post-mortem dlPFC tissue of suicide-completers compared to control 
subjects matched for cause of death, found a decrease in the astrocyte-specific gap junction 
proteins connexin-30 and 43 (Cx30 and Cx43, respectively) mRNA transcripts in a 
microarray analysis of global gene transcription (Ernst et al., 2011). A causal role for Cx30 in 
normal brain function has been established in a gene knock-out mouse model where mice 
show decreased motor coordination on the Rotarod task, decreased number of rearings in the 
open field and object exploration tasks, and greater anxiety-like behavior as assessed by 
increased avoidance of the center and corner preference in the open field test (Dere et al., 
2003). 
 In regards to cocaine addiction, cocaine administration and withdrawal results in 
increased expression of GFAP within the dentate gyrus, PFC, and NAc (Bowers & Kalivas, 
2003; Fattore et al., 2002). Bowers and Kalivas (2003) and Fattore et al. (2002) reported 
significant modifications in astrocyte number, size and shape complexity following cocaine 
experience in animal models. Microdialysis experiments examining the effect of 3 weeks of 
withdrawal from experimenter administered cocaine on basal extracellular levels of 
glutamate within the NAc found a cocaine-induced decrease in levels dependent upon the 
decreased function of the astrocyte-specific cystine/glutamate exchanger, a protein known to 
modulate the extracellular levels of glutamate within this brain region (Baker, Shen, & 
Kalivas, 2002; Baker, Xi, Shen, Swanson, & Kalivas, 2002). Additionally, reinstatement of 
drug-seeking promoted by a cocaine-priming injection was diminished in animals with prior 
cocaine experience and withdrawal when an intracranial (NAc) perfusion of cystine or 
systemically administered N-acetylcystine was given to normalize glutamate levels prior to 
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reinstatement (Baker et al., 2003). Pretreatment of rats with systemic N-acetylcystine before 
daily long-access (6 hr/day) cocaine self-administration sessions or experimenter 
administered cocaine injections, followed by 2-3 weeks of withdrawal, prevented the 
development of escalated drug intake, behavioral sensitization, reduced cocaine-primed 
reinstatement, and prevented the decrease in cystine/glutamate exchanger activity, returning 
basal glutamate levels to normal (Kau et al., 2008; Madayag et al., 2007). In line with 
alterations in the cystine/glutamate exchanger following cocaine, cystine uptake into 
astrocytes is the rate-limiting step in the synthesis of glutathione (GSH), a molecule 
important in balancing cellular redox in response to oxidative stress and with a potential role 
in decreasing the oxidative stress induced by cocaine administration (Uys et al., 2011). 
Experimenter administered cocaine followed by three-weeks withdrawal resulted in a 
decrease in GSH-S-transferase pi (GSTpi; the primary catalyst for glutathionylating proteins 
which generate GSH), and mimicking this decrease with a knock-out mouse model or 
administering an agent to inhibit GSTpi, facilitated cocaine CPP and locomotor sensitization 
(Uys et al., 2011). 
GLT1 (a.k.a. EAAT2) is a sodium-dependent transporter located exclusively on 
astrocytes within the CNS and is responsible for 90% of the removal of extracellular 
glutamate, it was therefore hypothesized to play a role in cocaine relapse as an increase in 
glutamate transmission facilitates this feature of addiction (Sari, Smith, Ali, & Rebec, 2009). 
To examine for an effect of GLT1 on relapse, Sari et al. (2009) trained rats to self-administer 
cocaine (2 hr/day, 10-14 days) followed by five days of extinction training with post-session 
injections of ceftriaxone, a β-lactam antibiotic thought to increase GLT1 expression. While 
cocaine experience itself did not increase the expression of GLT1 within the PFC or NAc, 
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administration of ceftriaxone attenuated cue-induced reinstatement of cocaine seeking and 
resulted in enhanced expression of GLT1 within the PFC and NAc. Cocaine self-
administration (2 hr/day, 14 days) followed by three-weeks of extinction training, did 
however, decrease the expression of GLT1 within the NAc but not the PFC of rats 
(Knackstedt, Melendez, & Kalivas, 2010). Moreover, ceftriaxone treatment restored GLT1 
levels, and prevented cue-induced and cocaine-induced reinstatement. Fischer-Smith, 
Houston, & Rebec (2012) extended findings of cocaine-induced changes in GLT1 expression 
when examining rats with long-access (6 hr/day; 11 days) cocaine self-administration 
followed by short (1 day) versus long (45 days) withdrawal within the NAc core and shell. 
They found both NAc regions to have decreased expression of GLT1, but that NAc core 
expression at the long withdrawal time point was significantly reduced to a greater extent 
than expression at either withdrawal time points for the NAc shell. 
Another approach for examining the role of GLT1 was with the administration of the 
atypical methylxanthine propentofylline (PPF), which is an adenosine uptake and 
phosphodiesterase inhibitor and has been linked with increased expression of GLT-1 
(Reissner et al., 2014). Systemic administration of PPF prior to a cocaine-induced 
reinstatement test inhibited cue- and cocaine-induced reinstatement (Reissner et al., 2014). 
This effect is potentially due to enhanced GLT-1 function buffering against cue-induced 
stimulated glutamate release in the NAc (Kalivas et al., 2005). Astrocytes are not the only 
glial cells in position to affect neurotransmission, as it is well established that microglial cells 
promote a healthy brain and OL membrane processes form the myelin sheaths that are 
required for much of mammalian neuronal communication. 
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1.4.2 Microglia 
 This review of microglial cells will be brief, as my examination of this cell type in the 
following series of studies is minor. Microglial cells are of mesodermal origin and retain 
many of the features of macrophages, including the initiation of inflammatory responses and 
innate immune signaling (Miguel-Hidalgo, 2009; Morris, Clark, Zinn, & Vissel, 2013). 
Microglial morphology exists two distinct forms depending on activation state; in the 
“resting” state cells are highly ramified with long processes and small cell bodies compared 
to the “activated” state where they appear as globular and “amoeboid” in shape (Morris et al., 
2013). In response to injury or pathogenic events, microglial cells change their morphology, 
migrate to the site of injury and perform a variety of functions including neuroprotection, 
support neurogenesis, direct the invading vasculature, remove apoptotic cells, influence 
synaptogenesis, and mediate developmental apoptosis (Morris et al., 2013). While previously 
thought of as dormant in their resting state, this “resting” state is a misnomer as microglia are 
dynamic surveyors of their environment, expanding and retracting their thin processes to 
contact neighboring neurons, astrocytes, blood vessels, sometimes engulfing tissue, and 
increasing their activity in response to neural activity (Morris et al., 2013). Microglial cells 
also express most of the receptors to neuropeptides, neurotransmitters, and astrocytic 
transmitters (Miguel-Hidalgo, 2009). 
 The vast majority of research on microglia and addiction has centered on alcohol and 
methamphetamine administration and reveals these drugs result in microglial activation and 
enhance innate immune gene induction (i.e. IL-1β, IL-6, TNF-α). However, only a handful 
of studies have examined the effect of cocaine on the CNS microglial response (see reviews 
Clark, Wiley, & Bradberry, 2013; Crews, Zou, & Qin, 2011). In post-mortem tissue from 
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human chronic cocaine users, elevated levels of activated macrophages and microglial cells 
in the anterior midbrain were detected via immunohistochemistry (Little et al., 2009).  
 Animal models using both experimenter-administered cocaine and self-administration 
procedures have revealed an increase in several inflammation related transcripts throughout 
the PFC, NAc, and striatum (Ahmed et al., 2005; Clark, Wiley, & Bradberry, 2013b; 
Piechota et al., 2010). For example, some of the findings of Ahmed et al. (2005), included 
increased expression of IL-6, IL-4, TNF within the PFC, a variety of microglial transcript 
increases in the VTA, septum, amygdala, lateral hypothalamus, and NAc using 
oligonucleotide arrays and qRT-PCR in rats with either 18 days of short access (1 hr/day) or 
extended-access (6 hr/day) cocaine self-administration (0.25 mg/0.1 ml infusion, IV), 
compared to animals undergoing the same experimental procedures excluding cocaine 
experience (further data analysis conducted by Clark et al. (2013) for microglial-related 
genes). Additional analyses of gene array data collected by Piechota et al. (2010) and 
analyzed by Clark et al. (2013), revealed a single injection of 25 mg/kg cocaine (IP) into 
mice sacrificed 1 hr post-injection to enhance the expression of several cytokine receptors 
(e.g., IL-6r and TNFα), oxidative stress molecules (e.g. nitric oxide synthase), and growth 
factors whose expression further increased with increased delay between injection and 
sacrifice time points (1, 2, 4 or 8 hr post-injection) within the rostral portion of the CP and 
NAc. 
 Activated microglial cells release reactive oxygen species (ROS), including 
superoxide and nitric oxide, which have a role in facilitating the apoptotic process (Clark et 
al., 2013; Costa, Yao, Yang, & Buch, 2013). In a microglial cell culture assay, cocaine dose 
dependently decreased cell viability via pro-apoptotic pathways, an effect mediated by ER 
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stress-related proteins (Costa et al., 2013). Specifically, CHOP, a protein that signals the pro-
apoptotic pathway, had increased expression levels following cocaine and inhibiting this 
increase, by siRNA mediated knockdown, increased cell viability in the presence of cocaine. 
Additionally, rats treated with IP injections of cocaine for 14 days (20 mg/kg) were shown to 
have enhanced CHOP protein levels in brain, validating the enhancement seen in cell culture. 
Consistently, cocaine self-administering rats were shown to dose-dependently decrease active 
lever responding when a ROS scavenger or TEMPOL (to reduce oxidative stress) was 
systemically administered or TEMPOL was microinjected into the NAc (Jang et al., 2014). 
While this last study only revealed oxidative stress within neurons, and not astrocytes, OLs 
or microglial cells, it is tempting to speculate that treatment with either of these drugs could 
potentially reduce the ER stress in microglial cells which may impact the course of cocaine 
addiction.  
1.4.3 Oligodendrocytes 
The vertebrate nervous system requires myelination for efficient and reliable action 
potential propagation that mediates communication within and between brain regions (Wake, 
Lee, & Fields, 2011). Myelination provides increased membrane resistance and lowers 
capacitance, thereby increasing nerve impulse velocity (Bhat et al., 2001; Kidd & Trapp, 
2010; Min et al., 2009; Murray & Steck, 1984). A single OL can wrap up to 60 internodal 
segments, contacting many different neurons simultaneously (Mathey, Arthur, & Armati, 
2010).  The relationship between OLs and neurons is mutual with cell-specific changes 
impacting the structure and function of the other connected cell. Friede (1972) demonstrated 
that the rate of axonal growth determined the rate of myelin formation, one mechanism being 
glutamate and ATP released by nerve conduction and sensed via OL NMDA, AMPA, and 
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mGluR 1 & 5 receptors (Fields, 2008; Kelland & Toms, 2001; Luyt, Varadi, & Molnar, 
2003; Wake et al., 2011). Changes in OL-specific protein expression can also affect axonal 
diameter, as seen in myelin oligodendrocyte basic protein (MOBP)-deficient mice with 
increased axonal diameters compared to wild type controls (Sadahiro et al., 2000). These 
mice showed no gross behavioral abnormalities, though only motor coordination was tested 
on Rotarod and forced bar-crossing tests (Yamamoto et al., 1999). 
Additionally, changes in OL specific proteins (e.g., oligodendrocyte-myelin 
glycoprotein (OMgp), proteolipid protein (PLP), & myelin basic protein (MBP)), can result 
in abnormal or absent nodes of Ranvier and decreased nerve conduction velocity (Boiko et 
al., 2001; Nie et al., 2006; Tanaka et al., 2009). Boiko et al. (2001) used 
immunohistochemistry to label retinal ganglion cells for sodium channels (Nav1.2 and 
Nav1.6) of normal Sprague Dawley rats, Shiverer mice and wild-type mice. Shiverer mice 
have a mutation in the MBP gene resulting in a severe deficiency in the formation of compact 
myelin (Chernoff, 1981). Along with hypomyelination, Shiverer mice have few or absent 
nodes of Ranvier distinguished by the clustering of Nav1.6 sodium channels in the nodal 
region and restriction of the Nav1.2 form to the intermodal, myelinated regions (Boiko et al., 
2001). Additionally, the Nav1.6 isoform was rarely detected and then only in clusters 
adjacent to Caspr-labeling (an indicator of nodes of Ranvier). 
OMgp is detected in clusters at the nodes of Ranvier in wild-type mice by 
immunohistochemical techniques, but is distributed diffusely along myelinated axons of 
Shiverer and PLP-null mice (Nie et al., 2006). Nie et al. (2006) also used electron 
microscopy to demonstrate abnormal node-paranode junctions in OMgp mutant mice, 
immunoblotting to show reduced Na channel α subunit expression, and compound action 
	  33	  
potentials recorded from the spinal cord revealed significantly decreased conduction velocity 
of OMgp-transgenic compared to wild-type mice. Moreover, PLP-null transgenic mice were 
shown to have reduced conduction velocities within various tracts of the spinal cord 
estimated from regression analyses of latencies recorded at three or more segments and the 
distances between recording sites compared to wild-type controls (Tanaka, Ikenaka, & Isa, 
2006). In the same experiments, PLP-null transgenic mice were also found to have reduced 
sodium and potassium channel clustering around paired clusters of Caspr labeling (to identify 
nodes of Ranvier) revealed by immunohistochemistry compared to their wild-type 
counterparts, similar to what has been found with Shiverer mice and OMgp-transgenic mice 
discussed above (Tanaka et al., 2006). These findings would suggest that the differential 
distribution of sodium channel isoforms is not mediated intrinsically by neurons alone, but 
requires the formation of proper axoglial junctions. In addition to decreased nerve conduction 
velocity resulting from OL protein changes, activation of OLs via glutamate induces 
depolarization, resulting in increased conduction velocity in the correspondingly wrapped 
axonal process, as assessed with electrophysiology (Yamazaki et al., 2007). This effect may 
be mediated by OL process swelling, which increases the conduction velocity by increasing 
membrane resistance (Morán & Mateu, 1983). 
Only a few laboratories have conducted behavioral testing with myelin-deficient 
mice. Shiverer mice with MBP gene mutations show severe motor deficits that become 
exacerbated with age, including a generalized tremor, paralysis of the hindquarter, 
progression to frequent seizures and death at around 50 days (Chernoff, 1981). Interestingly, 
these animals have been shown to have a normal ability to learn the location of a food reward 
in a T-maze; however, when the location of the reward is reversed to the opposite arm, they 
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show a deficit in reversal learning and make a greater number of errors by returning to the 
location of the original food-paired arm (Inagawa, Watanabe, & Tsukada, 1988). 
Heterozygous MBP-mutant mice (mld) showed a similar deficit in reversal learning 
compared to wild-type mice, but to a lesser degree than Shiverer, indicating a partial 
recovery when at least half the expression of MBP was returned to normal and myelination 
was less severely impacted (Inagawa et al., 1988).  
PLP-null mice have been examined for a variety of behavioral deficits including 
Rotarod, wire hanging and grip strength tests, Open field, Light/dark transition, hot plate, 
social interaction test in a novel environment, startle response/prepulse inhibition, porsolt 
swim test, elevated plus-maze, the Barnes spatial navigation task, and T-maze forced 
alternation tasks (Tanaka et al., 2009, 2006). PLP-mice exhibit an age-related decline in 
latency to fall in the Rotarod motor test that is correlated with the progressive demyelination 
observed in these animals (Tanaka et al., 2006). While there were no significant differences 
observed in the wire hanging, grip, open-field or pain nociception tests, PLP-null mice 
exhibited abnormal anxiety-like behavior (Tanaka et al., 2009). Tanaka et al. (2009) showed 
PLP-null mice to make significantly less transitions between the light and dark boxes, had a 
greater number of entries and time spent in the open arms of the elevated plus-maze, and a 
tendency towards a decreased total number of contacts in the social interaction test compared 
to wild-type controls. Moreover, PLP-null mice exhibit a mildly impaired prepulse inhibition 
when a 78 dB prepulse sound precedes both a 110 and 120 dB startle pulse. In the spatial 
navigation test, PLP-null mice show less exploration around the target hole (hole containing 
food reward on the acquisition trial), a greater number of errors to reach the target hole, spent 
a lesser percentage of time near the target, and also tended to travel greater distances to reach 
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the target than wild-type controls. PLP-null mice exhibited a robust deficit in working 
memory revealed in significantly greater errors made during training sessions of the forced 
alternation T-maze, and when a 30 sec or 60 sec delay was added between the forced and 
choice trials (requiring animals to remember the forced arm and alternate their entry to the 
rewarded arm). These studies provide evidence for links between myelin-specific protein 
expression, the structural integrity of myelin and axons, neuronal signaling, and behavioral 
consequences of altering OL specific genes. 
Direct manipulation of OL-specific protein expression on cocaine taking in animal 
models has yet to be examined, however, several labs have examined the effect of cocaine in 
various animal models and methods of administration on the expression of OL -density, -
specific proteins, and -mRNA transcripts. White matter from the anterior (precommisural) 
striatal level of rhesus monkeys with prolonged self-administration (30 injections of 0.3 
mg/kg each injection, for 300 sessions (days)) of cocaine showed a reduction in both PLP 
and MBP mRNA and protein expression levels (Smith, Beveridge, Nader, & Porrino, 2014). 
Within the dmPFC and OFC of rats with extended-access to cocaine self-
administration (0.5 mg/kg per 100 ml cocaine, 6-20 sessions of 1 hr/session followed by a 
minimum of 85 sessions of 6 hr/day) was a decrease in the density of OL cells, which 
correlated with working memory impairments in the delayed non-matching to sample T-
maze (George, Mandyam, Wee, & Koob, 2008). However, one caveat to this study is the use 
of the protein NG2+ as the marker for OL cells in their immunohistochemistry, as NG2+ 
positive cells have also been found to differentiate into gray matter astrocytes, neurons, or 
remain as NG2+ cells that are distinct from OLs (Mathey, Aurthur, & Armati, 2010). 
Cocaine self-administration (14 consecutive days, 3 hr/day, 0.75mg/kg/0.1ml, IV) has also 
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resulted in the hypomethylation of the Sox10 gene within the corpus callosum at 30 days of 
forced abstinence compared to drug-free, sham surgery controls, a gene which encodes a 
transcription factor essential in regulating OL differentiation (Nielsen et al., 2012).  
Experimenter-administered cocaine (continuous infusion of intradermal cocaine, ~40 
mg/kg/day for 28 days without withdrawal) resulted in decreased volume and expression of 
MBP in the splenium of the corpus callosum (CC) as measured by differences in fractional 
anisotropy (FA) seen on diffusion tensor imaging (DTI) and post-mortem histological 
analysis of CC size and immunohistochemistry for MBP (Narayana et al., 2009). 
Consistently, 14 days of 15 mg/kg (IP/day) cocaine followed by 30 days of abstinence in rats, 
also decreased MBP, PLP, myelin oligodendrocyte glycoprotein (MOG), and myelin 
associated glycoprotein (MAG) in the NAc (Kovalevich, Corley, Yen, Rawls, & Langford, 
2012). Interestingly, mice given daily injections of ceftriaxone (GLT-1 activator) with 
cocaine injections or only during the withdrawal period, saw no significant loss of myelin 
proteins at 30 days withdrawal compared to saline control animals, and ceftriaxone given 
alone had no effect on myelin protein expression (Kovalevich et al., 2012). Due to the limited 
understanding of the molecular changes that result from extended-access (6 hr/day) cocaine 
self-administration, the focus of this dissertation is on cocaine induced protein changes 
within the vmPFC of the rat and the cognitive consequences of altered glial physiology. 
1.5 White matter in humans 
1.5.1 White matter maturation and vulnerability to substance use 
Magnetic resonance imaging (MRI) studies have revealed distinct white and gray 
matter volume changes across human development. A longitudinal study from 
preadolescence through post-adolescence  (4-22 years) utilized MRI to measure cortical gray 
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and white matter volume within the frontal, temporal, parietal and occipital lobes of male and 
female children (Giedd et al., 1999). The net increase in white matter across this age range 
was 12.4%, increasing linearly with age. Gray matter, however, showed a region specific 
increase during preadolescence including maximum size in the frontal lobe at an average of 
11-12 years, 10-11 years for the parietal lobe, 16-17 years for the temporal lobe, and linear 
increases in the occipital lobe without significant decline or leveling within the age-range 
examined. Beginning in adolescence, however, gray matter declines linearly with age while 
white matter continues to expand through the fourth to fifth decades of life, at least in males 
as females were not examined (Bartzokis et al., 2001). Bartzokis et al. (2001) used a cross-
sectional study to examine males aged 19-76 years via volumetric MRI and confirmed an 
age-related linear loss in gray matter volume within the frontal and temporal lobes, while 
white matter continued to expand till age 44 for the frontal and 47 for the temporal lobes. The 
regional difference in maturation of white matter between the frontal and temporal lobes in 
the Bartzokis et al. (2001) study closely mirrors the age difference in gray matter increase 
within the same regions of the childhood study discussed above (roughly 3-4 years, with the 
frontal cortex reaching a maximum volume before temporal lobes). 
Adolescents have been reported to exhibit deficient executive cognitive functioning 
and behavioral self-control in experiments examining planning, attention, foresight, abstract 
reasoning, judgment, and self-monitoring (Bernheim, Halfon, & Boutrel, 2013; Luna, 
Padmanabhan, & O’Hearn, 2010). The Dual Systems Model has been proposed to explain 
adolescent behavior guided predominantly by motivational systems which develop at an 
earlier stage than the slower maturing cognitive control (PFC) mechanisms, and suggest 
these differential maturation processes underlie the increased risky decision making and 
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reward seeking (Bernheim et al., 2013; Willoughby, Good, Adachi, Hamza, & Tavernier, 
2013). Consistently, the majority of drug users are adolescents and young adults or adults 
whose use began as adolescents, and adolescent onset of drug use leads to a more rapid 
progression of abuse to dependency (Bernheim et al., 2013; Perry, Anderson, Nelson, & 
Carroll, 2007). Moreover, immature frontostriatal development in adolescence is associated 
with greater risk-taking, greater cocaine intake in adolescence lasting into adulthood, 
increased behavioral sensitization, and a decrease in the experience of the negative effects of 
drugs of abuse (Crews & Boettiger, 2009; Perry et al., 2007). Given the importance of the 
adolescence time point in normal brain maturation, it is important to sample this period for 
interactions between cocaine and development that may exacerbate cocaine use, cocaine-
related cognitive and CNS deficits, and the vulnerability to develop addiction.  
1.5.2 Imaging studies of chronic cocaine addicts 
 A frequently used method for in vivo imaging of white matter microstructural changes 
following cocaine use is DTI MRI, compared to more macrostructural changes measured 
more broadly as changes in gross volume. DTI measures the directionality of motion of water 
molecules and is based on the principle that water will move in all possible directions unless 
barriers exist in which it will preferentially travel along said barrier (e.g., axons or bundles of 
myelinated fiber tracts) (Moeller et al., 2005). This preferential movement along one axis is 
called anisotropic diffusion; organized structures like white matter fiber tracts exhibit a high 
degree of this form of water movement (Moeller et al., 2005). A reduction in anisotropy, or 
fractional anisotropy as measured in DTI, suggests a decrease in the organization of a 
particular structure and has been suggested to reflect subtle white matter pathology and/or a 
loss of integrity in fiber tracts (Moeller et al., 2005). An alternative explanation is an increase 
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in the number of fibers that cross in varying directions from the normal direction of the fiber 
tract, thereby resulting in a decrease in the preferential movement of water. 
Investigators using DTI and volumetric MRI have revealed significantly lower 
volumes of white and gray matter, and abnormalities in white matter microstructure in 
chronic cocaine users compared to healthy age-matched controls; Table 1 lists descriptions of 
the subjects, their cocaine histories, and white matter changes (Bartzokis et al., 2002; Lim, 
Choi, Pomara, Wolkin, & Rotrosen, 2002; Moeller et al., 2007; Moeller et al., 2005). 
Specifically, Lim et al. (2008, 2002) found compromised white matter microstructure, as 
measured by a reduction in the fractional anisotropy, and a trend towards decreased gray and 
white matter volume (via volumetric MRI) in the inferior frontal brain regions of chronic 
cocaine addicts; an effect associated with the duration of cocaine use (Lim et al., 2008, 
2002). Moreover, chronic cocaine addicts were found to have reduced white matter integrity 
of the corpus callosum, as measured by fractional anisotropy values from DTI, and a 
concomitant increase in behavioral measures of impulsive-behavior, both of which are 
reliable predictors of relapse (Moeller, et al., 2007; Moeller et al., 2005).  
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 An alternative approach to directly comparing volumetric differences in white matter 
following cocaine abuse is to compare the age-related increase in white matter volume 
normally seen in humans up to the fourth to fifth decades of life (Bartzokis et al., 2001). 
Bartzokis et al. (2002) used volumetric MRI to measure the frontal and temporal regions and 
conducted correlational analyses to evaluate the relationship between age and brain volumes 
while controlling for brain size variations due to overall body size, education, and race. By 
comparing the white matter growth slopes (e.g., the absolute rates of change per year in brain 
volumes) from cocaine dependent and control subjects, chronic cocaine users did not show 
the age-related increase in white matter within the frontal and temporal lobes as non-drug 
users and suggested cocaine may arrest normal white matter maturation. Studies of PFC 
damage in humans and animals consistently report that such damage leads to behavior 
dominated by impulses motivated by drive states, conditioned associations or habitual 
responses, therefore abnormal gray and white matter structure could also be implicated in 
these features that are involved in cocaine addiction (Damasio, 1996; Jentsch & Taylor, 
1999). 
Since chronic cocaine use has been consistently found to reduce white matter volume 
within humans measured with in vivo MRI techniques (Bartzokis et al., 2002; Lim et al., 
2002; Liu, Matochik, Ph, Cadet, & London, 1998; Ma et al., 2009; Moeller et al., 2007; 
Moeller et al., 2005; Volkow, Valentine, & Kulkarni, 1988), this could also reflect a 
disruption in the connectivity and efficiency of signaling between the PFC and underlying 
reward circuitry; a disruption potentially underlying the cognitive and behavioral control 
deficits, as well as the abnormal drive for cocaine seen with cocaine dependence (Fields, 
2008; Lim et al., 2002; Ma et al., 2009; Moeller et al., 2005). Post-mortem tissue analysis via 
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microarray technology of individuals with chronic cocaine use reveals significant mRNA 
reductions in the major myelin constituent, PLP, throughout the CP, internal capsule, NAc, 
and dlPFC (BA 46) (Albertson et al., 2004; Kristiansen, Bannon, & Meador-Woodruff, 2009; 
Lehrmann et al., 2003). Additionally, other myelin-specific mRNA for MBP, claudin-11 
(CLN), MOBP, and transferrin are reduced following cocaine abuse (Albertson et al., 2004; 
Kristiansen et al., 2009), Table 2. While the area of study of white matter changes in the 
brain of cocaine addicts is limited and correlational in nature, it raises many important 
questions: do these differences precede drug exposure and predispose individuals to develop 
addiction, do they result from chronic drug use, are the non-neuronal components of white 
matter affected by drug use, and do these non-neuronal components have an affect on brain 
function? To address these questions, animal models must be utilized to examine for cause-
effect relationships.
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1.6 Animal Models of Cocaine Addiction 
1.6.1 Active versus passive cocaine administration 
Several methodologies exist for studying the effects of cocaine on the CNS, common 
forms of administration being either passive, experimenter administered cocaine, or active 
self-administration of drug. However, a wealth of data suggests that active self-
administration of cocaine induces different neuroplasticity including changes in 
neurotransmitter release and turnover, protein expression, and gene expression (for review 
see Jacobs et al., 2003). For example, passively receiving yoked cocaine infusions led to a 
higher lethality rate than self-administration of the same amount of cocaine when rats had 
access to either 6-hr of 0.33 mg/infusion of cocaine or a maximum of 80 infusions over one 
session (Dworkin, Mirkis, & Smith, 1995). Additionally, Hemby, Co, Koves, Smith, & 
Dworkin (1997) utilized a yoked cocaine procedure where one rat was trained to self-
administer IV cocaine (0.33 mg/infusion) over a 6-hr session (maximum of 60 daily 
infusions) till stable baseline responding (25 days of SA, run 7 days a week) was achieved 
and another rat received yoked infusions paired to one self-administering animal, and 
conducted microdialysis for DA concentration within the NAc. Both yoked and self-
administering rats showed increased DA levels in the two-hr microdialysis session in 
response to cocaine delivery, but self-administering animals exhibited significantly greater 
concentrations than their yoked littermates. Moreover, on the following day both groups of 
animals experienced yoked cocaine infusions in the same pattern as the previous day, and 
while DA levels rose above baseline, the previously self-administering animals did not show 
the same increase above their yoked littermate when they were not actively administering.	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A similar effect has been seen in mice with either yoked or active-self-administration 
of cocaine (5 days, 90 min session, 0.5 mg/kg/infusion), in that a passive IP injections of 
cocaine (5.0 mg/kg) following self-administration sessions failed to raise self-administering 
mice NAc dopamine levels above yoked controls assessed via in vivo microdialysis, however 
this group did not measure DA levels during a self-administration session (Zapata, Chefer, 
Ator, Shippenberg, & Rocha, 2003). Furthermore, rats trained to self-administer cocaine 
(0.25 mg/kg) or rats yoked to self-administering animals for 2-hr sessions till stable 
responding was achieved, then put through extinction procedures, and reinstated with 10 
mg/kg IP cocaine injection prior to microdialysis procedures to assess glutamate and DA 
levels within the NAc, revealed both groups experienced elevated levels of DA in response to 
cocaine, but only animals with self-administration experience showed an increase in 
glutamate (McFarland et al., 2003). Therefore, while an elevation in DA increases in 
response to cocaine in general (either self-administered or non-contingently administered), a 
further increase requires cocaine to be actively administered, and glutamate increases only 
occur in self-administering animals, at least during reinstatement procedures.  
Consistently, acetylcholine (ACh) levels within the NAc were found increase to a 
greater extent and remain higher during and after a 3 hr cocaine exposure session in animals 
allowed to self-administer cocaine compared to yoked-cocaine experienced and saline control 
rats; cocaine self-administering animals were allowed to administer cocaine (0.42 
mg/kg/infusion) for three hour sessions over 13 consecutive days and yoked controls were 
matched for non-contingent cocaine delivery based on self-administering animals (Mark, 
Hajnal, Kinney, & Keys, 1999). 
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 As stated previously, the method of cocaine administration also has an effect on 
neurotransmitter turnover. Dworkin, Co, & Smith (1995) examined neurotransmitter turnover 
rate in cocaine self-administering rats, yoked controls (0.33 mg/infusion; average 30 days 
drug administration; 6 hr sessions; 7 days a week), or saline controls by administering 
labeled [14C]glucose, [3H]tyrosine and [3H]tryptophan through their jugular catheters 24 
hours following the last self-administration session and 60-90 minutes prior to sacrifice. 
Using high-pressure liquid chromatography, they found decreases in DA, serotonin (5-HT), 
norepinephrine (NE), and glutamate turnover within the frontal cortex, NAc, motor-
somatosensory cortex, dentate gyrus, and globus pallidus; increases in DA, 5-HT, NE, 
GABA, and aspartate acid turnover within the piriform cortex, temporal-auditory cortex, 
NAc, CP, pre-optic area- diagonal band, motor-somatosensory cortex, and cerebellum (not 
all neurotransmitters changed in all regions); and reversals depending on the contingency of 
cocaine administration (e.g., DA within the substantia nigra was decreased in the yoked-
cocaine animals compared to yoked-vehicle, but cocaine self-administering animals had 
equivalent turnover to yoked-vehicle animals). This same group utilized the same self-
administration and yoking procedures to access neurotransmitter turnover by pulse labeling 
for neurotransmitters via infusion of [14C]glucose, [3H]tyrosine and [3H]tryptophan through 
the animals’ catheters one hour into the 31st stable self-administration session, followed by 
sacrifice 60 to 90 minutes later (Smith, Koves, & Co, 2003). Self-administering compared to 
yoked-cocaine animals were found to have an increase in turnover of DA within the NAc, 
VP, septum, lateral hypothalamus and a decrease in the brain stem; a decrease in 5-HT within 
the medial hypothalamus and substantia nigra; a decrease in somatosensory cortex and lateral 
thalamus NE; a decrease in NAc, somatosensory cortex and ACC GABA; a decrease in 
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glutamate within NAc, VP, posterior cingulate cortex, entorhinal subicular cortex, brain 
stem, raphe, and visual cortex; and a decrease in entorhinal subicular cortex and brain stem 
aspartate turnover. 
 Protein expression within many brain regions is also differentially affected by the 
contingency of cocaine administration. Yoked-cocaine rats sacrificed 18 hr after the 30th 
yoked-cocaine session (0.33 mg/infusion; 6 hr/day, 7 days/week) exhibited decreased D1 
receptor binding of [3H] SCH23390 (indicating decreased receptor levels) within the NAc 
compared to self-administering and yoked-vehicle animals (Montis, Co, Dworkin, & Smith, 
1998). Consistently, D2 receptor expression within the CP and NAc were reduced within 
yoked-cocaine animals compared to cocaine self-administering and yoked-saline rats as 
measured by in vitro quantitative autoradiography following 5 weeks of cocaine experience 
(0.3 mg/kg; 2 hr/day sessions; 5 sessions/week) (Stefański et al., 2007). Interestingly, when 
D2 receptor mRNA was assessed in the VTA by in situ hybridization, only rats actively self-
administering cocaine showed increased expression. Fumagalli et al. (2013) examined for 
differences in BDNF protein expression within the NAc of rats either self-administering 
cocaine (0.25 mg/infusion; 2 hr sessions/day, 7 days/week; 14 total days), yoked-cocaine or 
yoked-saline immediately following, 24 hrs or 7 days after the last drug administration 
session. They found BDNF levels to be significantly elevated in the NAc of both yoked-
cocaine and self-administering animals, with the yoked-cocaine animals expressing 
significantly greater levels than self-administering animals when levels were examined 
immediately following the last drug session but not at 24 hrs withdrawal.  
 Gene expression within hippocampus (HPC), NAc, CP, and BLA are also affected by 
active cocaine administration differently than passive drug experience (Mutschler, Miczek, & 
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Hammer, 2000). Specifically, rats trained to administer 0.5 mg/infusion of cocaine over 8 
days, followed by a single 16 hr binge session and sacrificed either the day of the binge 
session (0-withdrawal), 24 hr or 14 days following the binge session showed decreased 
expression of zif268 mRNA within the HPC and VTA at the 0-withdrawal time point, and 
decreased in zif268 mRNA expression within the NAc, CP, HPC and BLA at the 14 day 
withdrawal time point compared to yoked-cocaine and saline controls. Zif268 mRNA 
expression was also found to be differentially expressed within the ACC, lateral and basal 
amygdala, NAc, and VTA dependent upon the contingency of cocaine infusions and whether 
discrete cues were paired with contingent cocaine infusions (Thomas, Arroyo, & Everitt, 
2003). Specifically, rats were divided into four groups: paired (light paired with active lever 
depression) and unpaired (intermittent tone played with active lever depression) cocaine 
self-administration (0.25 mg/infusion; 2 hr/session; avg 10 consecutive sessions to stable 
responding), and yoked-cocaine and yoked-saline groups (received same light/cocaine 
pairings as the paired group). Following stable self-administration, rats were kept in their 
home cages for 3 days without drug, followed by a short (5 x 1 sec light presentations) 
exposure to light cues in the operant chambers without lever access and sacrificed one hour 
later. The yoked-cocaine group exhibited enhanced zif268 mRNA within the ACC, ventral 
orbital cortex, lateral orbital cortex, lateral and basal amygdala, NAc, and VTA compared to 
the unpaired cocaine self-administration group and yoked-saline groups. Additionally, 
increased expression was seen in the yoked-cocaine group compared to the paired cocaine 
self-administration group for the ACC, amygdala, NAc and VTA regions. 
 Clearly, the method of cocaine administration has an effect on various aspects of 
neuroplasticity and the conclusions drawn regarding the effects of cocaine or potential route 
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causes of drug addiction would be drastically different based on these experimental 
procedures. Therefore, in the following series of studies, cocaine self-administration is 
utilized to better model human self-administration and hopefully the underlying changes that 
result from contingent drug self-administration. 
1.6.2 Length of self-administration session 
 The length of the self-administration session has been implicated in the progression 
from drug use to addiction, with longer sessions argued to better model this feature of the 
human condition (Ahmed & Koob, 1998; George et al., 2008). Specifically, rats given 6-hr 
versus 1-hr access to cocaine self-administration show an escalation of intake over time and 
only a short-lived return to baseline administration levels following abstinence before a 
reinstated escalation of intake (Ahmed & Koob, 1998). Direct comparisons of these two-
session lengths reveals distinct neuroplasticity within the mPFC (Ben-Shahar et al., 2007, 
2009). Rats were allowed to self-administer either cocaine (0.25 mg/infusion) or saline over 
7 days of training (1-hr sessions), after which the cocaine self-administering group was split 
into 6-hr cocaine access and 1-hr cocaine access groups and all three groups were trained for 
an additional 10 days followed by 1, 14 or 60 days of withdrawal in their home-cages prior to 
sacrifice and immunoblotting procedures (Ben-Shahar et al., 2009). Within the mPFC at 1 
day of withdrawal, select decreases in mGluR1 and mGluR5 protein expression were 
exhibited in the 1-hr access group compared to saline and 6-hr access groups, and homer 1b/c 
was increased in the 6-hr access group compared to the other two groups. At 14 days of 
withdrawal, only the 1-hr access group exhibited a decrease in homer 1b/c expression and 
NR2b was increased in the 6-hr group alone; at the 60-day withdrawal time point the only 
change was an elevation in NR2a within 6-hr access group. 
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 In a similar cocaine self-administration and withdrawal experimental design, Ben-
Shahar et al. (2007) demonstrated via receptor-autoradiography decreased NMDA, and 
increased D2 receptor densities within the mPFC of 1-hr access animals at a 20-minute 
withdrawal time point compared to saline controls, and increased expression of D1 receptors 
within the NAc shell of 6-hr access animals. Moreover, at 14 days withdrawal, there was a 
decrease in D2 receptors within the NAc shell of 1-hr animals compared to saline controls, an 
effect persisting into 60 days of withdrawal.  
Given the data presented revealing distinct neuroplastic changes within the mPFC of 
rats undergoing 6-hr access conditions and the impact of self-administration procedures over 
experimenter administered cocaine, the current series of experiments utilizes an extended 
access (6-hr) cocaine self-administration model to gain insight to the molecular consequences 
of excessive cocaine intake of relevance to the neurobiology of cocaine addiction. 
Additionally, if cocaine is altering non-neuronal cells, we believe we would be more likely to 
detect such changes in a model of robust-drug taking than shorter-access conditions. 
1.7 Summary 
 In summary, the data to date has suggested an integral role of the PFC underlying the 
reinforcing effects of cocaine and cocaine-induced behavioral and cognitive deficits. The 
similar afferent and efferent connections of the vmPFC in human and rodent with other brain 
regions implicated in addiction, cytoarchitectonic features, and related behaviors, make this 
region ideal for comparing the human condition with an animal model that can be more 
easily and reliably manipulated. The human literature is fraught with confounding subject 
factors, such as age of first drug use, duration of use, concurrent use of additional addictive 
substances, other environmental insults and/or physical and/or mental abuse, poverty, 
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coexisting mental disorders, etc, making it impossible to derive cause-effect relations 
between cocaine-taking and abnormal non-neuronal physiology. Given the limited evidence 
for a role of glial cells in addiction, and that experimental methods examining specifically for 
a glial role have demonstrated their influence on various aspects of cocaine-taking and 
seeking, it is imperative to further define the effects of cocaine on each of these cell types. 
Moreover, because these cell types express receptors able to sense the environment and have 
fundamental roles in maintaining the extracellular milieu, health of the brain, signaling 
efficiency, and so on, ignoring their role precludes any advancement in our neurobiological 
understanding of the etiology of cocaine addiction and related disorders, and impedes 
therapeutic progress for disease management. 
1.8 Specific Aims 
 My dissertation seeks to address the following specific aims: 
(1) Characterize glial cell changes in protein and related-mRNA expression in rats 
with extended access to cocaine self-administration. Based on previous clinical 
and preclinical findings of reduced OL myelin integrity, altered astrocytic 
glutamate transporters, and activated immune responses, I hypothesize that 
extended access to cocaine self-administration will decrease OL-specific proteins 
and related-mRNA expression levels, alter levels of astrocyte-specific proteins, 
and increase the levels of microglial markers within the vmPFC, relative to 
cocaine-naïve animals. 
(2) Characterize the behavioral consequences of decreased myelin basic protein 
(MBP) expression on a variety of PFC-dependent tasks, without cocaine 
treatment. Based on the previously discussed importance in myelin integrity and 
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normal expression of specific myelin proteins on normal OL and neuronal 
function, I hypothesize that reducing MBP expression within the vmPFC will 
disrupt normal vmPFC processing resulting in decreased working memory 
function and enhanced impulsive choice, relative to animals without experimental 
manipulation of MBP within the vmPFC. 
(3) Determine the functional significance of decreased myelin basic protein on IV 
cocaine acquisition, maintenance, dose, extinction, and reinstatement.  Based on 
the role of the vmPFC on acquisition of cocaine self-administration, extinction 
and reinstatement tests, I hypothesize that reducing MBP expression within the 
vmPFC will result in enhanced acquisition, delayed attainment of extinction 
criterion and augmented cocaine-seeking under various reinstatement procedures 
compared to animals to animals without experimental manipulation of MBP 
within the vmPFC. 
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Chapter 2 Extended access to cocaine results in decreased oligodendrocyte-specific 
protein expression within the vmPFC 
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2.1 Introduction 
 As discussed in the General Introductiongeneral introduction, cocaine addiction is a 
chronic disorder characterized by impulsivity, compulsive drug-seeking and -taking, and 
serious negative consequences (Camí & Farré, 2003; Jentsch & Taylor, 1999). High rates of 
relapse, even after an extended period of abstinence, and the lack of effective treatment 
options impede lasting recovery. Persistent cocaine-induced neuroadaptations that increase 
the probability of relapse have been identified in animal models of addiction. However, only 
a small literature exists on the role of glial cell types in the etiology of this disease. 
 Several methodologies exist for studying the effects of cocaine on the CNS, common 
forms of administration being either passive, experimenter-administered cocaine, or active 
self-administration of drug. However, a wealth of data suggests that active self-
administration of cocaine induces different neuroplasticity than either passive or 
experimenter-administered drug including: changes in neurotransmitter release and turnover, 
protein expression, and gene expression (see the General Introductiongeneral introduction for 
specific examples; Jacobs et al., 2003). Additionally, the length of the self-administration 
session has been implicated in the progression from drug use to addiction, with longer 
sessions argued to better model the escalation of drug intake in humans (Ahmed & Koob, 
1998; George et al., 2008). Specifically, rats given 6-hr versus 1-hr access to cocaine self-
administration show an escalation of intake overtime and only a short-lived return to baseline 
administration levels following abstinence before a reinstated escalation of intake (Ahmed & 
Koob, 1998).  
 A current trend in the pre-clinical study of addiction, particularly that conducted in 
rodents, is to incorporate a period of forced withdrawal to model periods of abstinence that 
occur frequently in addiction, either due to incarceration or during self-imposed cessation of 
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drug-taking (Fuchs, Branham, & See, 2006). Rodent studies have shown that prolonged 
periods of forced abstinence result in augmented cocaine-seeking behavior following re-
exposure to drug-associated environments and cues. This phenomenon is termed, “incubation 
of craving” (Grimm, Hope, Wise, & Shaham, 2001; Tran-Nguyen et al., 1998). While we do 
not know if this phenomenon occurs in human cocaine addicts, an incubation of craving has 
been demonstrated for nicotine-, methamphetamine-, and alcohol-dependent humans (Bedi et 
al., 2011; Li et al., 2014; Wang et al., 2013). Given the data presented, the current study 
utilizes an extended access (6-hr) cocaine self-administration model to gain insight to the 
short- and long-term molecular consequences of excessive cocaine intake of relevance to the 
neurobiology of cocaine craving and relapse.  
 As discussed in the General Introductiongeneral introduction, the PFC is involved in 
regulating the motivational salience of stimuli and the intensity of behavioral responding 
(Jentsch & Taylor, 1999; Kalivas et al., 2005). Chronic cocaine intake results in aberrant 
activity of the frontal cortex, leading to impaired executive processes such as attention, 
impulsivity, problem-solving and decision making – cardinal features of addiction (Jentsch & 
Taylor, 1999; Kasperski et al., 2011; Lim et al., 2002; Moeller et al., 2005). A neural 
projection particularly important for drug craving and seeking includes efferent fibers from 
the PFC to the NAc (Kalivas et al., 2005). The PFC sends glutamatergic efferents to the NAc 
shell and coreA neural projection particularly important for drug craving and seeking 
includes glutamatergic efferent fibers from the PFC to the NAc core and shell (Kalivas et al., 
2005). Cocaine experience results in amplified PFC glutamate signaling in the NAc because 
of reduced basal glutamatergic tone, resulting in less autoinhibition on PFC efferents and 
increased stimulated glutamate release (Baker et al., 2003; Kalivas et al., 2005). These 
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signals, combined with dopamine signaling from the VTA, lead to a reinstatement of 
cocaine-seeking when drug-related cues or drug-priming injections are administered in 
cocaine-withdrawn animals (Kalivas, Volkow, & Seamans, 2005; Kalivas et al., 2005; 
LaLumiere et al., 2012). Manipulations that reduce the activity of distinct PFC and NAc 
subregions have been shown to attenuate cocaine seeking in cocaine-withdrawn and/or 
behaviorally extinguished animals (Koya et al., 2009; LaLumiere et al., 2012; Ma et al., 
2014). Specifically, microinjections of baclofen/muscimol to induce inactivation of the 
vmPFC of rats decreased responding during an extinction test conducted at 30 days of forced 
abstinence from long-access (6-hr/day; 10 days) cocaine self-administration, demonstrating a 
neutralizing effect to the incubation of craving phenomemon normally seen at this time point 
of forced-abstinence (Koya et al., 2009). The incubation of craving phenomenon has also 
been linked to distinct connections between subregions of the PFC and NAc, and the 
maturation of silent-synapses within the NAc over a period of protracted withdrawal, 
whereby the formation of new synapses are composed mainly of NMDA receptors and their 
maturation includes the recruitment of calcium-permeable AMPA receptors (Ma et al., 2014). 
Within the NAc shell, reversal of silent-synapse maturation by optogenetic induced LTD of 
IL efferents, results in enhanced cue-induced cocaine seeking at a 45 day withdrawal time 
point when rats were previously trained to self-administer cocaine (0.75 mg/mg; 40 infusions 
during a single overnight session followed by 5 days of 2-hr/day access). Interestingly, when 
the NAc core silent-synapse maturation was reversed by the same optogenetic induced LTD 
of PL afferents, cue-induced cocaine craving at 45 days withdrawal was decreased to an even 
lower level than seen on day 1 of withdrawal. Therefore, the projections from the PFC to 
NAc subregions provide a neural circuit where malfunction in glial cell types could have an 
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impact on both intra- and intercellular communication resulting in excessive drug taking and 
seeking behavior. 
 As reviewed in the general introduction, glial cells have been shown to have essential 
roles in the regulation of neurotransmission, conduction of nerve impulses, neurotransmitter 
metabolism (including release), supply of energy metabolites, development and formation of 
synaptic connections, and healing damage (Crews et al., 2011; Miguel-hidalgo, 2009; Ullian 
et al., 2001). Astrocytes, OLs, and microglia also express receptors for many 
neurotransmitters and peptides (e.g., DA, glutamate, & GABA), making these cell types 
sensitive to neurochemical changes resulting from the administration of cocaine (Volterra & 
Meldolesi, 2005). Indeed, cocaine administration and withdrawal from cocaine both have 
been shown to increase the expression of GFAP, along with significant modifications in 
astrocyte number, size and shape complexity, within the dentate gyrus, PFC and NAc 
(Bowers & Kalivas, 2003; Fattore et al., 2002). Consistently, alterations in the 
cystine/glutamate exchanger, which permits astrocytic control over basal extracellular 
glutamate levels, alters glutamate signaling within the NAc and mediates reinstatement of 
drug seeking (Baker et al., 2003).  
 While astrocytes do not show classical electrical signaling characteristics of neuronal 
activation (i.e. action potentials), they have a form of calcium signaling initiated both 
spontaneously and through receptors on the cell surface (Araque, 2008). Calcium waves can 
be generated through stimulation of ionotropic receptors, allowing direct entry of calcium 
from the extracellular space, or through stimulation of metabotropic receptors, which activate 
IP3-dependent pathways (Káradóttir & Attwell, 2007). These calcium waves can propagate 
through the exchange of IP3 via gap junctions composed of connexin 30 and 43 proteins 
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(Cx30 and Cx43, respectively); hemichannels composed of these proteins are known to 
release ATP into the extracellular space leading to further calcium wave spread among 
neighboring astrocytes (Perea & Araque, 2002; Stout, Costantin, Naus, & Charles, 2002). 
Based on the existing literature of cocaine-mediated astrocyte alterations in cystine/glutamate 
exchange and astrocyte calcium signaling, we examined for changes in astrocyte specific 
proteins. Glutamine synthetase (GS), Cx30 and Cx43 expression levels were measured to 
determine whether glutamate recycling and intracellular communication were perturbed 
following long access to cocaine self-administration in short-term withdrawal and during 
long-term withdrawal during which animals exhibit incubated cocaine-seeking behavior. 
 As previously mentioned, chronic cocaine use in humans has been consistently 
correlated with reduced white matter volume (Bartzokis et al., 2002; Lim et al., 2002; 
Moeller et al., 2007; Moeller et al., 2005). This could reflect a disruption in the connectivity 
and efficiency of signaling within and between the PFC and underlying reward circuitry, and 
possibly account for the cognitive and behavioral control deficits leading to the abnormal 
drive for cocaine. Microarray analyses of post-mortem tissue from human cocaine addicts 
revealed reductions in the expression of myelin-related genes including myelin basic protein 
(MBP), proteolipid protein (PLP), myelin oligodendrocyte basic protein (MOBP), and 
myelin and leukocyte T-cell differentiation protein 2 within the NAc (Albertson et al., 2004). 
The abundance of MBP transcripts alone was sufficient to classify subjects as cocaine 
abusers with 80% accuracy (Albertson et al., 2004). Therefore, OL-specific proteins relating 
to myelin integrity were also examined for cocaine-induced decreases in expression during 
withdrawal from long access cocaine self-administration. 
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 Microglial cell activation has been linked to depression, a common co-morbid 
affective disorder with addiction (Crews et al., 2011). Alcohol, methamphetamine, 
depression and stress all have been shown to enhance innate immune gene induction within 
microglia (Crews et al., 2011). Stress has also been widely used as a mechanism to initiate 
relapse to drug seeking within cocaine experienced animals, and both stress and drugs of 
abuse lead to microglial activation that promotes microglial proliferation (Bossert, Marchant, 
Calu, & Shaham, 2013; Graeber, 2010). There is evidence that repeated alcohol use leads to 
cycles of immune gene activation which correlates with a decrease in positive affect and an 
increase in anxiety-like behaviors in rodents; common features seen in animals following a 
period of withdrawal from abused substances (Crews et al., 2011). Additionally, cells 
exposed to cocaine in culture and rats self-administering cocaine result in enhanced 
inflammation related-transcripts and markers of oxidative stress (Ahmed et al., 2005; Clark et 
al., 2013; Costa et al., 2013; Jang et al., 2014; Piechota et al., 2010). Microglia and 
macrophages express CD11b, an integrin important in migration, adhesion, and phagocytosis 
and a marker often used for identifying these cells types (Davis & Carson, 2013). To 
examine possible changes in microglial cell numbers following cocaine self-administration, 
the levels of microglial specific protein, CD11b, were measured.  
 It was hypothesized that long-access to cocaine self-administration would lead to 
changes in glial protein expression within the NAc and PFC. Additionally, it is hypothesized 
that varying withdrawal periods would produce differential effects on these protein changes, 
which might relate to the incubation of craving phenomenon. 
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2.2 Methods 
2.2.1 Animals 
 Adult (275-325 g) male Sprague-Dawley rats (Charles River Laboratories, Hollister, 
CA) were housed in a colony room controlled for temperature (25 °C) and humidity (71%), 
under a 12-hr reverse cycle room (lights on at 20:00 hrs). Animals were given ad libitum 
access to food and water, except during lever response training for food reinforcement. 
Animals were allowed to acclimate to the colony room for three days following arrival then 
were handled daily till self-administration procedures were complete. All animal procedures 
were in accordance with the guidelines of the National Institutes of Health Guide for Care 
and Use of Laboratory Animals (Publication 80-23, revised 1996) and were reviewed and 
approved by the University of California Santa Barbara, Institutional Animal Care and Use 
Committee.  
2.2.2 Lever Response Training 
 To encourage lever-pressing behavior for saline and cocaine, animals were first 
trained to lever press for food reinforcement using identical methods to those described by 
our group (Ben-Shahar et al., 2013; 45 mg pellets; Noyes, Lancaster, NH) on a FR1 schedule 
in sound-attenuating operate conditioning chambers (30 x 20 x 24 cm high; Med Associates 
Inc., St. Albans, VT) during either an overnight training session or during daily 1-hr training 
sessions (depending on the availability of operant chambers). Animals were food deprived 
24-hr prior to the initiation of training and maintained on a restricted diet for the duration of 
food training. The operant chambers contained two retractable levers with a stimulus light 
located above each lever, a food pellet dispenser located outside the operant chamber, a food 
trough between the levers, a house light on the opposite wall to the levers, a speaker 
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connected to a tone generator (ANL-926, Med Associates), and a fan to provide ventilation 
and mask extraneous noise. During the session, pressing the active lever resulted in the 
delivery of a food pellet and pressing the inactive lever had no programmed consequence. 
Animals that failed to reach the criterion of a minimum of 200 responses on the active lever 
during the overnight session, or a minimum of 100 responses on the active lever during two 
consecutive 1-hr sessions, received additional food training sessions until criterion was 
reached. Following successful acquisition of lever-pressing behavior (1 to 2 overnight 
sessions or 5-7 days of 1-hr daily sessions), food was freely available in the animal’s 
homecage for the remainder of the study. 
2.2.3 Surgery 
 Following lever response training, animals underwent surgical implantation of 
chronic IV catheters as previously described by our group (e.g., Ben-Shahar et al., 2013). 
Under ketamine/xylazine anesthesia (56.25 and 7.5 mg/kg, respectively, administered 
intramuscularly (IM); Abbott Laboratories, North Chicago, IL), animals were implanted with 
a chronic silastic catheter (13 cm long; 0.3 mm inner diameter, 0.64 mm diameter; Dow 
Coming Corporation, Midland, MI) into the right jugular vein. Each catheter ran 
subcutaneously around the shoulder to back where it was secured to a threaded 22-gauge 
metal guide cannula (Plastics One, Roanoke, VA), which surfaced from the midline of the 
animal’s back between the shoulder blades. A plastic plug covered the open end of the 
cannula to protect from contamination, and a smooth metal nut was secured around the 
threading of the cannula to prevent animals from chewing the catheter port. The cannula was 
held in place with a small square of Bard Mesh (C. R. Bard Inc., Cranston, RI) to which it 
was cemented, and the mesh was laid flat subcutaneously on the animal’s back. Banamine (2 
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mg/kg, subcutaneous, Butler Schein Animal Health, Dublin, OH) was administered to treat 
post-surgical pain. All animals were allowed a minimum of 5 days for recovery and IV 
catheter patency was maintained by flushing daily with 0.1 ml of sterile heparin (60 IU/ml; 
Sagent Pharmaceuticals, Schaumburg, IL) and timentin/saline (100 mg/ml; 
GlaxoSmithKline, Research Triangle Park, NC) or 0.1 Gentimicin/Cefazolin (1 mg/ml, 
Butler Schein Animal Health, and 5 mg/ml, Westward Pharmaceuticals, Eatontown, NJ, 
respectively). 
2.2.4 Self-Administration Training 
 Following surgical recovery, animals (n=10-15 per group at the start of each 
experiment) were trained to self-administer IV cocaine (0.25 mg/0.1 ml/infusion; National 
Institute on Drug Abuse, Bethesda, MD) during daily 6-hr sessions, or saline (0.1 
ml/infusion) during 1-hr or 6-hr sessions, on a FR1 schedule of reinforcement. At the 
beginning of each session, the animal’s catheter was connected to a motorized pump (located 
outside of the sound attenuated chamber) via a liquid swivel as previously described (e.g., 
Ben-Shahar et al., 2013). Active lever responses elicited a 5-sec activation of the infusion 
pump and a 20-sec presentation of a visual (white light) and auditory (tone generator, 70 dB, 
2 kHz) stimulus combination, during which additional responses had no consequences. 
Responses on the inactive lever were recorded but had no programmed consequences. 
Animals were trained to self-administer cocaine or saline for 10 sessions. To prevent 
overdose, the number of cocaine infusions permitted during the first two training sessions 
were limited at 100 (session 1) and 150 (session 2) and animals failing to meet self-
administration criterion (minimum of 50 infusions/6-hr session for the last 3 days of training) 
were excluded from the study. 
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 Two saline control groups were included in the current immunoblotting study to 
replicate previous results showing no protein expression differences between extended (6-hr) 
with short (1-hr) access to IV saline and to extend these findings to glial-specific proteins 
(Ben-Shahar et al., 2013; Ben-Shahar, Ahmed, Koob, & Ettenberg, 2004). In Expts 1 and 2, 
cocaine 6-hr and saline 6-hr animals were compared for protein expression alterations at 3 
and 30 days withdrawal following a cue-seeking test or untested, respectively. Expt 3a 
compared saline 1-hr and saline 6-hr at 3 and 30-days withdrawal following a cue-seeking 
test, and subsequent immunoblotting in Expt 3b only examined for 6-hr cocaine and 1-hr 
saline protein expression alterations during withdrawal, with or without cue-testing. All self-
administration training and testing occurred during the dark phase of the light cycle. 
Following the 10 days of self-administration training, animals remained in the colony room 
for a minimum of 3 days of withdrawal. 
2.2.5 Tests for Cue-elicited Cocaine-seeking 
 In Expts 1, 3a, and 3b, saline and cocaine self-administering animals were subjected 
to a 2-hr test for cue-elicited cocaine seeking under extinction conditions at either 3 or 30 
days of withdrawal from the last day of cocaine self-administration (Rats in Expt 3b were 
only tested at the 3 day withdrawal time point). The duration of this test was chosen to 
capture potentially relevant changes in receptor protein expression from the Ben-Shahar et 
al., 2013 publication, however, results show this test does not significantly affect MBP 
expression, the main protein of interest to this dissertation (see results and Table 6). Animals 
were tethered as with self-administration training and lever-press responses were recorded. 
Responses on the active lever elicited the tone + light compound stimulus previously paired 
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with cocaine/saline infusions, but no infusions were administered during this test. Responses 
on the inactive lever had no programmed consequences, but were recorded.  
2.2.6 Immunoblotting 
 At 3 or 30 days of withdrawal or immediately upon completion of the 2-hr cue test 
under extinction conditions at these two time points, animals were killed by rapid 
decapitation (Expt 1-3a), or anesthetized with 4% isoflurane (Expt 3b) and, as conducted by 
others (see Ghasemzadeh, Vasudevan, Mueller, Seubert, & Mantsch, 2009; Obara et al., 
2009) the dmPFC (anterior cingulate and dorsal PL cortices), vmPFC (ventral PL and IL 
cortices), NAc shell and core were dissected out over ice as indicated in Figure 1 (PFC and 
NAc). 
 As described previously by our group (Obara et al., 2009), the tissue for 
immunoblotting in Expts 1-3a was homogenized in a medium consisting of 0.32 M sucrose, 
2mM EDTA, 1% w/v sodium dodecyl sulfate, 50 µM phenyl methyl sulfonyl fluoride, and 1 
µg/ml leupeptin (pH=7.2) and 1 mM sodium fluoride, 50 mM sodium pyrophosphate, 20 mM 
2-glycerol phosphate, 1 mM p-nitrophenyl phosphate, 1 mM orthovanadate, and 2 µM 
microcystin LR were included to inhibit phosphatases. Samples were then subjected to low-
speed centrifugation at 10,000 g for 20 min. Protein determinations utilized the Bio-Rad DC 
protein assay (Bio-Rad, Hercules, CA), according to the manufacturer’s instructions and 
homogenates were stored at -80 °C. For Expt 3b, which involved tissue processing for both 
immunoblotting and qRT-PCR techniques, the methods are described in section 2.2.7 below. 
 For immunoblotting, protein samples (20 µg/lane) were subjected to SDS-
polyacrylamide gel electrophoresis and non-reduced when run on Bis-Tris gradient gels (4-
12%) and Tris-Glycine gradient gels (4-20%) (Invitrogen, Carlsbad, CA) or reduced when 
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run on Tris-Acetate gradient gels (3-8%) (Invitrogen). Bis-Tris gradient gels were used for 
separation of Cx30, Cx43, GS, MBP, MOG, and PLP, Tris-Glycine gradient gels for CLN, 
Cx32, and MAG and, Tris-Acetate gradient gels were used for separation of CD11b, CNP, 
Cx47, NF155, NG2+, and UGT8. Proteins were transferred to wet polyvinylidene difluoride 
(PVDF, BioRad) membranes, and were pre-blocked with phosphate-buffered saline 
containing 0.1% (v/v) Tween-20 and either 5% (w/v) bovine serum albumin (for CD11b,   
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Figure 1. Pictogram depicting the loci of dissection to obtain tissue for immunoblotting and 
qPCR. Whole brains were sliced into 2 mm sections using a brain mold. Tissue was then 
collected by gross dissection from the vm- and dm-PFC (A) using small forceps. The NAc 
shell and core (B) were extracted using a 16 ¾ gauge punch.   
PL#
IL#
Cg1#
dmPFC#
vmPFC#
shell%
core%
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Cx30, Cx43, Cx47, MBP, MOG, and NG2+), 1.5% normal horse serum or 5% (w/v) nonfat 
dried milk powder (for all other proteins) for no less than 2-hr at room temperature or 
overnight at 4 °C, followed by a 2-hr incubation with primary antibodies. The following 
primary antibodies were used: rabbit- anti-CD11b (Novus Biologicals, Littleton, CO; 1:500 
dilution); mouse-anti-CNPase (Millipore, Temecula, CA, 1:500 dilution); rabbit-anti-Cx30 
(Invitrogen, Carlsbad, CA; 1:500 dilution); mouse-anti-Cx32 (Chemicon International, 
Millipore); mouse-anti-Cx43 (Millipore; 1:1000 dilution); rabbit-anti-Cx47 (Invitrogen; 
1:500 dilution); rabbit-anti-GS (Thermo Fisher Scientific, Rockford, IL; 1:10,000 dilution); 
mouse-anti-myelin associated glycoprotein (Millipore; 1:1000 dilution); rabbit-anti-MBP 
(GenWay Biotech, San Diego, CA; 1:1000 dilution); goat-anti-MOG (LifeSpan Biosciences, 
Seattle, WA; 1:1000 dilution); mouse-anti-Neurofascin (R&D Systems, Minneapolis, MN; 
1:500 dilution); rabbit-anti-NG2 Chondroitin Sulfate Proteoglycan (Millipore; 1:1000 
dilution); rabbit-anti-oligodendrocyte specific protein (claudin-11 or CLN; Abcam, 
Cambridge, MA; 1:1000 dilution); mouse-anti-PLP (Millipore; 1:1000 dilution); rabbit-anti-
UGT8 (Proteintech Group Inc., Chicago, IL; 1:500 dilution). Membranes were washed, 
incubated with a horseradish peroxidase-conjugated anti-rabbit secondary antibody 
(Millipore; 1:40,000-1:100,000 dilution), anti-mouse secondary antibody (Jackson Immuno 
Research Laboratories, West Grove, PA; 1:40,000 dilution), or anti-goat secondary (Jackson 
Immuno Research Laboratories, West Grove, PA; 1:20,000 dilution) for 90 min at room 
temperature, washed again, and immunoreactive bands were detected by enhanced 
chemiluminescence using either ECL Plus (Amersham Biosciences, GE Healthcare Life 
Sciences, Pittsburgh, PA) or Pierce SuperSignal West Femto (Thermo Fisher Scientific, 
Rockford, IL). A rabbit anti-calnexin polyclonal primary antibody (Stressgen, Victoria, BC; 
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1:1000 dilution) was also used to index protein loading, transfer, and as a reference protein 
for comparison. The levels of immunoreactivity for all proteins were quantified using Image 
J (NIH, Bethesda, MD). 
 Each immunoblotting gel contained samples from each of the four treatments so 
comparisons could be made across drug treatment and withdrawal time-point or cue-testing 
experience. The goal of Expt 1 was to determine whether or not the incubation of cocaine 
craving phenomenon that occurs with the passage of time during withdrawal (WD) was 
correlated with altered expression of glial-associated proteins. Thus, all rats in Expt 1 were 
subjected to our cue test procedure to confirm the presence of incubated responding and the 
following four groups were compared for protein expression: SAL6h-3 days WD, SAL6h-30 
days WD, COC6h-3 days WD and COC6h-30 days WD. Expt 2 was conducted to determine 
whether the effects of cocaine self-administration history upon protein expression reflected 
merely a pharmacodynamic response to cocaine. To address this question, rats were left 
undisturbed in their home cages during withdrawal and did not undergo cocaine-seeking test 
procedures. I compared protein expression across the following 4 groups: SAL6h-3 days 
WD, SAL6h-30 days WD, COC6h-3 days WD and COC6h-30 days WD. Expt 3a directly 
compared 1-hr and 6-hr saline self-administration at 3 and 30 days withdrawal with a 2-hr 
cue-seeking test prior to sacrifice on the same glial-specific proteins. I compared the protein 
expression across the following 4 groups: SAL1h-3 days WD, SAL1h-30 days WD, SAL6h-
3 days WD, SAL6h-30 days WD. As the results from Expt 3a failed to indicate significant 
group differences in protein expression between rats allowed short vs. extended access to 
saline (see Results below), I opted to employ short-access saline self-administration 
procedures for Expt 3b to accommodate for the number of animals required for the direct 
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comparison of protein expression between cue-tested and test-naïve subjects. Secondly, in 
Expt 3b, I directly compared the tissue from animals subjected to our cue-testing procedure 
with tissue derived from animals left undisturbed in the home cage to confirm whether or not 
differences existed in the magnitude of saline-cocaine differences in protein expression 
revealed in Expts 1 & 2. Moreover, as the data from Expts 1 & 2 failed to indicate a main 
effect of, or interaction with, the Withdrawal factor (see Results below), all tissue was 
collected for Expt 3b at 3 days withdrawal only. Expt 3b compared protein expression in the 
following four groups at 3 days WD: SAL1h-cue-tested, SAL1h-untested, COC6h-cue-
tested, and COC6h-untested. 
 The immunoreactivity of proteins bands of interest for each sample was first 
normalized to their respective calnexin immunoreactivity. Then the relative change in protein 
immunoreactivity was expressed as a percent of the average immunoreactivity of SAL1h-3 
days WD (or SAL6h-3 days WD) group on the corresponding gel (n=3-4/gel).  This latter 
procedure was conducted to reduce inter-membrane variability resulting from different 
chemiluminescence and developing procedures.  
2.2.7 Quantitative Real-time Polymerase Chain Reaction (qRT-PCR) 
 In Expt 3b, animals were anesthetized with 2-3% isoflurane, decapitated, and the 
vmPFC was dissected out over ice as described for immunoblotting. This region was selected 
for study as it exhibited the most robust saline-cocaine differences in protein expression as 
determined by immunoblotting. Tissue samples were homogenized in QIAzol lysis reagent 
(Qiagen, Louisville, KY), using the Qiagen TissueRuptor, and separated into aqueous and 
organic phases by the addition of chloroform and centrifugation at 12,000 g. The aqueous 
phase was removed and purified for total RNA following the manufacturer’s instructions 
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using the RNeasy Lipid Tissue Mini Kit (Qiagen), and was tested for quantity and purity 
using a Nanodrop 1000 spectrometer (Thermo Scientific). A total of 500 ng of RNA was 
used for cDNA synthesis via reverse transcription PCR (RT-PCR) using the iScript cDNA 
Synthesis Kit according to manufacturer’s instructions (BioRad); aliquots of each sample for 
RT-PCR set were run without reverse transcriptase (aka NRT) as a negative control. The 
resulting cDNA was diluted first to 100 ng/µl for a stock solution, and then to 25 ng/µl to be 
used in qPCR analyses. qPCR was performed using the Sso Advanced Universal SYBR 
Green Supermix (BioRad) with a 20 µl reaction volume; this reaction mixture consisted of 10 
µl of the SYBR Green supermix, 6 µl biological grade water, 2 µl of 25 ng/µl cDNA, and 2 
µl of 0.01 nmol/µl forward and reverse primer. The reaction mixture was subjected to various 
cycling protocols in a BioRad CFX96 thermocycler depending on the target gene (Table 3). 
Oligonucleotide primer pair sequences were referenced from Padhi & Pelletier (2012), and 
generated by Eurofins MWG Operon (Huntsville, AL), except the reference gene 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which was developed by Integrated 
DNA Technologies (IDT, Coralville, IA); primer details and PCR conditions are presented in 
Table 3. All primer conditions were initially tested for specificity via a melting curve 
analysis (65 oC to 95 oC, in 0.5 oC increments every 3 sec) and were visualized on a 1% 
agarose gel with 50 µl of ethidium bromide. Each target sample was set to run in a technical 
duplicate for the target gene and with the GAPDH control gene. Negative controls consisted 
of NRT samples from each RT-PCR reaction, as well as a reaction devoid of cDNA (aka 
NTC). A serial dilution of 1:3 was done on 100 ng/µl control cDNA and run to measure the 
standard curve and efficiency of the reaction mixture; only plates with 90-110% efficiency 
were used for analysis. 
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2.2.8 Immunoblotting for samples generated for RNA and protein determination 
 The organic phase of the tissue preparation with QIAzol lysis reagent was further 
processed for the extraction of total protein. Any remaining aqueous phase was removed and 
isopropanol added to precipitate protein followed by centrifugation at 12,000 g. The 
supernatant was removed and the protein pellet was incubated in 0.3 M guanidine-
hydrochloride in 95% ethanol, followed by centrifugation at 7500 g, the supernatant removed 
and the process repeated twice. The protein pellet was air dried, re-suspended in 10 M urea 
and 50 mM DTT in water, broken up with a needle and incubated at room temperature for 1-
hr. Samples were then incubated at 95 °C for 3 minutes, sonicated in short bursts, and 
centrifuged at 10,000 g. 5 µl of loading dye consisting of 20% glycerol, 0.004% 
bromophenol blue, and 0.125 M Tris HCl, was added to 20 µl of each sample, vortexed and 
loaded into a Bis-Tris gradient gel (4-12%; Invitrogen). Following electrophoresis, proteins 
were transferred to PVDF membranes and further processed via immunoblotting procedures 
as described earlier. 
2.2.9 Statistical Analysis 
 Behavioral data statistical methods 
Two-way ANOVAs were conducted to examine for IV Treatment (COC vs SAL) X 
Test (Cue-tested vs Untested) interactions regarding the number of infusions, active lever 
presses, and inactive lever presses. For the cue-tested animals, two-way ANOVAs for IV 
Treatment (COC vs SAL) X Lever (active vs inactive) were conducted. Fisher’s LSD tests 
for multiple comparisons were used to deconstruct significant interaction effects. 
Significance was set at alpha = 0.05. 	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 Immunoblotting statistical methods 
Two-way ANOVAs were conducted on the data from the immunoblotting studies to 
examine for IV Treatment (COC 6h vs SAL 6h, or SAL 1h vs SAL 6h) X Withdrawal (3 or 
30 days following the last self-administration session) interactions, or for IV Treatment X 
Test (Cue-tested vs Untested) interactions. Fisher’s LSD tests were used to deconstruct 
significant interaction effects. Significance was set at alpha = 0.05.  
 qPCR statistical methods 
 Relative quantities of RNA transcripts were calculated, and normalized to SAL 1h-
untested levels, then subsequently normalized to the reference gene GAPDH according to 
methods described in Hellemans, Mortier, De Paepe, Speleman, & Vandesompele (2007). 
Values were then compared in a two-way ANOVA of Treatment X Test. 
All Data were analyzed with Prism 6 for Mac OS X, version 6 (GraphPad, Software Inc.). 
2.3 Results 
2.3.1 Expt 1: Examination of the effects of withdrawal from cocaine self-administration 
upon the expression of glial-related proteins in animals tested for cocaine craving 
during early and protracted withdrawal 
 As detailed in Ben-Shahar et al., 2013, rats with a 10-day history of 6-h access to IV 
cocaine exhibited a time-dependent intensification of responding on the active, cocaine-
associated, lever when assessed under extinction conditions (i.e., an incubation of cocaine 
craving).  Cocaine rats did not exhibit time-dependent changes in inactive lever responding, 
indicating that, the behavior of cocaine rats was selective for the cocaine-associated lever and 
therefore goal-directed. 
I, thus, examined for saline-cocaine differences in the change in glial-specific protein 
expression in animals tested for cue-reinforced behavior at 3 versus 30 days withdrawal. 
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Relative to rats with extended access to saline, cocaine self-administration produced early 
and persistent reductions in glial-specific protein expression within distinct subregions of the 
PFC and NAc during withdrawal (vm- and dmPFC immunoblotting data is summarized in 
Table 4). A comparison of vmPFC protein levels between saline and cocaine animals at 3 or 
30 days withdrawal revealed significant main effects of IV Treatment for MBP (Figure 2) 
[F(1,32)=5.96, p=0.021], MOG [F(1,35)=7.67, p=0.009], and NG2+ [F(1,36)=4.52, 
p=0.040]. The results of the ANOVA for these proteins did not indicate significant main 
effects of Withdrawal or significant IV Treatment X Withdrawal interactions (all p’s>0.05). 
Analyses of the other proteins examined within the vmPFC failed to reveal any group 
differences in protein expression (two-way ANOVAs, all p’s>0.05). Moreover, no 
statistically significant group differences in protein expression were found within the dmPFC 
for any of the proteins examined (two-way ANOVAs: all p’s>0.05). 
 Within the NAc core, a comparison of protein levels between IV Treatment and 
Withdrawal revealed a significant main effect of IV Treatment for Cx43 expression only 
(Figure 3) [F(1,48)=7.84, p=0.008; 2-way ANOVAs, all other p’s>0.05]. No statistically 
significant changes in protein expression were found within the NAc shell for either IV 
Treatment or Withdrawal for any of the proteins examined (two-way ANOVAs: p’s >0.05). 
2.3.2 Expt 2: Examination of the effects of withdrawal from cocaine self-administration 
upon the expression of glial-related proteins in the absence of behavioral testing 
 Due to the significant glial-protein expression changes observed within the vmPFC of 
Expt 1, I took a more focused approach in Expt 2 and only included the PFC subregions for 
this subsequent analysis. Relative to rats with extended access to saline, cocaine self-
administration produced early and persistent augmentations in glial-specific protein 
expression within distinct subregions of the PFC. In the vmPFC, a significant interaction 
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A. 
 
B. 
                
 
Figure 2. vmPFC immunoblotting results from Expt 1. Rats self-administering cocaine 
(COC) during extended access (6h) procedures and experiencing a 2h cocaine-seeking test 
prior to sacrifice exhibited decreased expression of MBP, MOG, and NG2+ within the 
vmPFC early in withdrawal (WD; 3 days), an effect that persisted into protracted withdrawal 
(30 days) compared to saline (SAL) self-administering controls. (A) The optical density for 
each protein within a treatment condition is represented as a percent of the SAL 6h-3 WD 
condition. (B) Representative immunoblots from SAL 6h-3 WD, SAL 6h-30 WD, COC 6h-3 
WD and COC 6h-30 WD treatment conditions. Calnexin (CAL) is used as a reference protein 
to control for differences in gel loading, and is not significantly affected by IV Treatment or 
Withdrawal conditions. *p<0.05, IV Treatment main effect of COC versus SAL. 
  
SAL$6h'3;$SAL$6h'30;$COC$6h'3;$COC$6h'30$
CAL$
MBP
MOG
NG2(+)
Calnexin
MBP
MOG
NG2(+)
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A. 
 
B. 
                  
 
Figure 3. NAc core immunoblotting results from Expt 1. Rats self-administering cocaine 
(COC) during extended access (6h) procedures and experiencing a 2h cocaine-seeking test 
prior to sacrifice exhibited decreased expression of Cx43 within the NAc core early in 
withdrawal (WD; 3 days), an effect that persisted into protracted withdrawal (30 days) 
compared to saline (SAL) self-administering controls. (A) The optical density for each 
protein within a treatment condition are represented as a percent of the SAL 6h-3 days 
withdrawal condition. (B) Representative immunoblots from SAL 6h-3 WD, SAL 6h-30 
WD, COC 6h-3 WD and COC 6h-30 WD treatment conditions. Calnexin (CAL) is used as a 
reference protein to control for differences in gel loading, and is not significantly affected by 
IV Treatment or Withdrawal conditions. *p<0.05, IV Treatment main effect of COC versus 
SAL.     
SAL$6h'3;$SAL$6h'30;$COC$6h'3;$COC$6h'30$
CAL$
Cx43$Cx43
Calnexin
Cx43
Calnexin
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between IV Treatment and Withdrawal was observed for Cx30 [F (1,51=6.01, p=0.018], 
Cx32 [F (1,49)=6.32, p=0.015], and PLP monomer [F (1,52)=3.96, p=0.052] (Figure 4). The 
PLP monomer levels exhibited by SAL 6h-3 were significantly lower than the other groups 
tested (post-hoc tests, p’s<0.05). For both Cx30 and Cx32 expression, the SAL 6h-3 
withdrawal group was significantly lower to COC 6h-3 and SAL 6h-30. For both PLP 
monomer and Cx30, the significant effects appear to be driven by a withdrawal effect within 
the SAL 6h groups, as the COC 6h groups are equivalently elevated compared to SAL 6h-3 
rats at both withdrawal time-points. Cx32 expression within COC 6h groups, while not 
significant, appears to be elevated at the 3-day withdrawal time point and return to the levels 
expressed by SAL 6h-30 controls. However, Cx32 significantly increased across withdrawal 
within IV SAL 6h animals, indicating an interesting interaction between the normal elevation 
in expression seen in SAL 6h animals and cocaine experience. 
In addition, I observed main effects of IV Treatment, but no main effects of 
Withdrawal or IV Treatment X Withdrawal interactions, for several other proteins within the 
vmPFC that reflected an elevation of protein expression in cocaine- versus saline-
experienced animals. These included: CLN [F (1,48)=12.12, p=0.001], MBP [F (1,51)=6.79, 
p=0.012], MOG [F (1,50)=5.96, p=0.018], and GS [F (1,52)=7.81, p=0.007]. Interestingly, 
although the PLP monomer was elevated in cocaine versus saline animals, the PLP dimer 
expression was decreased, in a manner independent of time in withdrawal [F (1,48)=8.35, 
p=0.006]. These data indicate that a mere history of cocaine self-administration is sufficient 
to produce enduring changes in vmPFC expression of glial-specific proteins.
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A. 
B. 
Figure 5. dmPFC immunoblotting results from Expt 2. Rats self-administering cocaine 
(COC) during extended access (6h) procedures and untested prior to sacrifice exhibited 
decreased expression of Cx32 within the dmPFC early in withdrawal (WD; 3 days), an effect 
that persisted into protracted withdrawal (30 days) compared to saline (SAL) self-
administering controls. A significant increase in MOG expression was seen in protracted 
compared to early withdrawal. (A) The optical density for each protein within a treatment 
condition is represented as a percent of the SAL 6h-3 WD condition. (B) Representative 
immunoblots from SAL 6h-3 WD, SAL 6h-30 WD, COC 6h-3 WD and COC 6h-30 WD 
treatment conditions. Calnexin (CAL) is used as a reference protein to control for differences 
in gel loading, and is not significantly affected by IV Treatment or Withdrawal conditions. 
*p<0.05, IV Treatment main effect of COC versus SAL; ^p<0.05, Withdrawal main effect of
3 versus 30 days. 
SAL$6h'3;$SAL$6h'30;$COC$6h'3;$COC$6h'30$
CAL$
Cx32$
MOG$
$
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 Within the dmPFC of rats left undisturbed in the home cage following self-
administration experience, a few changes in protein expression were revealed by the two-way 
ANOVAs (Figure 5). A significant main effect of IV Treatment for Cx32 revealed a 
reduction in protein expression following cocaine experience [F (1,52)=4.51, p=0.039], but 
no main effect of Withdrawal or IV Treatment X Withdrawal interaction (p’s>0.05)]. MOG 
levels were elevated at the 30d withdrawal time-point, regardless of self-administration 
experience [Withdrawal effect: F (1,49)=6.07, p=0.017; IV Treatment effect and IV 
Treatment X Withdrawal interaction, p’s>0.05]. The findings for the dmPFC are summarized 
in Table 4. As the dmPFC exhibited only a few significant protein changes in Expt 2, all 
subsequent studies (with the exception of adolescent studies conducted in Chapter 3) focused 
exclusively on the vmPFC. 
2.3.3 Expt 3a: Comparison of the effects of a history of short (1-h) versus extended (6-h) 
access to IV saline and behavioral testing upon protein expression. 
 In Ben-Shahar et al., 2013, rats allowed either short (1h) or long (6h) access to IV 
saline exhibited very similar levels of cue-reinforced responding in the absence of further IV 
saline administration. Surprisingly, both groups exhibited a time-dependent increase in active 
lever-pressing, suggestive of an incubation of responding. However, the increase in 
responding was not selective for the active lever and both groups exhibited a similar 
magnitude rise in responding on the inactive lever – an effect that may merely reflect 
behavioral hyper-reactivity to being returned to the operant chamber following a protracted 
period of absence.  
In a manner consistent with behavior, no group differences were observed between 
short- and extended-access saline animals for expression of any of the OL-specific proteins 
within the vmPFC [2-way ANOVAs: no main IV Treatment effects or IV Treatment X 
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Withdrawal interactions, all p’s>0.05]. However, we did observe a main effect of Withdrawal 
for the PLP-dimer, with increased protein expression at the 30-day, compared to the 3-day, 
withdrawal time point [PLP-dimer: F(1,41)=12.00, p=0.001]. Additionally, there was a 
significant decrease in CLN expression levels in SAL 1h and SAL 6h self-administering 
groups at the 30-day, compared to the 3-day, withdrawal time point (Figure 6) [F 
(1,41)=6.01, p=0.019]. No main effects of Withdrawal were significant for any of the other 
proteins (p> 0.05; Table 4). 
2.3.4 Expt 3b: Replication study to test directly for an interaction between self-
administration experience and behavioral testing upon protein expression 
 Expt 1 and 2 found opposite changes in OL-specific protein expression, and because 
these two experiments were conducted at different times and different investigators extracted 
tissue, Expt 3b sought to directly compare experimental procedures on animals run through 
self-administration at the same time with tissue extracted by a single investigator. 
 Self-administration behavior 
During self-administration training, cocaine animals earned significantly greater 
infusions than saline controls, and the number of infusions earned were equivalent between 
the rats slated for cue-testing and those slated to remain in their home cage during 
withdrawal [IV Treatment effect: F (1,44)=1142.00, p<0.0001; no Testing effect or IV 
Treatment X Testing interaction, p’s>0.05]. Average infusions were as follows: saline-
untested: 5.03 + 1.17, n=13; saline-tested: 4.15 + 0.68, n=11; cocaine-untested: 94.97 + 3.77, 
n=12; cocaine-tested: 97.64 + 3.63, n=12. All behavioral data is listed in Table 5. 
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A. 
 
B. 
          
 
Figure 6. vmPFC immunoblotting results from Expt 3a. Rats self-administering saline (SAL) 
during short (1h) or extended access (6h) procedures and experiencing a 2h cocaine-seeking 
test prior to sacrifice exhibited decreased expression of CLN and increased expression of 
PLP dimer within the vmPFC at 30 days (30) withdrawal (WD) compared to the 3 day (3) 
withdrawal time point. (A) The optical density for each protein within a treatment condition 
are represented as a percent of the SAL 1h-3. (B) Representative immunoblots from SAL 1h-
3 WD, SAL 6h-3 WD, SAL 1h-30 WD, and SAL 6h-30 WD treatment conditions. Calnexin 
(CAL) is used as a reference protein to control for differences in gel loading, and is not 
significantly affected by IV Treatment or Withdrawal conditions. *p<0.05, Withdrawal effect 
of 3 versus 30 days. 
  
SAL$1h'3;$SAL$6h'3;$SAL$1h'30;$SAL$6h'30$
CAL$
CLN$
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Self-administration Phase 
 Saline-Untested 
(n=13) 
Saline-Tested 
(n=11) 
Cocaine-
Untested 
(n=12) 
Cocaine-Tested 
(n=12) 
Infusions 5. 03 ± 1.17  
 
4.15 ± 0.68 94.97 ± 3.77 97.64 ± 3.63  
Active Lever 
Presses 
7.97 ± 1.90 6.58 ± 1.28 117.67 ± 8.04 125.00 ± 7.61 
Inactive Lever 
Presses 
4.08 ± 1.23 2.61 ± 0.35 1.21 ± 0.48 1.30 ± 0.70 
Cue Test Phase 
Active Lever 
Presses 
 11.36 + 2.53  96.58 + 16.80 
Inactive Lever 
Presses 
7.417 + 1.69 16.42 + 3.21 	  
Table 5.	  Behavioral outcomes obtained from Expt 3b, in which groups of animals were 
trained to self-administer saline (1 h/day) or cocaine (6 h/day) for 10 days. Half of the rats 
from each self-administration group were then tested for cue-reinforced responding at 3 days 
withdrawal (Tested), while the other half of the rats were left undisturbed in the home cage 
(Untested). Data represent the mean ± SEM of the number of animals indicated in 
parentheses. 
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 Similarly, both COC 6h-cue-tested and COC 6h-untested groups pressed the active 
lever significantly more than SAL 1h-cue-tested and SAL 1h-untested controls as revealed by 
a significant main effect of IV treatment [F (1,44)=404.80, p<0.0001], but no Test effect or 
interaction between these variables (p’s>0.05). Average active lever presses for SAL 1h-
untested, 7.97 + 1.90, n=13; SAL 1h-cue-tested, 6.58 + 1.28, n=11; COC 6h-untested, 117.67 
+ 8.04, n=12; and COC 6h-cue-tested, 125.00 + 7.61, n=12.  
 COC 6h-cue-tested and COC 6h-untested groups also pressed the inactive lever 
significantly less than SAL 1h-cue-tested and SAL 1h-untested controls revealed by a 
significant main effect of IV treatment [F (1,42)=6.35, p=0.016).  Average inactive lever 
presses for SAL 1h-untested, 4.08+ 1.23, n=13; SAL 1h-cue-tested, 2.61 + 0.35, n=11; COC 
6h-untested, 1.21 + 0.48, n=11; and COC 6h-cue-tested, 1.30 + 0.70, n=11. 
 Cue-test behavior 
Animals in the COC 6h-cue-tested group responded on both active and inactive levers 
significantly more during the 2-hr cue-seeking test than did SAL 1h-cue-tested controls 
[Treatment X Lever interaction, F (1, 43)=18.47, p<0.0001]. The active lever presses for the 
COC 6h-cue-tested group was greater than the inactive lever presses for this same group, as 
well as both the active and inactive lever presses for the SAL 1h-cue-tested controls 
(p’s<0.05). The inactive lever presses for cocaine and saline groups were not significantly 
different (p>0.05). Average active lever presses for the COC 6h-cue-tested and SAL 1h-cue-
tested groups during the cue test are 96.58 + 16.800, n=12 and 11.36 + 2.531, n=11, 
respectively. Average inactive lever presses for the COC 6h-cue-tested and SAL 1h-cue-
tested groups during the cue test are 16.42 + 3.209, n=12 and 7.417 + 1.694, n=12, 
respectively (Table 5). 
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 Immunoblotting results 
Protein and RNA extraction processes were optimized to enable detection of MBP, as 
future studies aimed to assess the functional relevance of this protein on behavior and 
cocaine addiction. Due to these differential extraction processes, only MBP was amenable to 
detection, thus, only this protein was assessed within the extracted vmPFC tissue. A two-way 
ANOVA of IV Treatment by Test revealed a significant main effect of IV Treatment for 
MBP, which reflected lower MBP in COC 6h-cue-tested versus SAL 1h-cue-tested controls 
(Figure 7) [F (1,32)=6.13, p=0.019; Test effect and IV Treatment X Test interaction, 
p’s>0.05]. This Treatment effect replicates the decrease in MBP seen in Expt 1 (cue-tested 
animals) and was clearly independent of Test condition. Data is presented in Table 4. 
2.3.5 Expt 4: Examination of an interaction between self-administration experience and 
behavioral testing upon mRNA expression 
 Analyses of the MBP-1 and -2 transcripts, which encode respectively for the 21.5 
kDa and 18.5 kDa isoforms of MBP, failed to show a significant change in expression in 
either COC 6h-cue-tested and COC 6h-untested rats, compared to SAL 1h-cue-tested and 
SAL 1h-untested controls (Treatment x Test ANOVA, p>0.05). Although the 18.5 kDa MBP 
isoform was the only isoform measured in the immunoblotting studies, protein levels were 
reduced by cocaine experience (Table 4).  Therefore, the changes in MBP expression due to 
cocaine, are not likely caused by preceding changes in gene transcription, and may reflect 
downstream protein degradation processes. MBP-3 primers were found to non-specifically 
amplify other transcripts in conjunction with the 17 kDa isoform of MBP and therefore were 
not analyzed for expression changes. MBP-4 and -5 were not run at the optimal cycling 
temperature and resulted in amplification of additional nonspecific transcripts as well.  
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Figure 7. vmPFC immunoblotting results from replication study Expt 3b. Rats self-
administering cocaine (COC) during extended access (6h) procedures exhibited decreased 
expression of MBP within the vmPFC compared to saline (SAL 1h) self-administering 
controls, regardless of experiencing a cocaine-seeking test (cue-tested) prior to sacrifice. 
Depicted data represent the optical densities for each protein within a treatment condition and 
are expressed as a percent of the SAL 1h-untested condition. A representative immunoblot 
from SAL 1h-untested, SAL 1h-cue-tested, COC 6h-untested and COC 6h-cue-tested 
treatment conditions lies below the graphical data. *p<0.05, IV Treatment main effect of 
COC versus SAL. 
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2.4 Discussion 
 Consistent with previous reports, a history of extended access to cocaine self-
administration produced a time-dependent increase in cocaine-seeking behavior under 
extinction conditions (Ben-Shahar et al., 2013; Grimm et al., 2001; Tran-Nguyen et al., 
1998). Although changes in glutamate receptors, and their downstream signaling cascades 
(e.g. AGS3), have been reported to occur during protracted withdrawal following extended 
cocaine access within the mPFC (Ben-Shahar et al., 2009, 2013; Bowers & Kalivas, 2003; 
Kalivas et al., 2005; Schmidt & Pierce, 2010), I failed to detect time-dependent changes in 
any of my glial specific markers that coincided with the incubation of cocaine-seeking 
behavior. Although correlative in nature, the temporal incongruence between protein/mRNA 
expression and behavior argue an unlikely role for cocaine-induced changes in the expression 
of glia-related proteins in the manifestation of the incubation of craving.  However, the fact 
that glia-related protein changes were observed during early withdrawal and persisted for at 
least 30 days demonstrates clearly that a history of excessive cocaine-taking produces 
enduring “glioadaptations” that are likely to impact brain function and have behavioral 
consequences of relevance to other aspects of addiction 
 The results of Expt 1 indicated that a history of cocaine-taking produced a persistent 
decrease in Cx43 an astrocytic-specific gap junction protein within the NAc core.  The 
present study is not the first to report an effect of cocaine experience upon the functional 
status of astrocytes. As discussed in the introduction to this chapter and Chapter 1, astrocyte 
specific GFAP expression is enhanced within the PFC, NAc core and shell from 
experimenter administered cocaine and 3 weeks withdrawal, suggesting cocaine can affect 
astrocytic process stability as GFAP provides intermediate filament scaffolding (Bowers & 
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Kalivas, 2003). Moreover, experimenter administered cocaine has been found to increase 
GFAP expression within the dentate gyrus, along with significant increases to cell numbers, 
size, and shape complexity (Fattore et al., 2002). Additionally, enhanced glutamate signaling 
within NAc core due to cocaine could interact with astrocytic ionotropic and metabotropic 
glutamate receptors (Porter & McCarthy, 1997). When stimulated, these receptors cause 
increases in cytoplasmic calcium concentrations within astrocytes; propagation of calcium 
waves is a form of intra and intercellular signaling and can affect gene transcription through 
calcium second messenger pathways (Araque, 2008). In astrocytes, Cx43, which forms gap 
junctions and hemichannels, mediates calcium wave propagation; therefore, an early and 
persistent reduction in Cx43 following extended cocaine access would be predicted to reduce 
calcium signaling both within and between astrocytes of the NAc core. Theoretically, 
impaired calcium signaling could result in immediate effects upon calcium-dependent 
enzyme activation, including those involved in regulating gene transcription, protein 
translation, synthesis and turn-over, which could be envisioned to have both short- and 
longer-term effects upon protein expression/function within astrocytes. A change in 
astrocytic calcium signaling could also result in alterations in astrocytic release of glutamate 
and ATP by calcium dependent exocytosis, leading to changes in neuronal excitability 
(Araque, 2008; Malarkey & Parpura, 2009). The functional relevance of altered astrocytic 
calcium signaling remains open as these findings are based on cell culture and brain slice 
studies (Araque, 2008; Malarkey & Parpura, 2009). 
 In Expt 1, I observed an early and persistent reduction in the OL proteins MBP, MOG 
and NG2+ within the vmPFC of cocaine self-administering animals.  Such findings from an 
animal model of excessive cocaine intake are consistent with clinical reports of decreased 
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white matter integrity in chronic cocaine users (Bartzokis, Beckson, Lu, Edwards, & Bridge, 
2002; Lim et al., 2002; Moeller et al., 2005, 2007). George et al. (2008) also reported 
decreases in NG2+ immunoreactive OLs within the PFC that correlated with deficits in 
working memory following long-access to cocaine. These authors suggested decreased 
labeling of NG2+ as indicative of decreased OL numbers; however, this particular protein is 
commonly used to identify OL progenitor cells (Armati & Mathey, 2010). Therefore, a 
reduction in NG2+ immunoreactivity could reflect a combined decrease in mature and 
progenitor OLs, or progenitors only. Alternatively, NG2+ positive cells have also been found 
to differentiate into gray matter astrocytes, neurons, or remain as a small population of 
mature NG2+ glial cells distinct from OLs (Mathey, Aurthur, & Armati, 2010). Therefore, 
changes in NG2+ levels are not specific to a particular cell type or a reflection of an effect of 
cocaine solely on OLs.  
 MOG is a minor component of compact myelin that is expressed during the later 
stages of OL development and has been proposed as a marker for maturity (Armati et al., 
2010; Coffey & McDermott, 1997). The fact that both MOG and NG2+ expression is 
reduced following cocaine self-administration in Expt 1 would suggest a reduction in both 
mature and progenitor OLs and compliments the finding of George et al. (2008). This raises 
an interesting hypothesis that the stunted increase in white matter maturation of chronic 
cocaine addicts compared to normal, healthy controls could reflect, in part, a decrease in 
progenitor OLs reaching maturity and properly myelinating axons (Bartzokis et al., 2002). 
Unfortunately, as the tissue processing techniques conducted in Expt 3b were optimized for 
MBP protein detection and simultaneous RNA extraction, there was insufficient tissue to 
replicate the results from Expts 1 and 2 for protein other than MBP. Thus, the co-regulation 
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of MOG and NG2+ by cocaine requires replication in future studies in order to provide a 
more solid basis for the study of these proteins in addiction-related changes in brain and 
behavior. Towards this end, a follow-up study of adolescent rats is described in Chapter 3 
that argues an independent regulation of NG2+ and MOG by cocaine.   
 MBP is a major protein component within the myelin sheath that is vital for the 
formation of myelin and the major dense line (Armati & Mathey, 2010; Atkins, Yon, 
Groome, & Sweatt, 1999). MBP is also reversibly phosphorylated at five locations mediated 
by protein kinase C (PKC) which can be activated following nerve impulse conduction, 
metabotropic receptor stimulation and rises in cytosolic calcium concentrations (Atkins et al., 
1999; Murray & Steck, 1984; Vartanian, Dawson, Soliven, Nelson, & Szuchet, 1989). 
Alterations in MBP phosphorylation and expression levels impact myelin compaction and 
structural properties that affect the conduction velocity and efficiency of action potentials 
(Atkins et al., 1999; Murray & Steck, 1984). Therefore, a decrease in the levels of MBP 
expression within the vmPFC could reflect an early deficit resulting from cocaine that 
impacts myelin integrity and subsequently neuronal communication. 
 It is notable that the cocaine-induced reduction in vmPFC MBP expression observed 
originally in animals tested for cue-reinforced responding (Expt 1) was replicated in a 
separate cohort of animals in Expt 3b, conducted several years later. Moreover, the results of 
Expt 3b also indicated that the cocaine-induced reduction in vmPFC MBP was apparent in 
animals left undisturbed in the home cage prior to tissue collection, indicating that a history 
of extended cocaine access is sufficient to elicit this myelin-related protein change. These 
latter results from Expt 3b are at odds with the results of Expt 2, in which an increase in MBP 
was observed in test-naïve, cocaine-experienced animals. At this time it is unclear, why 
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significant opposite changes in MBP, MOG, and no change in NG2+ levels observed in Expt 
2 were not consistent with Expt 1. It is unlikely, but possible, that the different times at which 
these experiments were conducted had unknown consequences on OL-specific protein 
expression and that tissue collection was not precisely consistent between the two studies. 
Given that decreased MBP expression seen in Expt 1 was replicated in Expt 3b when animals 
slated for cue testing or left untested were directly compared by a subsequent 
immunoblotting study, it will be important to replicate additional protein findings before 
conclusions can be drawn regarding a general effect of cocaine on myelin-specific protein 
expression. 
 The cocaine-induced reduction in MBP expression might reflect either decreased 
gene transcription or increased protein degradation. To begin to address these possibilities, 
we examined for changes in MBP mRNA expression within the same tissue sample 
employed in Expt 3b to detect changes in protein expression. In contrast to our hypothesis 
and despite the reduction in MBP protein expression, we did not detect any change in mRNA 
for two different MBP isoforms related to Treatment or Test. These data provide strong 
evidence against reduced gene transcription as underlying cocaine’s effects upon MBP, 
leaving the possibility that the mechanism underpinning cocaine’s ability to lower MBP 
expression reflects enhanced protein degradation. Unfortunately, this hypothesis is not easily 
addressed as the biogenesis and maintenance of the myelin sheath is poorly understood at 
present (Baron & Hoekstra, 2010). 
 Interestingly, despite observing rather robust cocaine-induced decreases in myelin-
related protein expression within the vmPFC, the current immunoblotting study revealed few 
myelin protein changes within the dmPFC of cocaine-experienced animals. No changes in 
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protein expression were observed in Expt 1, although Expt 2 revealed a time-dependent 
increase in MOG in test-naïve rats. Intriguingly, a time-dependent increase in dmPFC MOG 
expression was replicated within the study of adolescent rats described in Chapter 3. As 
described earlier, MOG is often used as a molecular marker for mature myelin, a time-
dependent increase, therefore, might reflect continued myelin maturation within the dmPFC 
of both adult and adolescent rats (Armati et al., 2010; Coffey & McDermott, 1997). 
However, as also discussed it remains unclear whether decreased dmPFC MOG in adult rats 
(Expt 2) is a reliable finding given the lack of change observed in Expt 1. 
As reviewed in Chapter 1, cocaine exposure in animal models and in cell culture 
elevates inflammation-related transcripts and innate immune signaling. CD11b serves as a 
marker of microglial cells involved in innate immune signaling. While we did not see a 
change in CD11b expression following cocaine self-administration, other markers of 
microglial activation may be more sensitive indicators of an effect of cocaine on this glial 
cell type. For example, Ahmed et al. (2005) found increased IL-6, IL-4, and TNF mRNA 
within the PFC of rats with 18 days of short (1h) or extended access (6h) cocaine self-
administration, and Piechota et al. (2010) found increased IL-6r and TNFα within the CP and 
NAc following a single injection of cocaine (25 mg/kg, IP) (further data analysis on 
microarray results from Ahmed et al. (2005) and Piechota et al. (2010) conducted by Clark et 
al., 2013). Administration of other drugs of abuse also result in enhanced immune gene 
expression including ethanol and methamphetamine (Loftis, Choi, Hoffman, & Huckans, 
2011; Zou & Crews, 2010). Specifically, hippocampal slice cultures treated with ethanol for 
two-hours resulted in the elevation of several innate immune proinflammatory genes 
mediated by the transcription factor NF-κB, including the cytokines TNFα, IL-1β, and IL6 
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(Zou & Crews, 2010). Moreover, mice treated for seven days with 1 mg/kg 
methamphetamine (IP) expressed enhanced protein levels for IL-2, IL-6, IL-1β, and IL-10 
within the HPC (Loftis et al., 2011). Thus, future studies, assessing an array of immune-
related proteins are required to more accurately examine for cocaine-induced changes in 
microglial function as it relates to the manifestation of drug-elicited changes in addictive 
behavior.  
 In summary, the results of the studies presented in this chapter shows that extended 
access cocaine self-administration in rats followed by a 2-hr cue-seeking test leads to early 
and persistent reductions in glial subtype-specific proteins that may mediate the hypofunction 
within the vmPFC. Given the procedural differences between Expt 2 and 3b, it remains to be 
determined whether or not the capacity of cocaine to reduce glia-related protein expression 
within brain varies as a function of behavioral testing for drug-seeking. As conducted for 
MBP in Expt 3b, future studies need to directly examine the effect of cue-testing on 
expression levels of other glial-specific proteins, in order to better understand the role played 
by pharmacological and non-pharmacological factors in mediating the effects of cocaine self-
administration upon the functional integrity of non-neuronal cells within brain regions 
exhibiting anomalous function in addiction. The present results for MBP clearly demonstrate 
that the cocaine-induced reduction in vmPFC protein expression is independent of behavioral 
testing, as well as changes in gene transcription. Thus, a reduction in vmPFC MBP 
expression is a pharmacodynamic response to excessive cocaine intake that occurs early in 
withdrawal, persists for at least 1 month following cessation of drug-taking and likely reflects 
impaired protein degradation. The functional relevance of reduced MBP expression for 
addiction-related behavior is examined directly in Chapter 4 and 5. The next chapter 
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examines the effect of cocaine on glial subtype-specific proteins within adolescent rats as 
adolescence is a period of enhanced impulsivity and risky drug-taking during which there is 
robust forebrain myelination (Bartzokis, Beckson, Lu, Edwards, & Bridge, 2002; Crews & 
Boettiger, 2009). Given the present results for cocaine-experienced adults, it is hypothesized 
that a history of extended cocaine access will have a very dramatic effect upon OL and 
myelin integrity, leading to greater deficits in frontal function. 	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Chapter 3 Effects of cocaine self-administration upon indices of myelin integrity in 
adolescents. 
	  98	  
3.1 Introduction 
 As discussed in the general introduction, human adolescence is a key developmental 
period for the frontal cortex, with white matter maturation continuing through mid to late 40s 
(Bartzokis et al., 2002). Immature frontostriatal development in adolescence is associated 
with greater risk-taking, greater cocaine intake (which can last into adulthood), increased 
behavioral sensitization, and a decrease in the experience of the negative effects of drugs of 
abuse (Crews & Boettiger, 2009; Perry et al., 2007). Moreover, the majority of drug users are 
adolescents or young adults, and adolescent onset of drug use leads to a more rapid 
progression of abuse to dependency (Bernheim et al., 2013; Perry et al., 2007). 
 Animal models of adolescent drug use are in agreement with many of the features of 
human adolescent use and shed light on possible molecular mediators of these behaviors. For 
example, Wong, Ford, Pagels, McCutcheon, & Marinelli (2013) showed that adolescent male 
rats (PND 42) self-administered more cocaine at low to moderate doses (0.15-0.60 mg/kg) 
during daily short access sessions (1.5 hr/day, ~7-10 sessions total) and more cocaine when 
available at a moderate dose (0.60 mg/kg) during long-access sessions (6 hr/day, 10 sessions 
total, only dose tested) than adult (PND ~88) rats. Moreover, adolescent rats were shown to 
escalate their self-administration of cocaine under long-access conditions to a greater extent 
than adults, would “pay a higher price” for cocaine by responding more for drug at increased 
fixed-ratio schedules (FR6, FR12, and FR24), and exhibited higher firing rates of VTA DA 
neurons, compared to adults. By increasing or decreasing VTA DA neuron activity (infusion 
of eticlopride or quinpirole, respectively into the VTA), Wong et al. (2013) revealed that 
adults could behave more “adolescent-like” upon systemic eticlopride pretreatment or 
adolescents more “adult-like” upon systemic quinpirole pretreatment in the number of 
cocaine infusions administered during short-access conditions. However, the debate over 
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whether adolescent rats self-administer more cocaine is still open, as many labs using a 
variety of procedures have either supported an age difference (Anker & Carroll, 2010; 
Schramm-Sapyta et al., 2011) or failed to show a difference (Frantz, O’Dell, & Parsons, 
2007; Harvey, Dembro, Rajagopalan, Mutebi, & Kantak, 2009; Kantak, Goodrich, & Uribe, 
2007; Kerstetter & Kantak, 2007; Leslie et al., 2004; Li & Frantz, 2009). One key factor that 
may help explain this discrepancy is the dose of cocaine used, as age differences are more 
apparent at low to moderate doses, rather than higher doses (Anker & Carroll, 2010; Kantak 
et al., 2007; Kerstetter & Kantak, 2007; Wong et al., 2013).  
 In addition to evidence for higher drug-taking, adolescent rats also exhibit greater 
drug-craving than adults, when assessed in relevant animal models. For example, adolescents 
with a history of short-access cocaine self-administration (~15 days, 2hr/session, 2 
sessions/day separated by 2 hrs, 0.4 mg/kg cocaine; 20 extinction sessions, 2 sessions/day 
separated by 2 hrs) exhibit greater lever-pressing under both extinction, as well as during 
cocaine- and stress-induced reinstatement procedures, compared to adult male rats (Anker & 
Carroll, 2010). Under these particular self-administration procedures, adolescents did self-
administer more cocaine than adults during the maintenance phase of testing, again 
highlighting the point that different experimental procedures can reveal differential effects of 
age on cocaine-intake. Consistent with the observation that adolescent animals are more 
susceptible to stress-induced drug craving, other studies have indicated that cocaine-
experienced adolescents are more prone than adults to exhibit anxiety in other behavioral 
paradigms. For example, a study by Alves et al. (2014), showed that adolescent cocaine 
exposure (15 days of IP treatment with 45 mg/kg cocaine/day, separated into 3 equal doses 
administered 1-hr apart + 10 days of withdrawal) results in abnormal behavior on the 
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elevated plus maze and Resident-Intruder paradigm when tested in adulthood. Therefore, not 
only do adolescents show heightened cocaine-seeking in response to stress, but adolescent 
cocaine exposure also results in altered stress responses that persist in adulthood. 
The majority of evidence presented above supports greater cocaine sensitivity in 
adolescent versus adult rats. The data from Chapter 2 indicates that a history of cocaine-
taking can produce enduring changes in the expression of glial-associated proteins in adult 
animals. Given that adolescence is a vulnerable period of neurodevelopment, the possibility 
existed that a history of cocaine-taking during adolescence would dramatically impact the 
developing PFC, and specifically glial cell protein expression. Adolescent rats were used as 
the subjects in similar cocaine self-administration and withdrawal procedures to Chapter 2, 
Expt 2. Based on the fact that adolescent rats are reported to take more cocaine than adults, 
we hypothesized that, relative to saline controls, the cocaine-induced changes in the 
expression of myelin-related proteins within the vmPFC would be more marked in 
adolescents than those observed in our study of adults (Chapter 2), and that adolescent 
cocaine experience might impact the expression of other proteins specific to other glial cell 
types, which we failed to detect in adult animals. 
3.2 Methods 
 
All methods are identical to those described in Section 2.2, with the following 
exceptions. Adolescent (PND 25, 100-125 g, at arrival) male Sprague-Dawley rats (Charles 
River Laboratories, Hollister, CA) were used as subjects for these self-administration 
experiments. Following surgical recovery, animals (n=10-15 per group at the start of each 
experiment) were trained to self-administer IV cocaine (0.15 mg/0.1 ml/infusion; National 
Institute on Drug Abuse, Bethesda, MD) during daily 6-hr sessions, or saline (0.1 ml/ 
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infusion) during 1-hr sessions, on a FR1 schedule of reinforcement. Additionally, at either 3 
or 30 days of withdrawal, animals were subjected to rapid decapitation procedures in the 
absence of behavioral testing in order to determine the effects of a history of cocaine-taking 
during adolescence upon protein expression, unconfounded by interactions with cue-testing 
procedures. 
3.3 Results 
3.3.1 Self-administration behavior 
As observed in adult rats (see section 2.3), cocaine self-administering adolescents 
earned a significantly greater number of infusions [main IV Treatment effect, F 
(1,43)=498.70, p<0.0001] and pressed the active lever more than saline controls [main IV 
Treatment effect, F (1,43)=22.04, p<0.0001]. No group differences were observed regarding 
the number of inactive lever presses (2-way ANOVA, all p’s>0.05; Table 6). 
3.3.2 Immunoblotting results 
Within the vmPFC, adolescent cocaine animals expressed significantly lower levels 
of NG2+ and lower CD11b, compared to saline controls [for NG2+, IV Treatment effect: 
F(1,44)=5.54, p=0.023; for CD11b, IV Treatment effect: F(1,45)=4.00, p=0.05], but the 
expression of neither protein varied with the duration of Withdrawal (Withdrawal effect or 
IV Treatment x Withdrawal interaction, p’s>0.05). No other proteins showed significant IV 
Treatment, Withdrawal, or IV Treatment x Withdrawal Interaction effects (p’s>0.05), Figure 
8. 
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 SAL 1h-3 (12) SAL 1h-30 (14) COC 6h-3 (11) COC 6h-30 (10) 
Infusions 4.89 + 0.77  5.53 + 0.78  116.94 + 9.03 * 123.37 + 6.69 * 
Active Lever 7.14 + 1.03 8.26 + 1.18 338.64 + 
139.57* 
421.70 + 
104.82* 
Inactive Lever 8.23 + 1.58 7.83 + 1.62 5.07 + 1.81 10.53 + 3.53 
 
Table 6. Summary of the behavior exhibited by adolescent rats during the 10 days of self-
administration training under long-access (6-h) procedures. Overall, cocaine (COC 6h) self-
administering animals exhibited a greater number of active lever presses and infusions than 
did their saline (SAL 1h) self-administering counterparts. However, there were no 
differences in behavior between the COC rats slated for tissue collection at 3 versus 30 days 
withdrawal (respectively, 3 and 30), nor were there differences between the SAL groups 
slated for tissue collection at these time-points. Data represent the means ± SEMs of the last 
3 days of training. The sample sizes are indicated in parentheses. *p<0.05 vs. SAL (main 
Treatment effect). 
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A. 
 
B. 
           
 
Figure 8. Adolescent vmPFC immunoblotting. Rats self-administering cocaine (COC) 
during extended access (6h) procedures and untested prior to sacrifice exhibited decreased 
expression of CD11b and NG2+ within the vmPFC early in withdrawal (WD; 3 days), an 
effect that persisted into protracted withdrawal (30 days) compared to saline (SAL 1h) self-
administering controls. (A) The optical density for each protein within a treatment condition 
is represented as a percent of the SAL 1h-3 condition. (B) Representative immunoblots from 
SAL 1h-3 WD, SAL 1h-30 WD, COC 6h-3 WD and COC 6h-30 WD treatment conditions. 
Calnexin (CAL) is used as a reference protein to control for differences in gel loading, and is 
not significantly affected by IV Treatment or Withdrawal conditions. *p<0.05, IV Treatment 
main effect of COC versus SAL. 
  
SAL$1h'3;$SAL$1h'30;$COC$6h'3;$COC$6h'30$
CAL$
CD11b$
NG2+$
	  104	  
Within the dmPFC, both cocaine and saline animals showed time-dependent 
enhanced expression of CLN [Withdrawal effect: F (1,46)=6.12, p=0.017], MBP 
[Withdrawal effect: F (1, 47)=8.22, p=0.006], MOG [Withdrawal effect: F (1,48)=13.76, 
p<0.001], and a trend for Cx30 [Withdrawal effect: F (1,48)=3.79, p=0.057], but for none of 
these proteins did expression vary as a function of cocaine experience (IV Treatment and IV 
Treatment x Withdrawal Interaction, p’s>0.05). Expression of the immune-cell marker 
CD11b showed a trend towards decreased expression following cocaine experience that just 
failed to meet statistical significance [IV Treatment effect: F (1,48)=3.76, p=0.059], but this 
trend did not vary as a function of withdrawal time (Withdrawal and IV Treatment x 
Withdrawal Interaction, p>0.05). None of the other proteins examined exhibited significant 
IV Treatment, Withdrawal, or IV Treatment x Withdrawal Interaction effects (p’s>0.05), 
Figure 9.
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A. 
 
B. 
                 
 
Figure 9. Adolescent dmPFC immunoblotting. Rats either self-administering cocaine (COC) 
during extended access (6h) procedures or saline (SAL 1h) untested prior to sacrifice 
exhibited increased expression of CLN, MBP, MOG, and a trend for Cx30 within the dmPFC 
in protracted (30) but not early withdrawal (WD; 3). CD11b showed decreased expression 
across early to protracted withdrawal, an effect that just failed to meet significance 
(p=0.059). (A) The optical density for each protein within a treatment condition is 
represented as a percent of the SAL 1h-3 condition. (B) Representative immunoblots from 
SAL 1h-3 WD, SAL 1h-30 WD, COC 6h-3 WD and COC 6h-30 WD treatment conditions. 
Calnexin (CAL) is used as a reference protein to control for differences in gel loading, and is 
not significantly affected by IV Treatment or Withdrawal conditions. *p<0.05, Withdrawal 
main effect of 3 versus 30, #p=0.059, trend to decreased expression over withdrawal, ^ 
p=0.057, trend to increased expression over withdrawal.
SAL$1h'3;$SAL$1h'30;$COC$6h'3;$COC$6h'30$
CAL$
MOG$
$
CD11b$
CLN$
Cx30$
MBP$
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3.4 Discussion 
 It was hypothesized at the outset of this Chapter that cocaine experience during 
adolescence would have a marked impact upon the expression of glial-associated proteins 
within the PFC, owing to the facts that adolescents are reported to consume more cocaine 
than adults and adolescence is a period of robust neurodevelopment, which is presumed to 
render the brain more susceptible to environmental insults such as drug exposure.  However, 
contrary to my hypothesis, I did not see the decrease in myelin-related proteins following 
extended access to cocaine in adolescent self-administering male rats as was seen in the adult 
vmPFC (Chapter 2), although the levels of NG2+ and CD11b were reduced in cocaine-
experienced adolescents versus saline controls. However, while I observed very few protein 
changes within dmPFC of adult rats (Chapter 2), several significant increases in myelin 
proteins were observed across withdrawal in the dmPFC of both saline and cocaine 
administering animals, supporting this developmental period as one of enhanced myelination.  
Myelin formation begins approximately PND 14 and accumulates rapidly over the 
next 30 days, followed by slow accumulation to the end of active myelination at PND 60 
(Akiyama, Ichinose, Omori, Sakurai, & Asou, 2002). Enhanced cerebral expression of 
myelin-related transcripts and proteins have been documented in mice and rats to peak in 
early adolescence (PND 21) with high and stable expression lasting through adolescence into 
adulthood (~2 years) (Akiyama et al., 2002; Mitchell et al., 1992; Sorg, Smith, & 
Campagnoni, 1987; Wiktorowicz & Roach, 1991). Specifically, the 14 and 18.5 kDa 
isoforms of MBP (comprising 70% of the total MBP in adult brain) are detectable at PND21 
and show increased expression up to 24 months in the cerebrum of rats (Akiyama et al., 
2002). Moreover, all isoforms of MBP were found to increase within the PFC of male rats 
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between PND 28 and 49 (Kodama, Kikusui, Takeuchi, & Mori, 2007). Consistently, PLP and 
MBP mRNA and protein levels have been found to increase in mice from PND 10-40 with 
stable transcription continuing to PND 50 (Mitchell et al., 1992; Sorg et al., 1987; 
Wiktorowicz & Roach, 1991). MOG follows slightly behind MBP expression, emerging 
within the forebrain white matter between PND 15 and 21 and accumulating through PND 60 
(Coffey & McDermott, 1997; Matthieu & Amiguet, 1990). 
 Therefore, the heightened level of expression in myelin-related proteins seen over 
withdrawal in adolescence likely reflects normal expression, an event that is no longer 
prominent in adult rats. Additionally, this enhanced expression may be buffering an effect of 
cocaine on myelin, as any decreases that occur in adult myelin is masked by the significant 
increase in transcription that translates to protein in adolescence. This would also be 
supported by the fact that cocaine does not seem to affect myelin-related transcription as 
neither the 21.5 nor 18.5 kDa MBP mRNA transcripts changed in response to cocaine, as 
discussed in Chapter 2. It is surprising we did not see a withdrawal-related increase in PLP 
expression given the increases in the other myelin-related proteins and enhanced PLP mRNA 
and protein expression during this developmental time period observed in other studies 
(Mitchell et al., 1992; Wang et al., 2008). 
 Contrary to adult rats, the vmPFC of adolescent rats showed very few changes in 
protein expression following cocaine or withdrawal. The decrease in NG2+ expression 
following cocaine is consistent with the data from adults from Chapter 2 (Expt 2), suggesting 
that cocaine may have an affect on OL precursor cells. As discussed in Chapter 1, I 
mentioned that this particular protein is not specific to OLs, but is also expressed in cells that 
mature into gray matter astrocytes, neurons and a small population of mature NG2+ glia 
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(Trotter, Karram, & Nishiyama, 2010). The majority of cells expressing NG2+ do develop 
into mature-myelinating OLs and a decrease in the expression of this protein following 
cocaine has now been replicated twice within my own work and that of George et al., 2008. 
NG2+ is a chondroitin sulfate proteoglycan, which suggests a role in the extracellular matrix 
and also contains sequences that would suggest binding partners with proteins relevant for 
cell migration and process movement (Trotter et al., 2010). It is not clear from the present 
immunoblotting findings whether the decrease in NG2+ is specific to this protein, represents 
a decline in the population of this cell/precursor cell group, or enhanced maturation of these 
cells to their mature phenotypes. Questions such as these would be better addressed with cell-
fate studies in conjunction with cocaine administration, and experimental manipulation of 
this specific protein on animal behavior. 
 It is surprising that similar withdrawal-related increases in myelin-related proteins 
were not observed within the vmPFC of adolescent rats as those observed in adults. Several 
studies have examined a caudal-rostral, and one study also a ventral-dorsal, gradient in the 
appearance and maturation of myelin within both mice and rat central nervous systems 
(Coffey & McDermott, 1997; Mitchell et al., 1992). MOG, in particular, is seen to increase 
first in the brain stem at PND 7, spreading throughout the ventrolateral region of the pons 
before extending through the entirety of the pons by PND 21; cerebellar MOG staining was 
not evident at PND 14 but uniformly present in cerebellar white matter at PND 21, while 
forebrain MOG staining was not evident prior to PND 21 with ventral corpus callosum 
staining present prior to dorsal portions about PND 28. All regions exhibited a clear presence 
of MOG within the white matter before being detected within the gray matter (Coffey & 
McDermott, 1997). Moreover, PLP mRNA expression within the spinal cord peaks about 
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PND 12 before becoming stable, where brain expression does not peak till PND 30 before 
becoming stable (Mitchell et al., 1992). Therefore, it is possible that we did not detect age-
related increases in vmPFC myelin-related proteins due to an earlier maturation of this 
region, though this seems unlikely and future studies will need to examine more 
systematically this ventral-dorsal difference in myelin protein expression specifically within 
the PFC, and perhaps also study how a history of cocaine impacts the caudal-rostral gradient 
of protein expression through studies of diencephalic and mesencephalic structures (e.g., 
NAc, VTA) that are also implicated in addiction. 
 Neither vm- nor dmPFC showed a difference in the expression of the microglial 
marker CD11b, which corresponds with the lack of cocaine effect on this protein within adult 
rats. To reiterate, this protein may not accurately reflect an effect of cocaine on microglial 
cells as other markers of inflammatory response and oxidative stress have been observed 
following cocaine both in vivo and in vitro (see Chapter 2, Discussion). Future studies will 
need to assess a wider array of proteins and/or microglial cellular responses to cocaine using 
the long-access cocaine self-administration model to glean a better understanding of the 
potential consequences of cocaine on this cell type. 
The current findings suggest adolescence is not a “vulnerable” period for cocaine-
induced impairment of OL maturation and myelination. However, future studies need to 
continue addressing the flexibility and vulnerability of the adolescent PFC and determine if 
transient or lasting effects of cocaine become apparent over time, specifically as it pertains to 
OL maturation and myelination and PFC function. The next chapter examines the behavioral 
consequences of experimentally decreasing MBP expression within the vmPFC of adult rats, 
given this protein was decreased following cocaine self-administration procedures in Chapter 
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2, Expt 1 and 3b. As was discussed in Chapter 1, the only studies examining the functional 
significance of MBP have been in mutant mice completely lacking expression of this protein, 
therefore the goal of the next chapter was to characterize the specific cognitive deficits 
associated with localized decreased MBP expression.  
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Chapter 4 Behavioral effects of reducing myelin basic protein within the vmPFC  
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4.1 Introduction 
 As shown in Expt 1 (Chapter 2), cocaine self-administration decreased myelin-
specific protein expression within the vmPFC of adult male rats. For MBP, the cocaine-
induced decrease in protein expression persisted for at least 4 weeks into drug withdrawal, 
occurred regardless of whether or not animals are tested for cocaine-seeking prior to sacrifice 
and did not reflect a change in the transcription of the major 21.5 or 18.5 kDa protein 
products of the gene encoding MBP. These data provide strong evidence that reduced MBP 
expression within the vmPFC is a cocaine-induced neuroadaptation that persists into 
protracted withdrawal, but the relevance of this particular neuroadaptation for behavior 
governed by this region is not yet known.  
 MBP is the only protein known to be essential to the formation of CNS myelin in 
mammals; its genetic deletion causes severe hypomyelination and premature death (Boggs, 
2006). The MBP gene codes for five splice variants which are both developmentally 
regulated and localized to specific regions of the cell (Boggs, 2006; Padhi & Pelletier, 2012). 
The 18.5 kDa MBP isoform comes in 8 different charge isomers depending upon the kind of 
post-translational modifications and net effect on the charge of MBP (Boggs, 2006). MBP is 
also rapidly and reversibly phosphorylated, giving hint to a potential role in a dynamic 
cellular process (Atkins, Chen, Klann, & Sweatt, 1997; DesJardins & Morell, 1983; Murray 
& Steck, 1984; Ulmer, 1988). The most dominant isoform of MBP in humans is the 18.5 kDa 
protein, which is also expressed in rodents (Boggs, 2006). It is the expression of this protein 
isoform that was decreased following cocaine self-administration in Expts 1 and 3b (Chapter 
2). MBP has a net positive charge that allows it to interact via electrostatic forces with the 
negative lipid head groups of the membrane, and also contains hydrophobic side chains that 
become embedded within the bilayer (Boggs, 2006). These are the main forces allowing 
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MBP to interact with the lipid membrane in order to adhere apposing sides to aid in the 
formation of the compact rings of myelin that surround axons (Boggs, 2006). Changes in the 
ratio of MBP to lipids, net increases or decreases in MBP protein levels, post-translational 
modifications that alter the net charge of MBP, and local ion concentrations all impact the 
ability and effectiveness of MBP to bind two lipid surfaces together to promote multi-bilayer 
formation (Boggs, 2006; Hu et al., 2004; Min et al., 2009).  
 MBP has additional interactions with the cytoskeleton, including actin and tubulin 
promoting polymerization and stabilization of fiber bundles; a process that is dynamically 
regulated by transmission of extracellular signals (Dyer, Philibotte, & Wolf, 1994; Dyer, 
1993; Hill & Harauz, 2005; Hill, Libich, & Harauz, 2005). For example, anti-
galactosylceramide antibody added to OL cultures mediates lipid and protein redistribution, 
changes in MBP phosphorylation, and depolymerization of microtubules. This latter effect is 
dependent on the expression of MBP, as these changes do not occur in OLs derived from 
Shiverer mice that lack this protein (Dyer, 1993). Therefore, changes in the expression of 
MBP could potentially impact the integrity of the myelin sheath, myelin process stabilization, 
OL response to nerve impulses, and ultimately affect neuronal communication due to a 
decrease in signaling efficiency from poor electrical insulation. As discussed in Chapter 1, 
few studies have examined the behavioral consequences of manipulating MBP; Shiverer 
mice with a deletion of the MBP gene exhibit severe motor deficits and a deficit in reversal 
learning on the T-maze (Inagawa et al., 1988). However, to date, there are no reports of 
specific experimental manipulation of MBP within distinct brain regions upon behavior. 
Therefore, the series of experiments described in this Chapter aim to characterize the effects 
of reduced MBP expression within the vmPFC on PFC-dependent behaviors in rats.  
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 The PFC is critical for recognition memory. Lesions of the vmPFC in nonhuman 
primates impairs recognition memory resulting in significant learning impairments on object-
in place and temporal order memory tasks (Warburton & Brown, 2010). Consistent with this, 
rats with mPFC lesions exhibit significantly impaired performance on the object-in-place 
task (Barker, Bird, Alexander, & Warburton, 2007). Recognition memory can also be 
assessed via a delayed non-matching to sample (DNMS) task. Rats with large aspiration 
lesions of the mPFC failed to choose the correct non-matching goal arm of a Y-maze when a 
20 sec delay was instituted prior to being allowed to choose between the two goal arms 
(Kolb, Buhrmann, McDonald, & Sutherland, 1994). Similar results have been observed using 
DNMS tasks under operant conditions. When rats were trained to press a lever following a 
light presentation and omit a response with a tone presentation, rats with ibotenic acid lesions 
of the vmPFC exhibited delayed acquisition of the response contingencies when a 10 or 20 
sec delay was instituted between cue presentation and availability of the lever to deliver food 
reward (light) or footshock (tone) (Delatour & Gisquet-Verrier, 1999). Moreover, rats with 
excitotoxic lesions of the mPFC exhibit reduced performance on the non-matching to sample 
T-maze, and distinct lesions of the PL/IL result in greater perseverative behavior in the 
matching-to-sample and reversal of the matching-to-sample T-maze than sham lesioned 
control rats (Dias & Aggleton, 2000).  
 Akin to the results of lesion studies, a history of psychomotor stimulant exposure also 
impairs performance on PFC-dependent recognition tasks.  For example, extended access to 
methamphetamine self-administration in both male and females rats decreases the 
recognition index for both novel-object and object-in-place recognition tasks (Reichel, Chan, 
Ghee, & See, 2012). Also, extended access (6 hr/day) to cocaine self-administration in rats 
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results in significantly lower correct alternations with the DNMS T-maze when a 70s or 130s 
delay is instituted between a forced run and choice run compared to drug-naïve controls and 
rats with short access (1 hr/day) to cocaine (George et al., 2008). The deficit in DNMS T-
maze performance was positively correlated with the density of neurons and NG2+ cells 
within the dmPFC and with NG2+ cells within the OFC. Therefore, experimental 
manipulation of MBP may alter the ability of the PFC to function properly in working-
memory dependent tasks and it is hypothesized that experimentally decreased MBP within 
the PFC will result in reduced performance within the DNMS T-maze with increasing delay 
between forced and choice runs. Furthermore, we hypothesize experimentally reduced MBP 
expression will result in impaired performance on the object recognition tasks, as indicated 
by reduced recognition index scores. 
 Sensorimotor gating deficits are common among neuropsychiatric disorders including 
schizophrenia, Huntington’s disease, and Tourette’s syndrome, and are observed following 
both acute and chronic administration of cocaine in rats (Martinez, Ellison, Geyer, & 
Swerdlow, 1999). Female rats injected with either 20 or 30 mg/kg cocaine (IP) exhibited 
decreased pre-pulse inhibition to a 120 dB tone when preceded by 20ms bursts of 73, 76, or 
82 dB pre-pulses. Moreover, rats implanted with subcutaneous pellets containing 120 or 240 
mg cocaine and tested three days later also showed deficits in pre-pulse inhibition to the 
same startle pulses (Martinez et al., 1999). In an animal model of schizophrenia with a 
genetic deletion of the Homer 1 gene, mice exhibit deficits in PPI and this sensorimotor 
getting deficit is associated with anomalies in PFC glutamate that include increased basal 
extracellular content and a failure to respond normally to an acute cocaine injection 
(Szumlinski et al., 2005). mPFC (ACC, PL, and IL) ibotenic acid lesions in rat result in 
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significantly higher PPI compared to control and lateral PFC lesions over startle pulses of 72, 
76, 80, and 84 dB (Lacroix, Spinelli, White, & Feldon, 2000). Thus, the PFC also governs, at 
least in part, sensorimotor gating processes and cocaine-induced impairment in PFC function 
is likely to contribute to drug-induced impairments in sensorimotor gating. To examine for a 
relationship between decreased MBP expression within the vmPFC and sensorimotor gating, 
rats in the following series of experiments were also run through identical PPI procedures to 
those employed by Szumlinski et al., (2005). We hypothesize a decrease in MBP within the 
vmPFC will impair normal sensorimotor gating resulting in increased startle responses 
following pre-pulses, compared to rats with unaltered MBP expression. 
 Impulsivity can be broadly defined as decision-making or action without appropriate 
forethought and is one major risk factor for the development of drug addiction (Sun, Cocker, 
Zeeb, & Winstanley, 2012). Impulsivity can be further decomposed into cognitive forms of 
impulse control that can similarly be measured across humans and animal models using 
delay-discounting paradigms that reveal preference for a smaller-sooner versus larger-
delayed reward (Sun et al., 2012). Delay-discounting procedures in rats have been used to 
show baseline impulsive choice differences that predict the acquisition and the rate of 
acquisition of cocaine self-administration (Perry, Larson, German, Madden, & Carroll, 
2005). Distinct subregions of the PFC have been shown to play various roles in delay 
discounting. For instance, reversible inactivation of the orbitofrontal cortex (OFC) with 
baclofen/muscimol was found to increase impulsive choice in less impulsive rats (measured 
at baseline) when the delay between behavior and the large reward was cued with a light 
(Zeeb, Floresco, & Winstanley, 2010). However, in highly impulsive rats measured at 
baseline, baclofen/muscimol OFC microinjections decreased impulsive choice in rats when 
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the delay between behavior and large reward delivery was not cued. In human imaging 
studies, choices anticipating immediate rewards increased signal activity in the mPFC and 
mOFC, while choice of the delayed option was associated with increased activity in the 
lateral PFC and OFC (Dalley, Everitt, & Robbins, 2011). In a BOLD fMRI study, human 
participants showed greater activity in the vmPFC when deciding between objects to acquire 
the larger reward (Blair et al., 2006). Moreover, rats with excitotoxic lesions to the mPFC 
showed a preference for a low-reward arm entry in a T-maze when the high-reward arm 
required traversing a barrier to obtain the reward, an effect that was shown to be based on the 
amount of effort required to obtain the reward as lowering the barrier reinstated the 
preference for the high-reward arm, and indicating a role of the mPFC in determining the 
amount of work an animal will engage in to obtain a specific reward (Walton, Bannerman, & 
Rushworth, 2002). Given the role of the PFC in impulsive choice and decision-making for 
obtaining a reward, we hypothesize that decreased MBP within the vmPFC will promote 
impulsive choice possibly by decreasing normal processing within the brain region. 
4.2 Methods 
4.2.1 Animals 
 Subjects were identical to those described in Chapter 2, with the following 
exceptions. Animals were given ad libitum access to food and water, except during training 
and testing on the DNMS T-maze. Animals were allowed to acclimate to the colony room for 
two days following arrival and were handled daily for the duration of the experiment.  
4.2.2 Surgical Procedures 
 Surgical procedures and lentiviral transduction vector delivery began 3 days 
following arrival of animals. Under ketamine/xylazine anesthesia (56.25 mg/kg, Henry 
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Schein, Dublin, OH, and 7.5 mg/kg, Lloyd, Shenandoah, IW, respectively, administered 
intramuscularly (IM)), animals’ skulls were stabilized in a stereotaxic apparatus (Stoelting, 
Wood Dale, IL) and were implanted with a chronic 22 gauge bilateral guide cannula (1.5 mm 
spacing between cannula, Plastics One) above the vmPFC [anteriorposterior (AP), +3.1 mm; 
mediolateral (ML) +0.75 mm; dorsovental (DV) -3 mm; nose set at -3.5 mm]. Four small 
screws and cranioplastic cement secured the guide cannula to the skull. While still under 
anesthesia, animals were removed from the stereotaxic apparatus and microinjectors (28 
gauge) were lowered bilaterally into the guide cannula and exited 2 mm beyond the end of 
the guide. Lentiviral transduction particles (LVV details described in subsequent section) 
containing short-hairpin RNA (shRNA) against MBP mRNA transcripts or control particles, 
were infused at a rate of 0.1 µl/min over 10 minutes (total volume is 1.0 µl/side) via a 
Harvard Apparatus PHD 2000 infusion pump (Harvard Apparatus, Holliston, MA), with a 5 
minute waiting period to allow for diffusion of the virus from the tip of the microinjector. For 
post-operative pain, banamine (2 mg/kg, subcutaneous, Butler Schein Animal Health, 
Dublin, OH) was administered subcutaneously twice daily for two days following surgery. 
Behavioral testing procedures began 3 weeks following virus infusion and to allow animals 
to fully recover from surgery. 
4.2.3 LVV information 
 Custom lentiviral transduction particles were ordered through Sigma-Aldrich to 
generate shRNA against MBP transcripts or empty vectors used as controls with a green 
fluorescent protein reporter expressed to verify transduction (LVV ctl, SHC003V; LVV1, 
product number: SCHLNV, clone ID TRCN0000090245; backbone pLKO.1-hPGK-Puro-
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CMV-tGFP; LVV2, product number SCHLNV, clone ID TRCN0000376806, backbone 
pLKO.1-hPGK-Puro-CMV-tGFP; St. Louis, MO). 
 To verify transduction efficacy in vivo of the LVV’s when microinjected into the rat 
vmPFC, animals (n=8-10/group) underwent identical surgical procedures as described 
earlier. Animals were allowed to recover and remained in the vivarium for 3 weeks, then they 
were anesthetized with 2-3% isoflurane and a microinjector filled with black India ink was 
inserted into the bilateral guide cannula (28 G, exited 2 mm beyond the bilateral guide) to 
mark where viral infusions had occurred. Animals were then decapitated and a punch of 
tissue around the ink spot was collected over ice for immunoblotting procedures identical to 
those described in section 2.2.6. 
4.2.4 Object recognition tests 
 Apparatus 
 Object recognition tests occurred in a square open field (1m length, by 1m width, 
with 50cm high walls) constructed of white Plexiglas walls and a clear Plexiglas floor, 
situated on the laboratory floor. The location of the open field and position of “extrafield” 
cues was constant throughout object recognition tests. A soft, 60-watt light illuminated the 
room and a fan masked extraneous noise. A video camera mounted on the ceiling directly 
above the field was connected to AnyMazeTM tracking software (Stoelting) and tracked the 
animals’ movement and interaction with the inedible objects. The objects for the novel object 
test consisted of glass blocks (5 cm length, 5 cm width, 7 cm height) and a metal ring (8.5 cm 
in diameter with a center 3 cm diameter circle cut out), swabbed with either lemon or almond 
(McCormick, Sparks, MD) scent prior to each test; the object deemed “novel”, the location 
of the novel object on the test, and the scent swabbed on the objects was counterbalanced 
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among subjects and duplicate identical objects were used to prevent both scents from being 
swabbed on the same object. The objects for the object-in-place test consisted of a light bulb, 
glass blocks (same as the novel object test), a 50ml centrifuge tube (Corning, Tewksbury, 
MA), and a glass jar (5.5 cm diameter, 5 cm high). The location of the four objects in the 
object-in-place test was constant for the exploration phase, but the two items with switched 
placements during the test phase was counterbalanced among subjects. The apparatus and 
objects were wiped down with 70% isopropyl alcohol between tests to mask odor. 
 Procedure 
 Prior to beginning testing, animals were placed individually into the open field 
apparatus for a 5-minute habituation session on two consecutive days and their total distance 
traveled, time spent immobile, and total number center entries (10 cm diameter circle in the 
center of the open field) were recorded. The animals were then split into two groups; half of 
the animals were tested in the novel object test followed by the object-in-place test, and the 
other half were tested in the opposite order. In the novel object test (methods similar to 
Reichel, Chan, Ghee, & See, 2012), animals were placed in the open field at the center of a 
wall, adjacent from the two identical objects with scent (either lemon or almond) and allowed 
to familiarize themselves with the objects for 3-minutes. Animals were returned to their 
home cages for a 90-minute waiting period before the animals were again placed in the open 
field and tested for their interaction time with one of the familiar objet and a novel object 
with a novel sent (i.e., one not employed during the familiarization test) scent over 3-
minutes. 
 On the object-in-place test, familiarization occurred over a 5-minute duration where 
animals were placed in the center of the apparatus and allowed to freely explore four distinct 
	  121	  
objects each placed in a distinct corner of the apparatus. The animals were again returned to 
their homecages for a 90-minute waiting period followed by a 3-minute test where the 
placement of two of the four objects was changed.  
 For both tests, object exploration was defined as sniffing or touching the object, but 
not climbing, sitting, leaning, or standing on the objects. For both tests, center entries were 
recorded and the time spent with the novel or repositioned objects was converted into a 
“recognition index” for statistical analysis: novel object test = (amount of time spent with 
novel object)/(time spent with both objects); object-in-place test = (amount of time spent 
with repositioned objects)/(time with all objects). 
4.2.5 Delayed non-matching-to-sample (DNMS) T-maze 
 The T-maze apparatus consisted of white Plexiglas walls and floor with three 
guillotine doors constructed of the same material. One door enclosed the starting box and 
was raised upon initiation of a trial and two other doors could be lowered once an animal 
entered a particular arm of the maze. The dimensions of the maze were as follows: length of 
central start arm, 60 cm; length of start box, 30 cm; length of left/right arms, 50 cm; width, 
15 cm; and height, 25 cm. 
 Rats were food deprived to 85% body weight and maintained on a restricted diet 
throughout T-maze testing. Habituation sessions to the T-maze started by placing the animal 
in the start box, raising the guillotine door and allowing the animal to freely explore the maze 
for 5-minutes. Habituation sessions were conducted twice daily till animals readily ate a food 
pellet at the end of each goal arm (45 mg pellets; Noyes, Lancaster, NH). Following 
habituation, animals were trained 10 trials/session on the DNMS task. Each trial began with a 
forced-choice run where the animal was only allowed entry to one rewarded goal arm 
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(randomly chosen) and one free-choice run where the animal had free access to both goal 
arms but only the opposite arm from the forced-choice run was rewarded. A “choice” 
required an animal to place two front paws and one back paw into one of the arms; no 
retracing was permitted. If the animal had alternated correctly and chosen the arm with a 
food reward, it was allowed to consume the food pellet before being returned to his cage. 
However, if the animal failed to alternate to the other arm from the forced-choice trial, they 
were confined to that arm without food reinforcement for 10-sec before being returned to 
their homecage. Between runs there was no delay, except to wipe the maze with 70% 
isopropyl alcohol to reduce olfactory cues. Training acquisition was set to >70% correct 
responses (animal correctly chose the opposite arm as the forced-choice run on the free-
choice run) during two consecutive days. Rats were then moved to the testing phase, where 
the number of trials was increased to 16 and a delay (10, 70, or 130s) was introduced 
between the runs. Each animal experienced one delay period per day, and each delay period 
was run twice (total of 6 testing days, two for each delay period). The number of trials to 
reach acquisition criterion and the percentage of correct responses of the three delays were 
calculated. Training and testing in this behavioral test is very time and labor-intensive (>2 
weeks/6 animals) and the laboratory is only equipped to run animals in cohorts of 6. Thus, 
the remaining animals were run through additional behavioral tests discussed below and 
animals slated for testing in the T-maze were run through these tests following completion of 
the paradigm. 
4.2.6 Pre-pulse Inhibition 
 The apparatus and procedures are similar to those described previously (Szumlinski et 
al., 2005), except the apparatus was fitted with 3.5 inch (inner diameter) cylinder tubes (8 
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inches, length) for rats. Animals were placed in sound-attenuated startle chambers (SR-LAB, 
San Diego Instruments) and six different trial types were presented: no pulse (st0; only 
background noise of 70 dB), startle pulse (st110; 110dB/40 msec), low prepulse stimulus 
(st74, 74 dB/20 msec; given alone), high prepulse (st90, 90 dB/20 msec; given alone), and 
st74 or st90 given 100 msec prior to the onset of the st110 startle pulse (pp74 and pp90, 
respectively). St0, st110, pp74, and pp90 trials were applied 10 times, while st74 and st90 
trials were applied five times, in random order with an average intertrial interval of 15 sec 
(range: 10-20 sec). The startle amplitude data were averaged across stimulus trials for each 
rat and prepulse inhibition was calculated as the percent decrease in response to a 110 dB 
startle tone when it is preceded by either a 74 dB or 90 dB prepulse tone. 
4.2.7 Within-Session Delay Discounting (WSDD) 
 Food training 
 To encourage lever-pressing behavior for the WSDD procedure, animals were first 
trained to lever press for food reinforcement (45 mg pellets; Noyes, Lancaster, NH). Animals 
were trained in standard operant conditioning chambers (30 x 20 x 24 cm high; Med 
Associates Inc., St. Albans, VT) containing two retractable levers with a stimulus light 
located above each lever, a food pellet dispenser located outside the operant chamber, a food 
trough between the levers, a house light on the opposite wall to the levers, and a fan to 
provide ventilation and mask extraneous noise. At the beginning of each 30-min training 
session, one lever was extended into the chamber; depression of the lever delivered a single 
food pellet on a FR1 schedule of reinforcement without the presentation of additional cues. 
Animals were trained daily on both levers (levers were randomly chosen on which was 
presented first in a day) till they reached >50 responses in a single session for both levers, at 
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which time they progressed to lever-training procedures. All experimental data were recorded 
using MedPC-IV software (Med-Associates, St. Albans, VT, USA). 
 Lever-training procedures 
 Lever-training procedures have been adapted from a previous publication (Zeeb, 
Floresco, & Winstanley, 2010). Each session began with the illumination of the houselight, 
followed by the extension of one lever 3-sec later. If the rat depressed the lever within 10-
sec, the lever was retracted and scored as a success, a food pellet was delivered into the food 
trough, the houselight extinguished 4-sec later, and the chamber was left in darkness for the 
remainder of the trial. If the animal failed to act on the lever within the 10-sec window, the 
lever was retracted and scored as an omission, the houselight extinguished 4-sec later, and 
the chamber left in darkness for the remainder of the trial. Each trial lasted 40-sec, with a 
total of 90 trials per testing session, and with no more than two consecutive presentations of 
the same lever. Lever-training acquisition criterion was set at 80 successful trial completions, 
and the total number of days to reach acquisition was recorded as well. 
 Delay-discounting 
 Delay-discounting procedures are nearly identical to those described in Zeeb et al., 
(2010) and will be described briefly here. Each trial began with the illumination of the 
houselight and the extension of the lever(s) 2-sec later. Similar to lever-training, the rat had 
10-sec to respond on the lever to receive food reinforcement before it was retracted; 
otherwise, the trial was scored as an omission and in both instances the houselight was 
extinguished and the remainder of the trial was in darkness. Responding on one lever (lever 
A) always resulted in the delivery of one food pellet, while the opposite lever (lever B) 
always resulted in the delivery of three food pellets delivered 0.5-sec apart; the position of 
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lever A and B were counterbalanced between subjects. Each session consisted of 4 blocks 
(56-minutes total) of 12 trials each (70-sec duration), with two forced-choice trials at the start 
of each block. In the forced trials, one lever was presented per trial (lever A and B presented 
randomly) to indicate to the animal the reward available for that lever and whether there was 
a delay between lever depression and reward delivery. In the first three testing sessions, both 
levers resulted in immediate rewards for all trials. Session 4 began testing on the delay-
discounting program, where a response in the first block of trials resulted in immediate 
reward for responses on both levers, followed by blocks 2-4 where a delay was introduced 
for the large reward lever (block 2, 15-sec; block 3, 30-sec; block 4, 45-sec) and resulted in a 
delay between lever responses and delivery of the food reward. For blocks 2-4, where a delay 
was present for lever B (large reward lever), a cue light located above lever B was 
illuminated immediately after lever depression and for the duration of the delay. Sessions 
continued 6 days per week until stable baseline responding was achieved for five consecutive 
days.  
4.2.8 Statistical Analysis 
 For the 2 object recognition tests, one-way ANOVAs of Viral Treatment were 
conducted for total distance traveled, time spent immobile, and number of center entries on 
Habituation Days 1 and 2, and for familiarization and testing days for each recognition test. 
One-way ANOVAs were also conducted for the recognition indices generated for the novel 
object and object-in-place tests. A T-test was conducted during familiarization of objects for 
the novel object and a one-way ANOVA was conducted during familiarization for the object-
in-place test to ensure no bias towards one object or location existed prior to testing. For the 
DNMS T-maze, days to reach training criterion were analyzed by one-way ANOVA of Viral 
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Treatment and two-way ANOVAs were used to analyze Viral Treatment x Delay for the 
percent correct alternations. For PPI, two-way ANOVAs of Viral Treatment (between 
subjects factor) x Startle Amplitude (repeated measures, within subjects factor) for baseline 
startle responses were conducted, and one-way ANOVAs of Viral Treatment on PPI to the 74 
dB and 90dB pre-pulses were conducted to examine for differences in sensorimotor gating.  
For WSDD, similar data analysis methods were used as conducted by Zeeb et al. 
(2010) in that an arcsine transformation was performed on the number of responses per block 
prior to statistical analysis in order to limit the effect of an artificially imposed ceiling (e.g. 
ten choices per block). Stable baseline behavior was assessed by a non-significant effect of 
Session x Delay when the large reward lever (delay lever) was analyzed across 5 sessions by 
two-way ANOVA. The last five days of stable responding were averaged for each animal at 
each delay period and used for subsequent analyses. Two-way ANOVAs of Viral Treatment 
x Delay were conducted for behavior on the large reward lever, small reward lever, and total 
number of omissions. Tukey’s multiple comparisons test was used for post-hoc comparisons 
of significant two-way ANOVAs and Fisher’s LSD tests were conducted for one-way 
ANOVAs. One-way ANOVAs of Viral Treatment on protein expression for MBP and MOG 
was used to analyze viral mediated changes in protein expression. 
4.3 Results 
4.3.1 Object recognition tests (novel object and object-in-place) 
 Viral treatment did not significantly alter the total distance traveled, time spent 
immobile, or the number of center entries during the habituation phase of testing on either 
day 1 or 2 (One-way ANOVA of Viral Treatment, all p’s>0.05; figure 10a).  
 During novel object familiarization, there was no statistically significant bias towards 
either of the identical objects [t(52)=0.85,  p>0.05]. Nor was there an effect of Viral 
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Treatment on the total distance traveled, time spent immobile, or total number of center 
entries (one-way ANOVAs, p’s>0.05). No group differences were observed for the 
recognition index in the novel object test (one-way ANOVA, p>0.05; figure 10b), nor were 
significant effects observed for the total distance traveled, time spent immobile, or center 
entries during the test session (one-way ANOVAs, p>0.05). 
Similar to the novel object test, there were no significant effects of Viral Treatment 
upon object recognition when assessed in the object-in-place test. No object bias was 
revealed during familiarization nor were group differences observed for the recognition index 
for displaced objects during the test (one-way ANOVAs, p’s>0.05; figure 10c). Group 
differences were also not apparent for the total distance traveled, time spent immobile, or 
number of center entries during either the familiarization or the recognition test phases of the 
study (one-way ANOVAs, p’s>0.05). 
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4.3.2 DNMS T-maze 
 Viral Treatment did not affect the total number of training sessions required to reach 
acquisition criterion (one-way ANOVA, p>0.05), nor was there an effect of Viral Treatment 
on the percent correct alternations in the T-maze (two-way ANOVA, p’s> 0.05; figure 11a). 
Increasing the delay between the forced and choice trials (10sec, 70 sec, 130 sec) lead to a 
decrease in alternation accuracy for all groups (Figure 11b) [Delay effect: F (2, 66)=4.51, 
p=0.015; no Viral Treatment effect or Interaction: p’s>0.05] with animals alternating less 
accurately at the 130 sec delay compared to the 10 sec delay [Tukey’s multiple comparisons 
test, p<0.05). 
4.3.3 Acoustic Startle and Pre-pulse Inhibition 
 Two-way ANOVAs of Viral Treatment x Startle Amplitude (repeated measures) 
failed to reveal a significant effect of Viral Treatment on sensorimotor gating either in basal 
activity in the chamber (0 dB) or in response to the 74, 90, or 110 dB tone intensities (all 
p’s>0.05). One-way ANOVAs of Viral Treatment on the percent inhibition of the startle 
elicited by the 110 dB tone preceded by the 74 and 90 dB pre-pulses also failed to indicate 
group differences (p>0.05; figure 12). 	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A. 
 
B. 
 
 
Figure 11. Summary of delayed non-matching to sample (DNMS) T-maze test results. (A) 
Viral treatment (LVV ctl, LVV1, LVV2) did not significantly affect the number of sessions 
required to meet the criterion of 2 consecutive days of  > 70% correct alternations between 
the forced run and choice runs (p>0.05). (B) Viral treatment also failed to affect the percent 
correct alternation (% Correct Alternation) when either a 10 sec (10), 70 sec (70) or 130 sec 
(130) delay was instituted between forced and choice runs (Viral Treatment, p>0.05). Rats 
did correctly alternate a greater proportion of choice runs when a 10 sec compared to 130 sec 
delay was instituted (* indicates a main effect of Delay, p<0.05).
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A. 
 
 
B.         C. 
 
                         
 
 
Figure 12. Summary of prepulse inhibition (PPI) test results. (A) Viral treatment (LVV ctl, 
LVV1, LVV2) failed to affect startle amplitudes in either basal activity in the chamber (0 dB) 
or in response to the 74, 90, or 110 dB tone intensities (all p’s>0.05). (B) Viral treatment had 
no effect on percent inhibition of the startle elicited by the 110 dB tone when preceded by the 
74 or (C) 90 dB pre-pulses (p’s>0.05) 
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4.3.4 Within-session delayed discounting 
 The total number of sessions to reach food-training criterion for both right and left 
levers were combined to examine for differences in acquisition. One-way ANOVAs of Viral 
Treatment on sessions to food training criteria revealed a significant effect of Viral 
Treatment [F (2, 33)=6.51, p=0.004]. Fisher’s LSD post-hoc tests revealed both LVV1- and 
LVV2-treated animals learned to self-administer food pellets faster than control virus-treated 
animals (figure 13a) (LVV1 vs. LVV ctl, p=0.005; LVV2 vs. LVV ctl, p=0.003). 
 The last 5 days of behavior on the large reward lever for each animal was determined 
to be stable as revealed by non-significant repeated measures two-way ANOVAs of Day x 
Delay (Day and Day x Delay, p’s>0.05). However, animals did show a significant effect of 
Delay [F (3, 144)=82.82, p<0.001]. Post-hoc comparisons of delay time at each day revealed 
all delays to be significantly different from one another except the 30 sec and 45 sec delays 
(Tukey’s multiple comparisons test, all days examined separately, p<0.05), indicating 
increased delay between behavior on the large reward lever and presentation of the reward 
resulted in animals responding less on that lever. Since behavior was stable over the last 5 
days, each animal’s responses over each delay for the last 5 days were averaged in order to 
compare Viral Treatment and Delay on lever responding behavior.  
 A two-way ANOVA of Viral Treatment x Delay for the average of the last five days 
of testing on the large reward lever, revealed significant main effects of Viral Treatment [F 
(2, 136)=5.63, p=0.005] and Delay [F (3, 136)=85.99, p<0.001], but no significant interaction 
(Viral Treatment x Delay, p>0.05; figure 13b). Overall, the LVV2 group exhibited the least 
impulsivity of the 3 groups tested, as indicated by greater total responses on the large reward 
lever across all delays (Fisher’s LSD, LVV2 vs LVV ctl, p=0.009; LVV2 vs LVV1, 
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p=0.002). Post-hoc comparisons also revealed a delay-induced reduction in large reward 
lever responding, with behavior plateauing at the 30 sec delay (Fisher’s LSD, p’s<0.05). 
Consistently, the LVV2 treated group responded significantly less on the small 
reward lever than either LVV1 or LVV ctl animals revealed by an analysis of the small 
reward lever for the last five days of testing resulting in a main effect of Viral Treatment [F 
(2, 136)=8.51, p<0.001; Fisher’s LSD, LVV2 vs LVV ctl, p<0.001; LVV2 vs LVV1, 
p<0.001]. Analysis of the small reward lever also revealed a significant main effect of Delay 
[F (3, 136)=38.35, p<0.001], but no interaction (Viral Treatment x Delay, p>0.05; figure 
13c). Post-hoc comparisons revealed a delay-induced enhanced small reward lever 
responding, with behavior plateauing at the 30 sec delay (Fisher’s LSD, p’s<0.05). 
 A two-way ANOVAs of Viral Treatment x Delay for the last five days of testing on 
omissions revealed a significant main effect of Delay [F (3, 136)=17.15, p<0.0001], but no 
effect of Viral Treatment or Interaction (p’s >0.05; figure 13d). Post-hoc comparisons of 
Delay revealed a delay-induced enhancement in lever response omissions, with behavior 
plateauing at the 30 sec delay (Fisher’s LSD, p’s<0.05).
134	  
A
. 
B
. 
C
. 
D
. 
Fi
gu
re
 1
3.
 S
um
m
ar
y 
of
 w
ith
in
-s
es
si
on
 d
el
ay
 d
is
co
un
tin
g 
te
st
 re
su
lts
. (
A
) V
ira
l t
re
at
m
en
t w
ith
 e
ith
er
 L
V
V
1 
or
 L
V
V
2 
si
gn
ifi
ca
nt
ly
 
de
cr
ea
se
d 
th
e 
to
ta
l n
um
be
r o
f t
ra
in
in
g 
se
ss
io
ns
 re
qu
ire
d 
to
 m
ee
t f
oo
d 
tra
in
in
g 
ac
qu
is
iti
on
 c
rit
er
io
n 
(>
50
 re
sp
on
se
s o
n 
th
e 
rig
ht
 a
nd
 le
ft 
le
ve
rs
, s
ep
ar
at
el
y)
 v
er
su
s r
at
s i
nf
us
ed
 w
ith
 c
on
tro
l v
iru
s (
LV
V
 c
tl)
. (
B
) A
ni
m
al
s t
re
at
ed
 w
ith
 L
V
V
2 
pr
es
se
d 
th
e 
la
rg
e 
re
w
ar
d 
le
ve
r 
ov
er
 a
ll 
de
la
ys
 (i
n 
se
c)
 m
or
e 
th
an
 L
V
V
 c
tl 
an
d 
LV
V
1 
an
im
al
s. 
(C
) A
ni
m
al
s t
re
at
ed
 w
ith
 L
V
V
2 
al
so
 p
re
ss
ed
 th
e 
sm
al
l r
ew
ar
d 
le
ve
r (
no
 
de
la
y 
be
tw
ee
n 
be
ha
vi
or
 a
nd
 fo
od
 re
in
fo
rc
em
en
t) 
si
gn
ifi
ca
nt
ly
 le
ss
 th
an
 L
V
V
 c
tl 
an
d 
LV
V
1 
an
im
al
s. 
A
 sh
ift
 u
pw
ar
d 
on
 g
ra
ph
 B
 a
nd
 
do
w
nw
ar
d 
on
 g
ra
ph
 C
, i
nd
ic
at
e 
de
cr
ea
se
d 
im
pu
ls
iv
e 
ch
oi
ce
 in
 L
V
V
 2
 tr
ea
te
d 
an
im
al
s. 
(D
) N
o 
di
ff
er
en
ce
 w
as
 o
bs
er
ve
d 
fo
r t
he
 n
um
be
r 
of
 o
m
itt
ed
 re
sp
on
se
s a
cr
os
s v
ira
l t
re
at
m
en
ts
. A
cr
os
s B
, C
, a
nd
 D
, t
he
re
 w
as
 a
 si
gn
ifi
ca
nt
 e
ff
ec
t o
f D
el
ay
 re
ga
rd
le
ss
 o
f v
ira
l t
re
at
m
en
t 
(p
’s
<0
.0
5)
. D
at
a 
us
ed
 in
 st
at
is
tic
al
 a
na
ly
si
s f
or
 B
, C
, a
nd
 D
 w
er
e 
ar
cs
in
e 
tra
ns
fo
rm
ed
 [a
rc
si
ne
 (s
qu
ar
e 
ro
ot
 (%
 re
sp
on
se
s/
10
)]
, t
o 
lim
it 
th
e 
ef
fe
ct
 o
f a
n 
ar
tif
ic
ia
lly
 im
po
se
d 
ce
ili
ng
 (m
ax
im
um
 o
f 1
0 
re
sp
on
se
s)
.
	   135	  
4.3.5 Verification of viral-mediated OL transduction by Western blotting 
 One-way ANOVA of Viral Treatment on MBP expression revealed a significant 
effect of Viral Treatment [F (2, 41)=4.00, p=0.026]. Fisher’s LSD post-hoc analysis revealed 
significantly reduced MBP expression in LVV2 compared to LVV ctl (p=0.015), but no 
effect of LVV1 upon MBP expression (p>0.05). One-way ANOVA of Viral Treatment on 
MOG expression revealed a significant effect of Viral Treatment [F (2, 25)=3.54, p=0.044]. 
Fisher’s LSD post-hoc analysis revealed significantly reduced MOG expression in LVV2 
compared to LVV ctl (figure 14; p=0.016), but again, no effect of LVV1 on MOG levels.	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Figure 14. Immunoblotting to confirm MBP knock-down. LVV2 treated animals exhibited a 
significant decrease in MBP and MOG expression levels within the vmPFC approximately 4 
months following virus microinjections, compared to LVV1 and control animals (LVV ctl). 
LVV1 animals did not show a significant decreased in either protein, compared to control 
animals. Data represent the optical density for each protein expressed as a percent of LVV ctl 
levels. Representative immunoblot images for each protein lay directly below the graphical 
representation of changes. *p<0.05. 
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4.4 Discussion 
 Contrary to the hypotheses proposed, virally mediated decreased MBP expression 
within the vmPFC did not impair working memory or learning within the object recognition 
tests or within the DNMS T-maze. Despite confirmation that our LVV2 construct 
significantly reduced MBP levels, LVV2 animals spent similar time interacting with new and 
displaced objects as familiar objects, did not differentially ambulate, and did not cross the 
center of the open field differently than controls. LVV2 animals also did not differ from 
controls in acquiring the T-maze task, nor were they differentially affected by an increase in 
delay between forced and choice trials. Surprisingly, decreased MBP expression lessened 
impulsive choice assessed in the WSDD task, opposite to the effect hypothesized for 
decreased myelin-integrity on vmPFC function and impulsive choice measures. 
 Distinct electrolytic lesions of the PL and IL subregions have been shown to decrease 
time spent in the center of an open field, and animals with IL lesions also showed a decrease 
in locomotor activity assessed via line crossings over a 10-minute test period in a circular 
open field apparatus (Jinks & McGregor, 2006). While we saw no differences in either of 
these dependent variables when MBP expression was decreased within the vmPFC, it is 
possible that this change in protein expression was not substantial enough to affect vmPFC 
function as an electrolytic lesion. Additionally, electrolytic lesions ablate fibers of passage, 
as well as local cellular populations, and would be predicted to have a greater impact than a 
specific OL manipulation. Moreover, given that we examined behavior in the open field over 
several sessions (two habituation sessions and two sessions per object recognition test), if 
increased anxiety-like behaviors had been a consequence of MBP manipulation, we would 
have expected this effect to be lasting and perhaps have been revealed between groups when 
the control animals habituated to the testing apparatus. Therefore, we do not believe that 
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decreased MBP expression within the vmPFC is affecting anxiety-like behavior mediated by 
this region that might confound performance in other memory-related tasks. 
 Our finding that MBP knock-down did not alter behavioral in object recognition tests 
is consistent with the results of excitotoxic lesion studies; large excitotoxic lesions centered 
on the PL (and encompassing the majority of the mPFC) failed to significantly alter rats’ 
interaction with either a novel object or displaced objects in a study conducted by Ennaceur, 
Neave, & Aggleton, (1997). Though this study examined different delay periods than the 
current study (1 min or 15 min vs 90 min, respectively), the results are nonetheless 
consistent. In another type of object recognition task, in which different sensory modalities 
are examined in combination with PFC lesions, Reid, Jacklin, & Winters, (2014) observed a 
significant effect of impaired OFC function on object recognition, but failed to detect an 
effect of mPFC lesion. Specifically, animals were tested in a Y-maze where the exploration 
phase consisted of visual examination of the object (clear plastic barrier between rat and 
objects) or tactile examination (red light illumination to prevent accumulation of visual 
information), followed by a 1-hour delay prior to the choice interaction between the old and 
novel object. A cross-modal test was also conducted where rats were exposed to tactile 
information during the exploratory phase followed by visual information only during the 
choice phase. Rats with mPFC excitotoxic lesions showed the normal increase in exploratory 
behavior of novel objects across all conditions (a finding consistent with the present results), 
whereas, rats with OFC lesions failed to increase their exploratory behavior in the cross-
modal condition when a 1-hr delay was instituted between exploratory and choice trial 
interactions. Together, these lesion data argue that the OFC, rather than the vmPFC, plays a 
more major role in recognition memory, arguing perhaps that the associations between 
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anomalies in vmPFC function and recognition memory observed in stimulant-experienced 
individuals might reflect a coincidence, rather than a cause-effect relation.  
 At the 10 sec delay of the DNMS T-maze, I observed no group differences on 
acquisition or percent correct alternation - a finding consistent with the results of lesion 
studies of the PL and IL at this delay time point (Delatour & Gisquet-Verrier, 2000; Delatour 
& Gisquet-Verrier, 1999; Delatour & Gisquet-Verrier, 1996; Dias & Aggleton, 2000; Li & 
Shao, 1998). However, ibotenic acid lesions of the vmPFC in rat have been shown to delay 
acquisition and impair performance on the T-maze when a 40 sec delay is incorporated 
between the sample or forced run and choice runs (Delatour & Gisquet-Verrier, 2000; 
Delatour & Gisquet-Verrier, 1996). When the last two training sessions in the Delatour & 
Gisquet-Verrier (2000) study were examined, no difference in percent correct choices were 
found between the sham and vmPFC lesioned groups, suggesting this deficit was overcome 
by the end of training. Given that more significant lesions induced by ibotenic acid result in 
performance deficits that are overcome with training, it is likely decreased MBP expression 
does not produce sufficient impairment of vmPFC function to reveal deficits in working 
memory, even when delays of 130 sec are instituted between forced and choice runs. Future 
studies could address this issue by infusing larger volumes or higher titers of virus to effect 
greater MBP knock-down than that produced in the study herein.    
 A consistent finding across studies of vmPFC damage is a deficit of reversal learning 
of new strategies once an original strategy has been established, reflected as behavioral 
inflexibility or attentional deficits within T-maze tests (Dias & Aggleton, 2000; Li & Shao, 
1998). The failure to detect any effect of vmPFC knock-down upon behavior in the T-maze is 
a finding in line with the behavioral phenotype expressed by Shiverer and mld mice (which 
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do not express MBP or contain only one copy of the gene, respectively) that also fail to show 
deficits in learning the location of a food reward in the T-maze. However, these mutant mice 
do show deficits in reversal learning when the location of the food reward is changed and 
repeatedly revisit the originally rewarded arm (Inagawa et al., 1988). I did not conduct 
reversal learning procedures in my study and therefore, the possibility still exists that we may 
have detected an effect of decreased MBP expression had we further assessed the animals on 
a matching-to-sample task, following the non-matching to sample task. This issue can be 
explored in future research. Taken together, both the current findings and previous studies of 
do not reveal a role of MBP in the vmPFC for anxiety-related or working-memory related 
tasks. 
 Contrary to our hypothesis, we did not detect an effect of decreased MBP expression 
on sensorimotor gating. Consistent with the current studies, both ibotenic acid and 
excitotoxic lesions of the vmPFC within rats failed to affect startle responses or prepulse 
inhibition (Lacroix, Broersen, Weiner, & Feldon, 1998; Sullivan & Gratton, 2002). Both of 
these findings contrast with specific dopaminergic manipulations of the rat vmPFC, including 
dopamine receptor antagonist (SCH31966 or sulpiride) or agonist (apomorphine) 
microinfusions result in disrupted prepulse inhibition without affecting startle responses 
(Broersen, Feldon, & Weiner, 1999; Ellenbroek, Budde, & Cools, 1996). Interestingly, local 
mPFC infusions of amphetamine (indirect DA agonist) or cis-flupenthixol (DA antagoinst) 
failed to have an effect on PPI. It is unclear why specific pharmacological manipulations of 
the vmPFC would result in PPI deficits without all DA modulators affecting PPI and without 
also seeing an effect of lesioning this brain area, and it remains to be determined exactly how 
the vmPFC is functioning to mediate this behavioral phenomenon. 
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 The only task in which we detected a significant effect of our MBP knockdown was 
in the WSDD task, in which the LVV2 group exhibited behavioral indices of decreased 
impulsive choice. While this finding is contrary to our hypothesis, a survey of the extant 
literature pertaining specifically to the role for the vmPFC in impulsive choice, as assessed 
with delay discounting, reveals inconsistent results. Administration of the D2 agonist 
quinpirole, or antagonist eticlopride, into the vmPFC (PL and IL) results in increased 
impulsive choice for the small, immediate reward over the larger delayed reward, but 
administration of the D1-like antagonist SCH23390, microinjected into the mPFC failed to 
have a significant effect on impulsive choice (Yates et al., 2014). However, Loos et al. 
(2010) found SCH23390 infusion into the vmPFC to increase impulsive choice. Excitotoxic 
lesions of the mPFC failed to increase impulsive choice for the smaller, immediate reward, 
however the lesions did produce a significant flattening of the within-session preference shift 
from large to small rewards (Cardinal, Pennicott, Sugathapala, Robbins, & Everitt, 2001). 
This latter lesion finding is similar to the current result that LVV2 animals with reduced 
MBP expression did not shift as readily to the smaller, immediate reward as did control 
animals. However, in other studies, reversible inactivation of the vmPFC, via muscimol 
microinjections, failed to effect impulsive choice and also did not “flatten” the preference 
shift in rats assessed in WSDD (Feja & Koch, 2014). Interestingly, muscimol microinjections 
into the vmPFC increased premature responses, perseverative responses, omissions and 
decreased accuracy on the 5-choice serial reaction time task (5-CSRTT) - effects consistent 
with those produced by NMDA receptor antagonism within the IL (Feja & Koch, 2014; 
Murphy, Dalley, & Robbins, 2005). This indicates the vmPFC, and specifically the IL 
subregion, may play a more important role in impulsive action (e.g. motor impulsivity 
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resulting in premature responding), than in impulsive choice or decision-making. 
Unfortunately, however, impulsive actions such as premature responding are not assessed in 
the WSDD paradigm.  Moreover, heightened impulsive choice has been associated with poor 
working memory capabilities (Winstanley et al., 2010), and my LVV-infused animals 
exhibited neither behavioral anomaly. Therefore, future examination of the role of MBP 
within the vmPFC and specifically the IL, should focus on tasks that measure impulsive 
action such as the 5-CSRTT, continuous performance test, and go/no-go paradigms, instead 
of tasks that assess impulsive choice and perseveration (e.g. WSDD, DNMS T-maze) 
(Winstanley et al., 2010). Examination of impulsive action tasks may shed light on the 
current finding of increased food training acquisition seen in animals with decreased MBP 
expression and may relate to learning ability.  
 An alternative explanation to enhanced impulsive action underlying increased 
acquisition of food-training could relate to the role of the vmPFC (specifically, the IL) in 
consolidation of new behavioral-outcome contingencies. As reviewed in the General 
Introduction, enhanced glutamate signaling within the vmPFC (via AMPA or mGluR1/5 
receptors) facilitates extinction learning while decreased signaling (via mGluR1/5 receptor 
antagonism) impairs extinction learning in cocaine-experienced animals (Ben-Shahar et al., 
2013; Fontanez-Nuin et al., 2011; LaLumiere et al., 2010). Moreover, enhanced GABA 
signaling within the vmPFC impairs extinction learning (LaLumiere et al., 2010). Both 
glutamatergic and GABAergic effects on extinction are seen on a subsequent test day, 
suggesting the activity of this region is involved in the learning of new contingencies, 
consolidation of the memory of this new contingency and guiding subsequent behavioral 
output. Local infusions of the active viruses generating shRNA against MBP transcripts 
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would affect OLs around the site of infusion and the corresponding local axons which they 
myelinate. I would hypothesize this local change in myelin would mainly effect local 
inhibitory interneurons, as excitatory neuronal axons project out of the area of transfected 
OLs and the majority of their myelin would remain undisturbed. It is possible that the 
signaling efficiency of these local inhibitory neurons is reduced, ultimately reducing the 
GABAergic signal on pyramidal cells, and thereby, increasing the output of the vmPFC. As 
stated previously, increased IL activity results in enhanced extinction learning and may 
therefore explain the enhanced learning of food training seen in animals with decreased MBP 
expression. Along similar lines, decreased IL activity is associated with behavioral 
disinhibition (Feja & Koch, 2014; Ji & Neugebauer, 2012). Therefore, enhancing the activity 
of the vmPFC (via disrupting local inhibitory neurons) may partially explain the decreased 
impulsive choice exhibited by LVV2 rats in the within-session delay discounting procedure. 
Additionally, pharmacological manipulations of the PL and IL have shown these regions to 
differentially affect drug-seeking and impulsive-like behavior, and electrophysiological 
experiments have shown enhanced IL activity to decrease PL activity (Ji & Neugebauer, 
2012).  Given the above, future assessment of the cognitive effects of decreased MBP 
expression might be more fruitful if the knock-down is localized to the IL specifically, as this 
subregion appears to be more consistently implicated in behavioral inhibition of relevance to 
impulsive action.  
 A molecular target of particular interest for future study is PLP, as this protein also 
exhibited decreased expression following extended access cocaine self-administration and 
whose genetic deletion results in a variety of cognitive deficits. As reviewed in the General 
Introduction, mice lacking PLP exhibit abnormal anxiety-like behaviors in the elevated-plus 
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maze, light/dark box, and social interaction test, along with mildly impaired PPI and robust 
memory deficits exhibited on the T-maze (Tanaka et al., 2009). Although these mice do not 
express PLP throughout their life, these robust deficits, coupled with my evidence for an 
enduring cocaine-induced reduction in vmPFC PLP expression, warrant a more systematic 
examination of cognitive deficits when PLP is experimentally manipulated within distinct 
brain regions in adult animals. Moreover, a combination of decreased MBP and PLP within 
the vmPFC may better model the cocaine-induced decreased expression and potentially 
highlight associated cognitive deficits. 
 Overall, the present results do not suggest a deficit of vmPFC function following 
decreased MBP expression, but perhaps still suggest a change in signaling efficiency locally. 
Future studies will need to focus on tests where vmPFC damage (e.g. lesion studies) have 
been consistently shown to affect behavioral output, instead of PFC-dependent tests that are 
not specific to the PL or IL. Additionally, future studies will need define what the observed 
decreased impulsive choice means, for example, are the animals perseverating on the large 
reward lever, are they less sensitive to the effect of delay on devaluing the incentive 
motivational properties of the reward, or perhaps these animals exhibit a deficit in reversal 
learning impairing them from withholding a response on the large reward lever. Further 
characterization of the structural consequences of decreased MBP expression in adult rats, 
along with electrophysiological approaches and comprehensive behavioral testing is needed 
before we have a clearer understanding of the role for MBP in cognitive, emotional, 
sensorimotor and motivational processing.   
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Chapter 5 Decreased MBP expression within the adult rat vmPFC does not affect 
cocaine self-administration, extinction, or reinstatement behavior. 
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5.1 Introduction	  
 As reviewed in Chapter 1, chronic cocaine use is associated with deficits in executive 
function mediated by the PFC. In humans, disruptions in vmPFC function by physical assault 
or cocaine use results in deficits in working memory, decision-making tasks (e.g. gambling 
tasks), and measures of impulsivity (e.g. delay discounting, go/no-go tasks). Moreover, 
imaging studies of chronic cocaine addicts demonstrate altered PFC neural activity during 
these tasks that predict relapse following a period of abstinence. The PFC functional 
anomalies might relate to changes in myelination as there is evidence for both reduced white 
matter within the PFC of chronic cocaine users and decreased expression of myelin-related 
proteins in postmortem tissue from cocaine addicts (Albertson et al., 2004; Bartzokis, 
Beckson, Lu, Edwards, & Bridge, 2002; Kristiansen et al., 2009; Lehrmann et al., 2003; Lim 
et al., 2008, 2002; Moeller et al., 2005, 2007). Due the limitations of imaging methodology 
and the interpretational confounds inherent in studying humans, it is difficult to determine the 
distinct contribution of particular PFC subregions to the cognitive deficits associated with 
chronic cocaine use and impossible to decipher the cellular and molecular underpinnings of 
perturbed PFC function.  
 Animal models of cocaine addiction enable the delineation of cause-effect relations 
between cocaine-taking and the functional status of particular brain regions, as well as the 
ability to systemically examine the underpinnings of cocaine’s effects upon brain function. 
As reviewed in Chapters 1 and 4, cocaine produces also anomalies in PFC function in rodent 
models of cocaine addiction. Consistent with reduced PFC function following cocaine 
experience, I observed decreased expression of myelin-related proteins within the vmPFC in 
rats with a 10-day history of extended access to IV cocaine (Expt 1 & 3b) that may impart 
abnormal neuronal signaling. While the results of Chapter 4 fail to indicate marked effects of 
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MBP knock-down upon PFC-dependent behaviors in cocaine-naïve animals, those negative 
data do not preclude the possibility that the lower MBP expression observed within the 
vmPFC of cocaine-experienced rats might underpin an aspect of drug-taking or –seeking 
behavior. Indeed, there is behavioral neuropharmacological evidence indicating that 
manipulations of the vmPFC influences cocaine acquisition, extinction and reinstatement 
(Gass & Chandler, 2013; Schenk et al., 1991; Weissenborn et al., 1997). Thus, I hypothesize 
that a reduction in vmPFC MBP levels will facilitate addiction-related behaviors in rats as 
manifested by increased drug intake, as well as increased drug-seeking during abstinence and 
in response to stimuli that trigger relapse.   
 To address this hypothesis, I employed the well-characterized extinction-
reinstatement model of drug relapse, which enabled a within-subjects approach to studying 
the effects of vmPFC MBP knock-down upon: 1) the acquisition and maintenance of drug-
intake; 2) the dose-response function for drug-intake; 3) the extinction of drug-seeking; and 
4) the capacity of cocaine-associated cues and non-contingent cocaine priming injections to 
reinstate drug-seeking behavior, following extinction. 
5.2 Methods 
5.2.1 Animals and Surgical Procedures 
 Animals were identical to those described in Chapter 2 with the following exceptions. 
Animals were allowed to acclimate to the colony room for two days following arrival before 
surgical procedures began, were handled daily for the duration of the experiment, had ad 
libitum access to food and water, and were surgically implanted with IV catheters. Surgical 
implantation of guide cannulae and LVV infusion was identical to that described in Chapter 
4. 
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 Two weeks were allowed for recovery from intracranial surgeries and to allow the 
LVV to transduce before IV catheter implantation. Under 2-3% isoflurane anesthesia, 
animals were implanted with a chronic silastic catheter as previously described in Chapter 2.  
5.2.2 Self-Administration Training 
 Three-weeks post-LVV infusions (and 1 week following jugular catheter 
implantation), animals (n=10-15 per group at the start of each experiment) were trained to 
self-administer IV cocaine (0.25 mg/0.1 ml/ infusion; National Institute on Drug Abuse, 
Bethesda, MD) during daily 2-hr sessions, on a FR1 schedule of reinforcement. Animals 
were trained in identical standard operant conditioning chambers as described in Chapter 2. 
At the beginning of each session, the animal’s catheter was connected to a motorized pump 
via a liquid swivel as previously described and the self-administration program was identical 
to that described in Chapter 2. One exception was the session length, which was shortened to 
2 hrs/day to increase the feasibility of the study. Self-administration training was conducted 
daily until animals reached stable self-administration levels (<10% variation in the number of 
infusions earned across 3 days), at which time, the dose of cocaine was varied in order to 
generate a within-subjects dose-response function to determine the effect of MBP knock-
down upon cocaine sensitivity.  For this, rats were allowed to self-administer a lower cocaine 
dose (0.125 mg/0.1ml/infusion) for 5 consecutive days and then the dose was raised to 0.50 
mg/0.1 ml/infusion for an additional 5 days.  
5.2.3 Extinction and Reinstatement procedures 
 Following the dose-response phase of study, I next determined whether or not MBP 
knock-down influenced an animal’s ability to learn to suppress responding on the cocaine-
associated lever in the absence of cocaine availability. Responding under such extinction 
conditions is considered to reflect drug-seeking behavior and is interpreted as drug-craving.  
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To extinguish responding, the animals entered 2-hr, daily, extinction training sessions during 
which the animals were tethered, but responding on the active lever resulted in no 
programmed consequences (i.e., no cocaine infusion or presentation of the cocaine-paired 
cues).  Behavior was considered extinguished when animals emitted  <25 active lever presses 
within a session, across 2 consecutive days. Once animals had met this criterion, they 
underwent a cue-primed reinstatement of cocaine-seeking test. At the beginning of the cue-
prime test, a 20-sec presentation of the tone and light compound stimulus previously paired 
with cocaine-delivery was presented. Active lever presses resulted in additional cue-
presentations on an FR1 schedule of reinforcement, but no cocaine delivery. Following this 
cue-primed test, lever-pressing behavior was again extinguished by daily testing in the 
absence of cocaine or cocaine-paired cues and then animals were subjected to tests for 
cocaine-primed reinstatement. For cocaine-primed reinstatement, rats were injected IP with 5 
mg/kg and 15 mg/kg cocaine (tests separated by a phase of extinction training), immediately 
before tethering the animals in the operant chambers for 2 hrs. During cocaine-primed 
reinstatement testing, active lever presses resulted in neither cocaine delivery nor the 
presentation of the cocaine-paired cues. Throughout training, maintenance, dose-response 
testing, extinction and reinstatement testing, inactive lever presses were recorded, but had no 
programmed consequences.   
5.2.4 Imaging of LVV transduction 
 To verify transduction and placement of microinjections within the vmPFC, animals 
undergoing behavioral testing were anesthetized with 2-3% isoflurane, decapitated and brain 
tissue removed and stored in a solution of 4% paraformaldehyde and 30% sucrose for a 
minimum of 3 days. Brain tissue encompassing the vmPFC was sectioned at 50 µm and 
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examined at 4X, 40X, and 60X magnification under a fluorescent microscope to visualize the 
location and extent of cellular transduction (figure 15). 
5.2.5. Statistical Analysis  
 To examine for differences in LVV treatment on acquisition and maintenance of 
cocaine self-administration, a two-way ANOVA of Viral Treatment x Day was conducted on 
the proportion of active lever presses (Active lever presses/Total lever presses, expressed as a 
percent) and the total number of infusions across the first 9 days of self-administration. To 
examine the cocaine dose-response sensitivity for each Viral treatment, a two-way ANOVA 
of Viral Treatment x Dose was conducted on the proportion of active lever presses and 
infusions. A one-way ANOVA of Viral Treatment on the total number of days to initially 
extinguish lever response behavior was conducted for the proportion of active lever presses. 
The last two days of each extinction phase prior to reinstatement procedures were averaged 
for each animal and used to compare against behavior during the reinstatement tests. A two-
way ANOVA of Viral Treatment x Phase was conducted for the proportion of active lever 
presses to assess for differences in LVV on reinstatement of cocaine-seeking. 
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Figure 15. Summary of histological findings.  A) Cresyl violet-stained tissue sections (50 
uM) through the PFC were examined from a subset of LVV-infused rats as an index of 
microinjector tip location. The majority of the microinjector tips (black dots) were localized 
within the PL, with no evidence for localization within the IL. (B and C) In vivo transduction 
efficacy by, and spread of, the LVV constructs within the PL were verified by 
immunofluorescence for the GFP reporter. Representative micrographs (4× magnification) of 
tissue sections from 2 different rats revealed very localized transduction around the point of 
microinjection with little to no spread.  Arrows point to the midline of the brain. (B’) 40× 
magnification of the GFP immunofluorescence from the rat in panel B. (C') 60X 
magnification of the GFP immunofluorescence from the rat in panel C. In all cases, the GFP 
immunofluorescence was diffuse and it was difficult to discern discrete cellular anatomy. 
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5.3 Results	  
5.3.1 Self-administration acquisition and cocaine dose-response function 
 A two-way, repeated measures ANOVA of infusions earning during the first 9 days 
of self-administration training failed to demonstrate a change in intake across days or a 
difference in intake among virally treated animals (no Main effects or Interaction effects, 
p’s>0.05). Thus, MBP knock-down within the vmPFC did not alter the stable levels of 
cocaine-taking observed during the acquisition phase of cocaine self-administration (figure 
16a). However, analysis of the proportion of total lever-presses directed at the active lever 
(an index of reinforcement) over the first 9 days of training revealed a significant progressive 
shift in response allocation [Day effect: F(8,176)=9.24, p<0.001], which varied as a function 
of viral treatment [Viral Treatment x Day, F(16,176)=1.88, p=0.025], (figure 16b). 
Deconstruction of the significant interaction along the Day factor revealed significant virus 
differences on Days 1 and 3-5, with Fisher’s LSD post-hoc tests indicating lower 
reinforcement in LVV2 vs. LVV clt on Day 1 (p=0.048), and greater reinforcement on Day 4 
(p=0.041) and Day 5 (p=0.040) and in LVV2 vs. LVV1 on Day 3 (p=0.010). Thus, although 
MBP knock-down did not influence the total amount of cocaine administered at the 0.25 
mg/inf training dose, LVV2 treated animals exhibited signs of greater cocaine reinforcement 
during self-administration training.  
 To examine whether or not MBP knock-down influenced the dose-response functions 
for cocaine-directed behavior and intake, two-way ANOVAs of Viral Treatment x Dose were 
conducted on the ratio of active vs. total lever-presses and on the number of infusions earned 
during the dose-response phase of study. The number of cocaine infusions earned decreased 
as a function of cocaine dose  [F(2,70)=463.50, p<0.001; all doses significantly different 
from one another, LSD, p’s <0.05], but we observed no significant main effect of Viral 
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Treatment or an interaction effect (p’s>0.05; figure 16d).  Group differences were not 
observed regarding the allocation of lever-pressing behavior during dose-response testing, 
with rats in all groups emitting nearly 100% of their responses on the active lever, regardless 
of dose and regardless of LVV infusions  (figure 16d; all p’s>0.05).  Thus, MBP knock-down 
within the vmPFC does not appear to influence sensitivity to the reinforcing properties of 
cocaine nor does it alter the dose-response function for cocaine intake, at least at the doses 
assessed in this study.
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5.3.2 Extinction and Reinstatement 
 To examine whether or not MBP knock-down influenced the ability to learn to 
suppress drug-seeking behavior in the absence of cocaine and cocaine-paired cues, we 
examined for group differences in the rate of extinction learning as indicated by the number 
of days to reach extinction criterion. However, group differences were not observed for the 
number of days to initially extinguish lever responding (one-way ANOVA, p>0.05); LVV 
ctl, 5.92 + 0.79; LVV1, 4.71+ 0.45; LVV2, 5.91 + 1.12).  Thus, MBP knock-down does not 
appear to influence the ability to learn to suppress drug-seeking behavior in the absence of 
cocaine delivery or the presentation of the cocaine-paired cues.   
 I next examined whether or not vmPFC MBP knock-down influenced drug-seeking 
behavior in response to cocaine-paired cues or cocaine priming injections. A two-way 
ANOVA of Viral Treatment x Phase revealed the expected main effect of Phase (figure 17) 
[F(3,127)=16.36, p<0.001], with rats in all groups exhibiting greater active lever responding 
during the Cue- and 15 mg/kg cocaine-primed reinstatement tests versus that exhibited by the 
rats during the last 2 days of extinction training, indicating that these procedures reinstated 
cocaine-seeking behavior. In contrast, the level of responding exhibited following the 5 
mg/kg cocaine priming injection was not significantly different from that exhibited during 
extinction (figure 17; p>0.05), indicating that this cocaine dose was not sufficient to reinstate 
responding.  Viral Treatment did not significantly impact behavior during any phase of 
testing (p’s>0.05; figure 17). Thus, MBP knock-down within the vmPFC does not influence 
the capacity of either cocaine or cocaine-associated cues to reinstate drug-seeking behavior, 
following extinction.	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Figure 17. Summary of viral treatment on extinction and reinstatement. Viral treatment did 
not significantly affect goal-directed behavior across extinction or reinstatement tests as 
indicated by no group differences at any time during testing. . The total lever-presses directed 
at the active lever (% Active lever presses) during reinstatement tests elicited by presentation 
of the cocaine-paired cue  (CUE) and a 15 mg/kg cocaine injection (15 COC) was higher 
than both that exhibited during the last 2 days of extinction training (EXT) and that elicited 
by a 5 mg/kg cocaine priming injection (5 COC), *p<0.05 to EXT; #p<0.05 to 5 COC.  
	  157	  
5.4 Discussion 
In the following series of experiments, I failed to find a significant effect of MBP 
knock-down within the adult rat vmPFC on cocaine intake during the acquisition and 
maintenance of cocaine self-administration when 0.25 mg/inf cocaine was available, nor did I 
observe any knock-down effect upon cocaine intake across a range of doses. MBP knock-
down within the vmPFC influenced cocaine-directed behavior (indexed by the % total lever-
presses directed at the active lever) only during the first 5 days of self-administration 
training, but no effect of knock-down was apparent during later training, dose-response 
testing, extinction training or testing for cue- or cocaine-primed reinstatement. These data 
argue that the reduction in vmPFC MBP expression observed in cocaine self-administering 
rats (Chapter 2) does not appear to contribute significantly to the manifestation of addiction-
related behaviors in a well-validated animal model of cocaine-taking and relapse. The failure 
to observe robust and consistent effects of shRNA infusion upon addiction-related behavior 
does not reflect a failure of our shRNA constructs to transduce OLs within the vmPFC as 
immunohistochemical evidence supported OL transduction within the brains of the cocaine 
self-administering animals and the immunoblotting results of Chapter 4 indicated the 
effectiveness of the LVV2 construct in reducing MBP expression in cocaine-naïve animals. 
However, the volume of tissue showing viral transduction is small and only encompasses a 
minor portion of the PL. Therefore, the mostly negative findings herein may likely reflect an 
insufficiency of knock-down to disrupt vmPFC activity as it relates to cocaine-self-
administration, extinction and reinstatement procedures. 
In Chapter 4, I provided immunoblotting evidence that LVV2 infusions caused a 
roughly 30% reduction in MBP within the vmPFC, a decrease that closely mirrors that 
produced by a history of cocaine-taking under long-access procedures in Chapter 2 (Expt 1 
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and 3b). However, the data in Chapter 4 clearly indicate that a 30% knockdown of MBP was 
insufficient to cause obvious cognitive disruption in drug-naïve animals, and only moderately 
decreased impulsive choice and enhanced food acquisition training. Consistent with this 
latter result for food-induced responding, MBP knock-down facilitated cocaine reinforcement 
early during the acquisition of cocaine self-administration, as indexed by an increased 
proportion of total lever responses directed at the active lever in LVV2 rats, versus one or the 
other groups tested. Immunoblotting was not conducted in cocaine-experienced animals to 
avoid interpretational confounds associated with drug-induced changes in MBP expression. 
While the detection of the GFP reporter by immunofluorescence in cocaine-experienced 
animals argues that both shRNA constructs transduced cells within the PL, the relative in 
vivo efficacy of the two shRNA constructs cannot be ascertained by immunohistochemical 
procedures.  Given that identical LVV infusion procedures were employed in this study of 
cocaine-experienced animals as those employed in the drug-naïve rats described in Chapter 
4, it is presumed that LVV2 elicited an ~ 30% knock-down of MBP protein expression in 
cocaine-experienced animals, while LVV1 and the control construct had no effect on MBP 
expression.  The observation that only LVV2 influenced, albeit moderately and transiently, 
cocaine reinforcement during early training is consistent with the presumption that only 
LVV2 impacted MBP protein expression. However, the fact that cellular transduction was 
observed within vmPFC of all 3 virus groups upon completion of behavioral testing but the 
effect of LVV2 upon behavior was transient in both this series of cocaine experiments, as 
well as during behavioral testing in cocaine-naïve animals (Chapter 4), demonstrates that if 
the ~30% reduction in MBP expression produced by LVV2 was sufficient to impair vmPFC 
function to influence certain behaviors (e.g., augment instrumental responding for positive 
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reinforcers), this functional impairment could be over-come by subsequent training. 
However, it is important to highlight again the discrete location of LVV transduction, as a 
more pronounced effect of LVV2 may be seen if a larger area had been transduced by the 
virus. 
The studies outlined in Chapters 4 and 5 are the first to ascertain the effects of local 
knock-down of MBP and this assumption and the extent of protein knock-down induced by 
either shRNA construct cannot be known. There currently exists only one publication 
examining the effect of decreased MBP on cognitive function of which mice lacking 
complete expression of MBP RNA (Shiverer) or significantly reduced levels (mld) exhibit a 
deficit in reversal learning that is proportionate to the amount of MBP expressed (less MBP 
corresponds with greater learning deficits), but maintain the ability to learn the original 
location of a food reward in a T-maze (Inagawa et al., 1988). Mld mice express 2% MBP 
RNA (compared to wild-type control mice), but exhibit a significant improvement in reversal 
learning compared to Shiverer mice that produce 0% MBP RNA (Inagawa et al., 1988; 
Popko et al., 1987). Moreover, as low as 25% MBP RNA of normal is sufficient to produce 
intermediate levels of myelination assessed by electron microscopy (Popko et al., 1987). 
Therefore, only a ~30% decrease in protein expression (~70% expression of normal levels) in 
the current study is unlikely to cause a robust deficit in vmPFC function and may explain the 
lack of effect on cocaine self-administration, extinction and reinstatement behaviors. 
Several other myelin specific proteins were also affected by cocaine administration 
(e.g. MOG, NG2+, PLP) in conjunction with MBP, raising the possibility of a cumulative 
effect of decreased myelin-related protein expression on vmPFC function as it relates to 
cocaine self-administration, extinction and reinstatement procedures. One promising 
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candidate is PLP as discussed in Chapter 4, as mice lacking PLP exhibit abnormal anxiety-
like behaviors, mildly impaired sensorimotor gating, and robust memory deficits on the T-
maze (Tanaka et al., 2009). Given the limited number of publications regarding behavioral 
deficits following complete loss of MBP and PLP, and that changes in neuronal conduction 
have only been studied in cultures completely lacking expression of myelin specific proteins 
(e.g. OMgp, PLP, & MBP), it is difficult at this time to interpret what a partial loss of one 
protein (e.g. MBP) or the cumulative effect of multiple protein decreases may mean for the 
function of a brain region (Boiko et al., 2001; Inagawa et al., 1988; Nie et al., 2006; Tanaka 
et al., 2009, 2006). 
Targeting MBP expression within the vmPFC of the current experiment was based on 
the cocaine-induced decreased expression discovered in Chapter 2. However, specifically 
targeting this brain region may not fully elucidate the behavioral ramifications of a loss of 
this protein. In the few experiments that have examined for cocaine-related decreased 
myelin-protein expression, the focus was on the white matter within the anterior striatal level 
of rhesus monkeys, the splenium of the CC and the NAc (tissue punches often containing the 
anterior commissure), where the decrease in MBP and myelin-related mRNA transcripts 
represents myelin abnormalities within fiber tracts containing the axons from many brain 
areas (Kovalevich et al., 2012; Narayana et al., 2009; Smith et al., 2014). It is possible that 
the current local manipulation of MBP within the vmPFC does not create substantial enough 
loss of myelin integrity to promote vmPFC dysfunction, and by targeting larger fiber tracts 
(e.g. CC) to reduce neuronal signaling efficiency affecting input from a variety of brain 
regions, a deficit in MBP may become more apparent. As fiber tracts were not specifically 
sampled in the original immunoblotting procedures of Chapter 2, additional experiments 
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sampling the rostrum, genu, and splenium of the CC would need to be conducted to 
determine whether or not a history of long-access cocaine intake produce similar changes in 
MBP mRNA and protein expression as those found in the previous references discussed. 
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Summary of Studies and Findings 
 The data presented in this dissertation are the first to examine for an effect of long-
access (6h/day) cocaine self-administration on glial-related protein expression within the 
PFC of adult and adolescent male rats. Adult rats tested for cue-elicited cocaine-seeking 
during a 2-hr test were found to have decreased myelin-specific protein expression within the 
vmPFC (IL and ventral PL); this effect was present at 3 days withdrawal and persisted for at 
least 30 days. These myelin-specific changes were not found within the dmPFC (dorsal PL 
and ACC), nor were they observed within the NAc shell or core subregions. A follow-up 
study was designed to ascertain whether or not the reduction in myelin-specific protein 
expression exhibited by adult cocaine-experienced animals reflected a pharmacodynamic 
response to cocaine or some interaction between cocaine and the test for drug-seeking in 
which rats were not subjected to the cocaine-seeking test procedures. Interestingly, adults not 
experiencing a cocaine-seeking test prior to sacrifice exhibited increased myelin-specific 
protein expression within the vmPFC, as well as enhanced expression of the astrocytic 
proteins that regulate glutamate recycling and internal communication of signaling molecules 
(GS and Cx30, respectively). As the possibility existed that differences in the localization of 
the tissue punches between the 2 immunoblotting experiments and the different times at 
which the experiments were conducted may have underpinned the discrepancies in results, I 
subsequently ran a replication study to directly compare the expression of one particular 
protein, MBP, in rats subjected to the cocaine-seeking test versus those that were test-naïve. 
To determine whether or not cocaine-induced changes in MBP protein expression might 
reflect alterations in gene transcription, MBP mRNA levels were also examined. MBP was 
specifically chosen based on consistent findings in both the preclinical animal and clinical 
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literature indicating decreased MBP expression following a history of cocaine (Albertson et 
al., 2004; Kovalevich et al., 2012; Narayana et al., 2009; Smith et al., 2014). While I did not 
find an effect of cocaine on MBP transcription, I did replicate my initial finding of decreased 
protein expression following cocaine experience. Consistent with the available literature 
(Albertson et al., 2004; Kovalevich et al., 2012; Narayana et al., 2009; Smith et al., 2014), 
the cocaine-induced decrease in MBP expression was observed regardless of whether the 
animals were tested for drug-seeking prior to sacrifice. From the results obtained in Chapter 
2, I concluded that a history of excessive IV cocaine administration is sufficient to produce 
an enduring reduction in the total protein expression of MBP, specifically within the vmPFC. 
Moreover, I concluded that this pharmacodynamic response to cocaine does not reflect a 
reduction in gene transcription and thus, likely reflects increased protein turn-over, the 
mechanism(s) of which still require elucidation. I also concluded that the cocaine-elicited 
reduction in vmPFC MBP expression was temporally dissociated from the manifestation of 
“incubated” cocaine-seeking and thus, was unlikely to underpin the development of this 
behavioral phenomenon. 
Adolescence is a period of robust forebrain myelination that is characterized by a 
high prevalence of risk-taking, including drug-taking (Crews & Boettiger, 2009; Perry et al., 
2007).  Adolescents typically consume more drug than adults and this greater drug 
consumption is theorized to relate to their neural immaturity, but likely also reflects glial 
immaturity.  Thus, studies in Chapter 3 determined whether or not the more immature 
adolescent brain might be more susceptible to the effects of cocaine-taking on glial-related 
proteins. Remarkably, I did not find any effect of cocaine on myelin-related proteins within 
the vmPFC of adolescent male rats, but a decrease in the microglial marker CD11b, and the 
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non-specific OL precursor cell marker NG2+. The failure to observe changes in myelin-
specific proteins was unexpected given that adolescence is a time of major PFC maturation 
and myelination; however, this was not the case. In support of the relative immaturity of the 
PFC during cocaine self-administration testing of adolescents, I observed increases to occur 
over the course of the 30-day withdrawal period for many myelin-specific proteins within the 
dmPFC of both cocaine- and saline-self-administering rats. While these latter data highlight 
the adolescent period as an important time for increased myelin protein expression within 
dmPFC that may reflect enhanced myelination, the present results clearly do not support a 
greater sensitivity of adolescents to the effects of cocaine upon protein indices of myelin 
integrity and if anything, argue that the relative immaturity of the adolescent PFC may render 
it less susceptible to cocaine-associated anomalies in myelin-specific proteins and perhaps 
also myelination.  This latter conclusion is cautionary, however, as I only examined for 
cocaine-induced changes in protein expression within mPFC subregions at 3 and 30 days 
withdrawal (i.e., in young adulthood).  As myelination in humans continues into the 40’s, it 
remains to be determined whether or not adolescent cocaine experience might perturb the 
later developmental trajectory of myelin-related protein expression/myelination within 
frontal cortex to impact the function of this structure and behavior in later adulthood. 
 To determine the functional relevance of reduced MBP expression within the vmPFC 
for behaviors associated with the function of this region, I next experimentally manipulated 
MBP protein levels by microinjecting LVV particles capable of generating shRNAs against 
MBP mRNA. While the ultimate goal was to assess the effect of decreased MBP levels on 
cocaine addiction-related behaviors, I deemed it important at the outset of behavioral testing 
to examine for LVV effects upon general cognitive, motivational, emotional and 
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sensorimotor processing to facilitate interpretation of the results of subsequent cocaine 
studies.   Pilot immunoblotting data indicated that of the 5 commercially available LVV 
particles, the LVV1 and LVV2 particles were the only particles with any in vivo knock-down 
efficiency (at least under our microinfusion procedures), although LVV1 was less efficacious 
than LVV2 at reducing MBP expression in this pilot study. Nevertheless, I tested adult rats 
for effects of infusing either shRNA construct into the vmPFC on working memory, anxiety-
like behavior, learning and impulsive choice measures. Post-mortem determination of in vivo 
knock-down efficiency within a subset of rats in this study using immunoblotting confirmed 
significant knock-down of MBP by LVV2 within micropunches of tissue from the vmPFC 
(~30% reduction in total protein expression of the major 18.5 kDa MBP isoform), while 
knock-down of this isoform was not detected in LVV1-infused animals.  Despite confirming 
a ~30% reduction in MBP expression within vmPFC of LVV2 rats, LVV2 infusion failed to 
affect a majority of behaviors tested, with the exceptions of facilitated acquisition of 
instrumental responding for food and decreased impulsive choice within the WSDD 
paradigm. Thus, I concluded from the results of Chapter 4 that LVV2 is more efficacious 
than LVV1 at reducing MBP expression in vivo, however, a 30% reduction in MBP within 
the vmPFC is likely not sufficient to impact robustly the function of this region, at least in 
drug-naïve subjects. Nevertheless, I clearly established that my intra-vmPFC LVV infusions 
procedures impacted little the primary reinforcing properties of food/the ability to acquire an 
operant response, motor activity, working spatial memory, long-term spatial memory, 
sensorimotor or emotional processing, all of which might influence drug-taking or –seeking 
behavior. 
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 As a history of cocaine reduced MBP expression within the vmPFC by ~30% 
(Chapter 2), in the final experiment, I examined the possibility that MBP knock-down within 
the vmPFC might facilitate cocaine addiction-related behavior. For this, I employed identical 
LVV infusion procedures as conducted in Chapter 4, presuming that LVV2 would elicit a 
~30% reduction in MBP expression akin to that produced by a history of cocaine-taking and 
impact behavior, while LVV1 would likely be without effect upon MBP expression or 
behavior. As the results of Chapter 2 already demonstrated that the manifestation of 
“incubated” drug-craving produced by a history of long-access cocaine self-administration 
could be temporally dissociated from drug-elicited changes in vmPFC MBP expression, I 
opted to study the effects of vmPFC MBP knock-down upon the acquisition and maintenance 
of cocaine self-administration under short-access self-administration procedures, which also 
facilitated the study of the effects of virus infusion upon cocaine dose sensitivity, as well as 
the extinction and reinstatement of cocaine-seeking. Immunohistochemical evidence from a 
subset of rats supported transduction within discrete areas around the microinjector tip within 
the vmPFC (mainly PL localization) by all 3 LVVs in cocaine-experienced animals.  
However, akin to the results of Chapter 4, the effect of vmPFC knock-down of MBP on 
cocaine reinforcement was modest at best and only manifested as a transient increase in 
cocaine-directed responding during early self-administration training. I observed absolutely 
no effect of LVV infusion upon drug-taking across a range of cocaine doses, nor did I 
observe any effect of LVV infusion upon measures of drug-seeking in the absence of IV 
cocaine.  Presuming that the in vivo knock-down efficiencies of the LVVs were equivalent in 
this cocaine study as in the study of cocaine-naïve animals, these data indicate that a ~ 30% 
reduction in MBP expression is insufficient to promote higher drug-taking or relapse. 
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However, the small zone of transduction left the majority of the PL intact and may account 
for the lack of significant behavioral findings.  
 Extrapolating these findings back to the immunoblotting results from Chapter 2, it is 
not likely that the ~30% reduction in vmPFC MBP expression observed in highly cocaine-
experienced rats contributes majorly to any aspect of their “addicted” phenotype and may 
represent an epiphenomenon of cocaine experience with no causal relation.  While the 
present results do not support a critical role for MBP in regulating various aspects of cocaine 
addiction-related behavior, the present results by no means preclude the possibilities that (1) 
a reduction in vmPFC MBP expression might influence drug-taking behavior under 
procedures that engender very high drug consumption (e.g., long-access models), (2) the 
possibility that cocaine-elicited perturbations in MBP, in conjunction with other anomalies in 
myelin-specific protein expression, might impact more robustly drug-taking and –seeking 
behaviors, and/or (3) the use of larger infusion volumes of viral treatment might transduce a 
larger volume of tissue resulting in changes in cocaine addiction-related behavior.  Given that 
cocaine-induced reductions in myelin-specific protein expression persist into protracted 
withdrawal, future study of the potential relevance of this glioadaptation and accompanying 
protein changes are warranted. 
A Reflection Upon Past Knowledge 
 As discussed in the General Introduction, the current state of our knowledge 
regarding the effects of cocaine on OLs, and specifically, on myelin-related protein 
expression, is very limited. At the outset of this dissertation, only three post-mortem clinical 
studies existed reporting on the expression of myelin-related proteins in the brains of cocaine 
users. The results of these studies revealed decreased MBP, MOBP, PLP, and CLN within 
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the striatum and changes in PLP expression within the dlPFC, the direction of which 
appeared to depend upon whether or not the individual was dependent upon cocaine or upon 
crack/cocaine (Albertson et al., 2004; Kristiansen et al., 2009; Lehrmann et al., 2003). 
Moreover, in vivo imaging studies of chronic cocaine addicted humans consistently reveal 
decreased white matter within the inferior frontal white matter and CC (Bartzokis et al., 
2002; Lim et al., 2008, 2002; Moeller et al., 2005, 2007), which is consistent with the post-
mortem results for myelin-related protein expression. Although this collection of clinical data 
supports the notion that a history of cocaine-taking perturbs myelin, particularly in forebrain, 
the reliance on self-reported cocaine and other drug use, in conjunction with confounding 
subject factors of age of first drug use, other environmental insults, poverty, mental/physical 
abuse, comorbid mental disorders, etc., render it impossible to derive cause-effect relations 
between cocaine use in humans and OL physiology. Therefore, the use of animal models of 
cocaine addiction is essential to the investigation of cocaine on OLs.  
 To my knowledge, there are five publications regarding the effects of cocaine 
administration (either experimenter- or self-administered) on changes to OL-related gene 
transcription and protein levels in animal models (George et al., 2008; Kovalevich et al., 
2012; Narayana et al., 2009; Nielsen et al., 2012; Smith et al., 2014). Consistent with the 
immunoblotting results presented in Chapter 2 for rats with a 10-day history of extended 
access cocaine self-administration, decreased MBP protein and/or mRNA expression 
following cocaine has been reported within the white matter of the NAc and CC in a study of 
cocaine self-administering non-human primates (300 days of cocaine experience), or in mice 
injected with cocaine for 14-28 days, (Kovalevich et al., 2012; Narayana et al., 2009; Smith 
et al., 2014). The present results extend these earlier findings, as well as the results from 
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post-mortem studies of humans, by demonstrating that a relatively short history of cocaine-
taking (10 days) is sufficient to reduce protein expression of myelin-specfic proteins at least 
within the vmPFC.  Moreover, my findings demonstrate that the cocaine-induced reduction 
in myelin-specific protein expression persist into protracted withdrawal in adult cocaine-
experienced animals. Lastly, my results demonstrate that cocaine-induced changes in myelin-
specific proteins can be observed from tissue sampled from grey matter, indicating that a 
history of cocaine-taking is capable of also influencing myelin integrity in points of synaptic 
contact that is presumed to influence local circuitry (see discussion below).  
 In addition to the 3 animal studies highlighted above, George et al. (2008) reported a 
decrease in NG2+ immunoreactive cells within tissue containing the ACC, PL and IL regions 
from the PFC of rats with a more extensive IV cocaine self-administration history than that 
employed herein (6-20, 1h sessions + a minimum of 85, 6h sessions; 0.5 mg/kg/inf cocaine). 
My results indicating that a 10-day history of IV cocaine (0.25 mg/inf; 6 hrs/day) decreased 
NG2+ protein expression within vmPFC (PL/IL) extend these latter findings of George et al. 
(2008) by demonstrating that (1) months of cocaine self-administration experience are not 
required in order to observe a cocaine-induced reduction in NG2+ protein expression; (2) the 
cocaine-induced reduction in NG2+ protein expression persists into protracted withdrawal; 
and (3) NG2+ protein expression responds to cocaine in a similar manner in adolescents as in 
adults. NG2+ protein serves a marker for OL precursors, astrocytes, mature NG2+ cells, and 
neurons (though, not commonly found colocalized with neuronal markers.). While the results 
of the present series of immunoblotting experiments cannot discern the origin of the NG2+ 
signal, the capacity of self-administered cocaine to lower NG2+ levels within the PFC of 
both adults (George et al., 2008; Chapter 2) and adolescents (Chapter 3) could reflect a drug-
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induced reduction in NG2+-type cells, a reduction in immature OLs, astrocytes, or neurons, 
and future studies could seek to clarify the nature of this protein adaptation using double- or 
triple-labeling of proteins and immunohistochemical approaches in order to have a deeper 
understanding of how cocaine self-administration history influences cellular integrity within 
PFC subregions.      
Of the human and rodent research to date, only two studies have drawn correlations 
between decreased changes in indices of myelin integrity due to cocaine experience and 
cognitive deficits. Moeller et al. (2005) found increased impulsivity measured on the Barratt 
Impulsiveness Scale-II in cocaine users with decreased fractional anisotropy measured by 
DTI within the anterior CC. Moreover, George et al. (2008) found working memory function 
positively correlated with the number of NG2+ immunoreactive cells within their tissue 
derived from the entire PFC (e.g., ACC, PL, and IL), as well as within the OFC of rats. These 
correlations indicate a relation between the functional status of glia within forebrain and 
cognitive function and this relation supports cocaine-elicited changes in glial function within 
forebrain in the cognitive deficits reported in cocaine-experienced individuals.  Chapters 4 
and 5 are the first studies, in my knowledge, to examine for a direct effect of manipulating 
OL-specific protein expression within the vmPFC on cognitive function and cocaine 
addiction-related behaviors. Although a reduction of MBP produced few significant findings, 
I did see a decrease in impulsive choice, enhanced acquisition of food training, and a slight 
increase in lever preference during acquisition of cocaine self-administration. Decreased 
impulsive choice seen in Chapter 4 is similar to the flattening of the large reward preference 
in animals with mPFC excitotoxic lesions (Cardinal et al., 2001), but contrasts with the 
effects of pharmacological manipulations of DA and GABA systems that either enhance or 
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do not significantly alter impulsive-like behavior (Feja & Koch, 2014; Loos et al., 2010; 
Yates et al., 2014). Electrophysiological experiments have shown an inhibitory influence of 
the IL on the PL (Ji & Neugebauer, 2012), therefore some of the discrepancy regarding 
whether the vmPFC has a role in impulsive choice may stem from manipulations that 
encompass both regions instead of refining manipulations to distinct subregions. As my viral 
infusions were localized to a small portion of the PL, decreasing MBP levels within the PL 
(specifically) appears to account for the decreased impulsive choice also noted in rats with 
larger excitotoxic lesions of the mPFC (Cardinal et al., 2001). 
 Although the effects were few, it is exciting to demonstrate a behavioral change by 
the manipulation of a single OL protein within a defined brain region in rats. These findings 
further highlight the importance of understanding how cocaine-related changes in OL protein 
expression contribute to the etiology of cocaine addiction, and normal cognitive function. As 
has been discussed, there are very few published papers examining for non-neuronal changes 
following cocaine, and even fewer looking at the functional significance glial-specific protein 
expression changes on behavior, making the interpretation of the data presented herein 
difficult and mostly conjecture. Advances in biotechnology have revealed how the extensive 
network of processes from a single OL can myelinate up to 60 internodal segments, impact 
axonal diameter via OL-specific proteins, promote normal node of Ranvier formation, and 
partially determine action potential propagation speed (Boiko et al., 2001; Mathey, Arthur, & 
Armati, 2010; Nie et al., 2007; Sadahiro et al., 2000; Tanaka et al., 2009). Given their 
widespread reach, it is likely that a loss of or damage to OLs could produce a significant 
affect on neuronal processing and the overall output of a brain region, ultimately affecting 
behavior. Moreover, limiting the study of addiction to neuronal mechanisms neither 
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facilitates a complete understanding of the disease nor reveals the full array of targets for 
therapeutic treatment. Therefore, not only is it imperative for research to continue elucidating 
the functions of OLs in normal physiology and their dynamic interactions with neurons and 
other glial cell types, but also how these cells are impacted during disease and the functional 
significance of those changes. 
Future Directions  
 The data presented in this dissertation just begins to uncover the effects of cocaine on 
nonneuronal cells, and OLs specifically. Several inconsistencies from the immunoblotting 
results in Chapters 2 and 3 will need to be addressed prior to further testing of the functional 
significance of glial-specific protein changes. First, although I replicated the results in Expt 1 
showing that both cue-tested and test-naïve animals exhibit decreased MBP levels following 
long-access cocaine self-administration, there was not sufficient tissue to reexamine MOG, 
NG2+, PLP or CLN levels to verify a specific effect of cocaine. It is interesting that NG2+ 
was decreased within the vmPFC of both adults (cue-tested) and adolescents (test-naïve) 
within Chapters 2 and 3, respectively, and NG2+ immunoreactive cells were decreased 
within the ACC, PL, and IL combined regions and OFC of the George et al. (2008) study. As 
discussed previously, a decrease in NG2+ does not necessarily implicate a change in OLs, 
however, this consistent finding warrants further study as to whether this is evidence of OL 
precursor cell loss or enhanced maturation of these cells to mature OLs. NG2+ positive cells 
represent a unique target of investigation as they have been shown to differentiate into OLs, 
astrocytes and neurons, form synaptic specializations with neurons, express GABA and 
glutamate receptors and can generate action potentials (Fields, 2008; Trotter et al., 2010); 
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their role in normal brain function and their impact on cocaine-related behaviors remain 
unresolved questions.  
Future investigation into the OL-specific protein changes following cocaine will need 
to address whether myelin protein expression is affected in the absence of withdrawal and 
whether these changes persist beyond 30 days. Though I did not see an effect of withdrawal 
on protein expression, which argues against reduced OL-specific protein changes as 
underpinning the “incubation of craving” phenomenon, the persistence of these changes may 
underlie the enduring anomalies of frontal activity observed in chronic cocaine users and the 
propensity for relapse even after substantial periods of abstinence (Bechara & Damasio, 
2002). Moreover, correlational studies examining the impact of cocaine on OL proteins and 
cognitive function (such as that of George et al., 2008) may help define the specific 
behaviors and tests to examine for the functional significance of changes when 
experimentally manipulating single proteins or combinations of proteins within distinct brain 
regions in the future. 
While we examined changes in OL proteins, whose decrease would be hypothesized 
to cause a loss of myelin integrity, there are currently no studies specifically examining for 
general structural changes to myelin following cocaine. The composition of lipids and 
proportion of MBP to lipid content determines the strength of the adhesive properties and 
stability of synthetic membrane preparations (Hu et al., 2004; Min et al., 2009). Moreover, 
animals with complete knockout of PLP, MBP, CNP, and myelin associated glycoprotein 
have regions of loosely stacked and uncompact myelin, reduced spiraling, and distorted and 
inconsistent periodicity (Edgar et al., 2009; Inoue, Nakamura, Mikoshiba, & Tsukada, 1981, 
1982; Uschkureit, Sporkel, Stracke, Bussow, & Stoffel, 2000). Therefore, the fact that long-
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access cocaine self-administration was shown in this dissertation to disrupt the normal levels 
of myelin structural proteins highlights the importance of looking directly at the myelin for 
obvious cocaine-induced abnormalities. Though, MBP only decreased by ~30%, and this is 
not likely to greatly impact the integrity of myelin given even 25% mRNA expression of 
normal is sufficient to produce intermediate levels of myelination, a combination of myelin-
related protein changes may lead to greater structural deficits. These basic characterization 
studies need to be conducted prior to the generation of hypotheses related to the potential 
impact on neuronal signaling efficiency and ultimately the activity of brain regions that affect 
behavioral output. 
The expression levels of proteins OMgp, and PLP have been shown to affect the 
formation of nodes of Ranvier and conduction velocity of nerve impulses (Boiko et al., 2001; 
Nie et al., 2007). It remains to be seen whether a partial loss of protein expression also 
produces deficiencies in neuronal conduction. Though the initial experiments would need to 
be conducted in cell culture preparations, similar LVV microinfusion experiments could be 
used in the future to assess the electrophysiological properties of brain regions connected to 
the LVV transduced structure and examine for alterations in neurotransmission via 
microdialysis procedures. As rats withdrawn from extended cocaine administration produces 
an increased resting membrane potential and lack of the characteristic bistable neuronal 
membrane properties within the mPFC (Trantham et al., 2002), it would be intriguing to see 
if LVV2 infusion into the vmPFC mimicked any of these cocaine-induced properties. 
Changes in basal glutamate and DA tone within structures such as the PFC and NAc may not 
only reflect cocaine-induced alterations in receptor composition, but may also reflect changes 
in the signaling efficiency of afferents. While this is highly speculative, it could be possible 
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that inefficient neuronal conduction due to myelin anomalies may partially underlie 
decreased release of neurotransmitters. To provide preliminary evidence for such a 
mechanism, infusion of LVVs against MBP into the CC (containing a large proportion of 
axonal fibers) may produce a substantial enough decrease in overall myelin integrity to 
examine for changes in the electrophysiological properties of brain regions receiving 
afferents via these tracts and specific changes in neurotransmission by looking at basal 
neurotransmitter tone. Moreover, examining a combination of decreased myelin-specific 
proteins found to decrease following cocaine on these measures might highlight a general 
impact of OLs on brain function as it relates to cocaine addiction. Of course, it would be 
prudent to examine for cocaine-induced changes in myelin-related proteins within the CC 
prior to looking at the general consequences of changing myelin-specific protein expression. 
Specifically decreasing MBP within the vmPFC had few behavioral consequences, 
while this likely reflects a minor contribution of specific MBP decreases on vmPFC function, 
the use of additional behavioral tests may expose further effects. For example, inactivation 
(muscimol) or NMDA receptor antagonism of the IL has been shown to increase impulsive 
action assessed on the 5-CSRTT task revealed by premature and perseverative responding 
and decreased accuracy (Feja & Koch, 2014; Murphy et al., 2005). Moreover, knockout of 
MBP (Shiverer and mld) has been shown to negatively affect reversal learning on the T-maze 
(Inagawa et al., 1988). Therefore, behavioral tasks that examine for deficits in specific brain 
loci versus general PFC dysfunction, may indicate a stronger effect of MBP expression 
changes. 
The small zone of transduction following bilateral infusion of 1 ul/hemisphere into 
the PL, begs the question of whether a larger region of transduced cells would promote more 
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robust behavioral changes. Future studies that systematically test how infusion volume 
influences the extent of transduction, could define an optimal dose to decrease MBP 
throughout the extent of the PL and/or IL. Following, such viral transduction 
characterization, the studies presented herein could be replicated to examine for more 
pronounced effects on impulsive choice and cocaine-paired lever responses during 
acquisition. Defining the appropriate volume of virus to infuse for the size of area targeted, 
would promote a subregional analysis of decreased MBP on behavior that may help in 
elucidating the functional significance of MBP and specific brain loci. 
Conclusion 
 In summary, the data within this dissertation represent an initial investigation into the 
consequences of cocaine on non-neuronal cells and specifically on proteins expressed within 
OLs. The results indicate that cocaine decreases myelin-related proteins within the vmPFC of 
adult male rats undergoing long-access cocaine self-administration and withdrawal 
procedures, although the reliability of these findings need to be replicated in future 
experiments. This dissertation also represents a first query to the functional consequences of 
reduced OL protein expression following cocaine exposure. While specifically decreasing 
MBP within the vmPFC (mainly PL) produced few behavioral consequences, I did show 
enhanced food training and responding during cocaine acquisition and a decrease in 
impulsive choice. Although this work is preliminary, it is expected to inspire future 
investigation into the role nonneuronal cells have on cocaine addiction and as potential 
targets for the generation of therapeutic agents for the prolonged and debilitating 
consequences of chronic cocaine use.	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